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This section provides a medium through which Canadian 
surgeons can declare themselves, briefly and informally, on 
the day-to-day affairs of surgery.
The Broken Hip
“ Breaking a hip” usually refers to frac­
ture of the upper part of the femur 
through the neck or in the region of the 
trochanters. In either location, hip frac­
tures present clinical problems that may 
lead to death or loss of independence for 
an elderly person. Women are particularly 
at risk since they are most affected by 
osteopenia and many of them live alone.
The incidence of hip fractures in North 
America is approximately 5 per 1000 peo­
ple between the ages of 70 and 79 years 
and 20 per 1000 between 80 and 89 years; 
71% of victims are women (mean age 73 
years).1
In a study from the Mayo Clinic,2 
proximal femoral fractures amounted to 
30% of all admissions to hospital for 
fractures and 50% of all days spent in 
hospital for their treatment.
Several publications from Europe have 
suggested that there has been a substan­
tial increase in the incidence of hip frac­
tures.3'5 Melton and colleagues2 on the 
other hand have shown that the increase 
is the result of a larger elderly population. 
When sex- and age-specific tests are 
applied, there does not appear to be a rate 
increase. Any increase in total numbers
of fractured hips does, however, imply a 
need for additional health resources. In 
Scandinavia, the average hospital stay is 
24 days during which the mortality is 
8.6%. The mortality at 1 year is 27%. 
Thereafter, it is similar to that of the nor­
mal population.6
In Canada, the average length of hospi­
tal stay is closer to 12 days but that applies 
only to acute-care hospitals. The in- 
hospital stay would increase if convales­
cent, rehabilitation and chronic-care 
hospital days were included.
Fractures of the femoral neck within 
the capsule of the hip joint (subcapital) 
damage, to a variable extent, the blood 
supply of the femoral head. If the head 
dies, it will collapse between 1 and 2 years 
from the time of fracture. The fracture 
may in the meantime heal, but the head 
becomes deformed and the joint painful 
and stiff. In treating femoral neck frac­
tures, it is most important to reduce the 
fracture as accurately and as soon as pos­
sible if blood flow to the head is to be 
maintained. The reduction must be held 
by internal fixation using a device that can 
adapt to minor shortening of the femoral 
neck as the fracture settles.
Intertrochanteric fractures on the other 
hand do not affect the blood supply to 
the femoral head. They do, however, 
occur at an angular location in the femur 
where there are major bending moments. 
These fractures are unstable — often the 
thin bone in that region of the femur is 
shattered. The fracture usually occurs in 
bones that are moderately or severely 
osteoporotic. Internal fixation is essential 
for treatment.
Zukor and colleagues, in this issue 
(pages 391 to 395), compare two tech­
niques of internal fixation for inter­
trochanteric fractures. There is little to 
choose between them: in one technique, 
the long, curved, steel rods of Ender are 
introduced through a small port in the 
lower inner aspect of the femur just above 
the knee joint. Three to five rods are 
pushed up the medullary cavity of the 
femur until their pre-curved leading upper 
ends are located in the femoral head. The 
advantage of their use is in the small sur­
gical procedure required, using a wound 
remote from the fracture site and the 
patient’s groin. There were no operative 
infections in the reported series of 53 
cases. The other technique involves open
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reduction and internal fixation using a 
compression screw and a sliding, fixed- 
angle nail plate. It is a bigger operation, 
takes longer and, in Zukor’s series, was 
accompanied by infection in seven 
patients (13.7%), two of whom died.
Why not manage all intertrochanteric 
fractures with Ender rods? In fact, in 
Zukor’s series there was a higher inci­
dence of reoperation with Ender’s rods 
due to their migration inside the femur, 
an increased incidence of cardiovascular 
complications and an increased overall 
mortality. Not enough experience has 
been gained to favour one method over 
the other. Close matching of many more 
patient pairs is required to draw reliable 
conclusions.
In the first half of this century and 
before, breaking a hip was often the last 
significant physical act in the lives of the 
elderly. I vividly remember the day
George Bernard Shaw fell from a ladder 
as he pruned an apple tree. His hip broke 
and he died shortly after that. He was one 
of many elderly but otherwise well, think­
ing, productive people for whom, now, 
a broken hip is an unfortunate and pain­
ful incident in life but not necessarily the 
finale. With present techniques, survival 
is usual and return to normal living, 
common.
Two main events have made possible 
this remarkable change: the development 
in 1912 of stainless steel and in 1925 the 
invention of the three-flanged hip nail by 
Smith-Petersen. The quality and proper­
ties of steel have been refined since then. 
The design of the fixation device and the 
surgical procedure have greatly improved. 
With safe anesthesia and bold rehabilita­
tion, the majority of patients no matter 
how old are returned to their preinjury 
state. Patients are out of bed within 48
hours, before bed sores, pneumonia and 
bladder infection develop.
While the treatment of broken hips has 
improved substantially the prospects for 
survival and return to normal living, hip 
fracture is still a dangerous injury. 
Attempts at reducing the frequency of its 
occurrence, often from minor trauma, 
should be directed at the treatment and 
prevention of its underlying cause, 
osteopenia of the ageing population.
Charles Sorbie, mb, ch b, frcs, frcsc
Member,
Editorial Board.
Professor and Head,
Department of Surgery,
Queen’s University,
Kingston, Ont.
K7L 3N6
continued on page 395
SESAP IV Question
ITEM  247
A man sustains blunt chest trauma causing a pneumothorax and multiple rib fractures. After several sequential tube 
thoracostomies, the chest roentgenogram shown above is obtained 15 days later. His temperature is now 39.2 C. He has 
mild pleuritic pain, and the chest tube is no longer draining. The best management would be
(A) a ten-day course of systemic antibiotics
(B) multiple additional chest tubes
(C) thoracotomy and evacuation (decortication) of the pleural cavity
(D) instillation of enzymes via the chest tube
(E) instillation of antibiotics via the chest tube
For the incomplete statement above select the one answer that is best of the five given. For the critique of Item 247 see 
page 458.
(Reproduced by permission from SESAP IV  Syllabus; Surgical Education and Self-Assessment Program No. 4. For enrol­
ment in the Surgical Education and Self-Assessment Program No. 4, please apply to the American College of Surgeons, 
55 East Erie St., Chicago, IL 60611.)
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CORRESPONDENCE
►
*  Contributions to the Correspondence section are welcomed.
^  They should be written and double spaced.
r Penile Dressing After
Hypospadias Surgery
^ To the editors.—A successful result fol­
lowing hypospadias repair, or any penile 
surgery requiring penile skin flaps or skin 
. mobilization, depends on the following 
factors among others:
► ~‘l
• Adequate tissue vascularity.
r • Absence of excessive edema1,2
postoperatively, since its presence may 
enhance thrombosis of the small vessels 
and prevent formation of new vessels to 
y the flap.
. • Absence of hematoma1,2 within the
skin flap.
• Adequate immobilization of the 
penis postoperatively.
^ • Avoidance of excessive pressure on
the tissue due to very tight dressings.
The wide variety of dressings used1'3 
after penile surgery, especially hypospadias 
 ^ repair, suggests the lack of a simple, ade­
quate dressing that will meet most of the
y criteria. We describe a simple, effective
penile dressing for hypospadias repair that 
we believe may be similarly employed in 
other reconstructive penile surgery, par- 
" ticularly to reduce edema, bleeding and 
hematoma.
versely over the suprapubic area behind 
the dorsal aspect of the penis (Fig. 1). The 
Prolene suture is passed through the skin 
of the suprapubic area above the cylinder 
of dressing so that the penis is hyperex- 
tended over the cylinder of the dressing. 
The tension in the Prolene suture can be 
varied to maintain hemostasis.
Comments
The advantages of this simple dressing 
are as follows:
• Postoperative edema is markedly 
reduced, decreasing morbidity and 
enhancing primary healing.
• The penis is adequately immobi­
lized, giving the tissues optimal healing 
conditions.
• Bleeding, especially from the cor­
pora cavernosa, may be further controlled 
by either increasing the bulk of the 
cylinder or the tension on the Prolene 
suture without compromising the surgi­
cal suture lines or the skin flaps.
• Since no part of the wound is occlu- 
sively covered, it is easy for both the med­
ical and nursing staff to examine and 
assess the surgical repair.
• Fecal soiling of the dressing, as may 
occur in children, is completely eradi­
cated.
March 1985, pages 183 to 186), I was 
pleased to read the article by A. Camp­
bell Derby, entitled “ The military 
surgeon—not least in the crusade” .
Regarding the Canadian field surgical 
team in Korea attached to 8055 MASH 
for 90% or more of its tour, Dr. Richard 
Hooker was an American surgeon who 
wrote the book MASH and wrote under 
a pseudonym. His proper name is Richard 
H. Hornberger, and he practises thoracic 
surgery in Maine. I met him in Toronto 
at the Mount Sinai Hospital, several years 
after working with him and other sur­
geons at MASH 8055. The 25th Canadian 
field surgical team serving in Korea was 
commended by General James van Fleet 
during its tour of duty there, thus:
Van Fleet wrote that the Canadian unit, 
which had augmented the surgical section of 
an American army mobile from May to 
August, “ showed resourcefulness and initia­
tive in integrating themselves into the hospi­
tal, working tirelessly for extremely long hours 
in order that the wounded might receive 
prompt care” .
Attention was given to medical officers 
Major Charles Egan of Kingston, Major G.G. 
Lippert of Kitchener and Captain William 
Crawford of London, Ontario, and also to the 
enlisted men of the unit.1
G.G . L ip p e r t , m d , cm , frcsc, facs
 ^ Technique
Early in the operation, a 2-0 Prolene
suture is inserted through the glans penis, 
» with the needle left on; it is used for 
retraction of the penis. At the end of the
* surgical procedure, three to four plain
gauze dressings are tightly rolled into a 
r  cylinder. The cylinder is placed trans-
FIG. 1—Penis hyperextended over cylinder 
of gauze dressings with suture through supra­
pubic area.
Penile erections, when they occur with
this dressing, may be slightly painful but
are not a serious problem.
Benjamin  A. Okafo , md
H . G. Kiruluta , m d , frcsc
Health Sciences Centre,
Memorial University of Newfoundland,
St. John’s, Nfld.
A1B 3V6
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The Military Surgeon
To the editors.—In a recent issue (vol. 28,
Ste. 305,
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Transluminal Angioplasty in 
Peripheral Vascular Disease
To the editors.—We have read Sheiner’s 
editorial (Can J  Surg 1985; 28: 193-4), 
commenting on our article on translumi­
nal angioplasty for advanced peripheral 
vascular disease (Can J  Surg 1985; 28: 
150-2). First, we do not calculate our ini­
tial success rate to be 41%; 70% of
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patients had a lessening of symptoms or 
return of previously absent pulses, or 
both, after dilatation. Repeat angioplasty 
was performed in nine patients, but the 
interval between first and second 
angioplasty ranged from 2 to 51 months.
Whether the success rate is 41% or 
70%, the important issue raised in our 
article is that dilatation can be successful 
in many of these high-risk patients with 
advanced peripheral vascular disease 
using percutaneous translum inal 
angioplasty. Morbidity and mortality are 
low and surgery remains an option.
Robert Maggisano, md, frcsc 
Beverly A. Jones, md, frcsc 
Eric Saibil, md, frcpc
Sunnybrook Medical Centre,
2075 Bayview Ave.,
Toronto, Ont.
M4N 3M5
Splenectomy for Idiopathic 
Thrombocytopenic Purpura
To the editors.—The report by Roy, For­
tin and Leblond on splenectomy for idi­
opathic thrombocytopenic purpura (Can 
JSurg 1985; 28; 160-2) appears to present 
a skewed view of pulmonary complica­
tions following this procedure. They 
report an incidence of 66% for those who 
had the splenic bed drained versus 20% 
for those who did not; the overall pulmo­
nary complication rate was 27.5%. A 
review of complications in a similar group 
of adult patients with steroid-resistant idi­
opathic thrombocytopenic purpura in our 
hospital revealed only one pulmonary 
complication in 24 cases (4%), in a patient 
not having drainage postoperatively. I 
agree that morbidity is increased substan­
tially with drainage of the splenic bed; 5 of 
9 patients drained (56%) had a postoper­
ative complication, while only the pulmo­
nary complication was noted in the 15 
patients not drained (7%). The compli­
cations in our series were deep venous 
thrombosis, subphrenic abscess, upper 
gastrointestinal bleeding and wound 
infection.
Roy and colleagues mention two 
studies1,2 in which the pulmonary com­
plication rate was 5.8% and 4.4%; these 
figures appear more accurate for this 
complication. The incidence of pulmo­
nary complications is increased following
removal of greatly enlarged spleens, as 
might be expected. Effusion and atelec­
tasis have an incidence of 38% and 
21 %3 respectively while there is no 
increase in the risk of pneumonia.4
It would be interesting to know, in 
Roy’s study, the breakdown of pulmo­
nary complications and whether spleno­
megaly might have affected their pulmo­
nary complication rate. This may well be 
a more important factor in creating this 
complication than the presence or absence 
of a drain.
Timothy Wesley-James, md
Resident in Urology,
Ottawa Civic Hospital,
1053 Carling Ave.,
Ottawa, Ont.
K1Y 4E9
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rSURGEONS’ UPDATE
What's new in surgery is the subject of this column. The short items are designed to let readers know 
who's doing what and why. Surgeons are interested in what other surgeons are doing in 
research, education, practice and administration. Surgery is a vibrant specialty, and, as 
its practitioners, you must be the source as well as the readers of this column.
y
*■
►
y
y
Canada Health Act Court Action
Whether or not the legal representatives 
of the Canadian Medical Association 
enter a courtroom this month to argue 
with their counterparts who are acting on 
behalf of the federal government and the 
Province of Ontario about the constitu­
tionality of the Canada Health Act and 
of the province’s compliance, new CMA 
president, general surgeon William J. 
Vail, of Newmarket, Ontario, says he’s 
not holding his breath about a final 
decision.
In an interview with CJS, Vail declined 
to speculate on the implications of win­
ning or losing the historic argument with 
government, but he alluded to the ration­
ale behind the CMA’s action, citing as 
one of the priorities during his term of 
office “ to ensure or try to ensure that the 
interests of the members of the profession 
are protected,” particularly when “ gov­
ernments at whatever level interfere with 
the doctor-patient relationship” .
In mid-July, the CMA challenged the 
federal government’s authority to dictate 
how the provinces must run health insur­
ance programs if they want to draw on 
federal coffers for part of the costs of care 
and alleged that the conditions governing 
the cost-sharing arrangements were incon­
sistent with the Canadian Charter of 
Rights and Freedoms. The Association 
filed a statement of claim in the Supreme 
Court of Ontario that Ontario — in com­
plying with the Canada Health Act — was 
impinging on the personal rights of Dr. 
James McPhee and Ruby Evelyn Kelley. 
On the one hand, the province requires 
Ms. Kelley to be a member of the health 
insurance plan and, on the other, refuses 
to reimburse her for the costs of health
Contributions to this column are welcome. 
Please send your material to: Mrs. Amy 
Chouinard, Canadian Journal o f Surgery, PO 
Box 8650, Ottawa, Ont. K1G 0G8.
care from McPhee, even though the serv­
ices are insured under the plan and 
McPhee is a qualified medical practitioner 
as defined by the Canada Health Act.
Vail took office just days after 
Canada’s attorney general denied allega­
tions, maintaining that any infringement 
was within justifiable limits.
Said Vail, “ The subject matter is basi­
cally out of our hands now as far as mak­
ing any influence. We’ve made our deci­
sions and the matter is now a judiciary 
type of process.”
Out of the Association’s hands, per­
haps, but not far from its thoughts, as 
Vail’s list of priorities showed. During his 
presidency Vail aims to deal with the 
issues surrounding the numbers of phy­
sicians in Canada and to continue to let 
the public know that health services are 
not being adequately funded.
While none of Vail’s priorities promises 
to be free of controversy, he is reasona­
bly comfortable with medical politics. He 
has been a long-time member of , the 
Ontario Medical Association, has held a 
variety of offices for the provincial body 
since the mid-1960s and chaired the board 
of directors of the national association 
from 1981 to 1983.
CMA Secretariat to 
Investigate Organ Shortage
Over the next year, the secretariat of 
the Canadian Medical Association will be 
collecting statistics on the numbers of 
people who are awaiting organs for trans­
plantation and will be investigating ethi­
cal means of alleviating any shortage.
The CMA’s Committee on Ethics has 
reported that “ there is a recurrent, 
though implicit, criticism of physicians
CMA President William Vail
for failing to persuade relatives to autho­
rize the removal of healthy organs from 
recent victims of sudden and/or acciden­
tal d e a th ,”  and tha t “ when the 
patient/victim has already manifested his 
(or her) consent, such as by signing the 
appropriate portion of his (or her) 
driver’s licence or some other consent 
form, no other consent is legally 
required.”
Between the lines in the committee’s 
report was the space separating first- 
contact physicians from  surgical 
specialists on the issue. CMA President 
Bill Vail as chief of surgery and, since 
1963, consulting surgeon for York 
County Hospital, acknowledged the 
dilemma of needing vital organs to save 
lives and of asking a bereaved family for 
organs from an individual who, though 
clinically dead, is still alive to them. “ I 
think it’s a matter of public relations — 
in other words, getting you and me as 
members of the public to know that such 
situations take place so that when it does 
happen to us we are better prepared to 
deal with it. My experience is that most 
people — most next of kin — are amena-
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ble but I have encountered next of kin 
who are not and they have their own good 
private reasons.”
Dr. Wilbert J. Keon, director general 
of the University of Ottawa Heart Insti­
tute, agrees but is keenly aware of the res­
trictions engendered by a shortage of 
healthy organs. Said Keon, in an inter­
view with CJS, “ The major problem is 
the reluctance of physicians, out of 
respect to the grieving family, but there 
is nobody who can do this as effectively 
as the family physicians. There is an obli­
gation on the part of all medical practi­
tioners to see that healthy organs are not 
wasted, given the tremendous success of 
kidney transplant programs and, to a 
lesser degree, heart and liver transplants. 
Our own experience in heart transplan­
tation is a good example. We have done 
six transplants successfully, and 24 
patients expired while on the transplant 
list. The experience is universal. Vital 
young people are expiring from single 
organ disease. One week we had an 
18-year-old and a 22-year-old girl expire 
just because they needed a heart. This is 
tragic.” Currently, the institute has eight 
patients who will die without a new heart 
— two are too sick to leave hospital.
A look at five healthy people who 
received another heart to live through 
Keon’s hands clarifies the frustration of 
knowing that healthy organs are on their 
way to the grave. At the end of next 
m onth , the third recipient, Clive 
Devereaux, will have survived a year.
A new organization that may be able 
to play the public relations role envisioned 
by Vail is called Transplant International.
Launched on July 18 at University Hospi­
tal in London, Ontario, the organization 
was the brainchild of Nephrology and 
Transplant Division chief Calvin Stiller 
and Bill Brady of CFPL radio. The group 
will attempt to familiarize people with the 
concept of being a donor and perhaps 
encourage them to decide for themselves 
rather than put the onus on their family 
at the time of an accident. Anne Lake, 
the executive coordinator, said that a 
brochure about the group and a donor 
card that will satisfy the requirements in 
all the provinces (currently, the consent 
forms on driver’s licences are not univer­
sally accepted) will be available. Before 
joining Transplant International, Lake 
worked at a transplantation centre in 
Toronto. She commented that more than 
80% of people say they would donate a 
family member’s organs compared with 
about 60% who would donate their own. 
She said families often called the centre 
after losing a loved one in an accident say­
ing, “ I found the consent form on the 
driver’s licence when I got home. Is it too 
late to use the organs?” She maintained 
that many people have signed the consent 
forms but not many medical or surgical 
staff are searching for the forms in emer­
gency rooms. She said the organization 
will be attempting to reach the public 
through rotary clubs and other local 
groups. It will also be publishing a news­
letter, “ Transplant Lifeline” , that will 
focus on the successes in transplantation 
as well as encourage people not only to 
donate but to let their relatives know their 
wishes. Obviously, the more people who 
make their consent known, the fewer the
Party celebrated first anniversary of Ottawa’s second heart transplant recipient, Daniel Galon 
(third from left). Others attending party were, from left, Mila Galon (Daniel’s mother), Jean- 
Guy Villeneuve (heart recipient, first anniversary, May 29), Clive Devereaux and Neil Showell 
(heart recipients) and Ross Davies (cardiologist assisting Keon). In front are Cecile Michaelson 
(most recent heart recipient) and W .J. Keon.
physicians who will be caught between 
their colleagues and their patients’ fami­
lies, dodging the label of callousness.
Manitoba University Head 
of Surgery Steps Down
After 12 years as head of the Depart­
ment of Surgery at the University of 
Manitoba, Allan R. Downs, FRCSC, is 
embarking on a year of academic leave 
to pursue research on vascular grafts.
For the next 6 months he will be work­
ing with Drs. Jean G. Couture and 
Robert Guidoin at Laval University, 
focusing on late complications. He then 
will spend 3 months at New England Med­
ical Center, Tufts University, Boston, fol­
lowed by a stint at St. Mary’s Hospital 
in London, England, where he did some 
of his postgraduate training. He plans to 
observe and update his knowledge on the 
investigation and treatment of vascular 
diseases.
Leaving his position as surgeon in chief 
at University Hospital, he began his sab­
batical immediately, settling into Quebec 
City by mid-July.
Early this month he was part of the 
faculty providing a course on peripheral 
vascular surgery at the annual scientific 
meeting of the Royal College of Physi­
cians and Surgeons of Canada held in 
Vancouver, contributing an overview of 
aortoiliac occlusive disease.
A westerner born in Saskatchewan, 
Downs joined the University of Manitoba 
first as an undergraduate, receiving his 
medical degree there; after completing the 
McLaughlin travelling fellowship and 
study abroad, he returned in 1960 as a 
faculty member. Besides distinguishing
continued on page 458
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Hip Pinning, Past and Present: Richards’ Compression- 
Screw Fixation Versus Ender’s Nailing
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The authors trace the operative treat­
ment of intertrochanteric hip fractures 
from the earliest to the most modern 
methods and describe how current fixa­
tion devices evolved. The operative and 
perioperative morbidity, mortality and 
outcome in 57 patients treated by 
Ender's nailing were compared with 
those of 51 patients treated by Richards' 
compression-screw fixation. Results 
were comparable to those found in an 
extensive review of the literature except 
for a higher mortality in the group 
managed by Ender's nailing. The authors 
conclude that both methods of treatment 
are acceptable and that the ultimate 
choice of fixation device should be based 
on the surgeon's experience tailored to 
the individual patient's needs.
Les auteurs font I'historique du traite- 
ment chirurgical des fractures intertro- 
chanterienne de la hanche, depuis les 
methodes les plus anciennes jusqu'aux 
plus nouvelles, et ils decrivent revolution 
des presents dispositifs de fixation. Les 
resultats de meme que la morbidity et la 
mortalite operatoires et peroperatoires 
notes chez 57 patients traites par 
enclouage de Ender ont ete compares 
avec ceux de 51 patients traites par fixa­
tion a I'aide de vis de compression de 
Richards. Les resultats obtenus etaient 
comparables a ceux releves dans une 
vaste revue de la litterature, sauf pour 
un taux de mortalite plus dleve dans le 
groupe traite par enclouage de Ender.
Les auteurs concluent que les deux 
modes therapeutiques sont acceptables 
et que le choix definitif du dispositif de 
fixation doit reposer sur I'experience du
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chirurgien par rapport aux besoins indivi- 
duels des patients.
Hip fractures are a serious problem, tak­
ing up ever-increasing amounts of health­
care dollars.1'3 Up to 20% of orthopedic 
beds are occupied by patients with hip 
fractures and a recent study estimated the 
annual cost of treatment in the United 
States to be $1 billion.4 The morbidity 
associated with this fracture is incalcula­
ble and the mortality in the first 4 to 6 
months after operation is reported to be 
12% to 15%.5-7 Intertrochanteric frac­
tures occur most commonly in post­
menopausal, osteoporotic women, due to 
low-energy injuries such as falling.
Early operation is universally accepted 
as the treatment of choice of these frac­
tures, in order to avoid the complications 
of prolonged bed rest (up to 3 months) 
that would otherwise be necessary.8 
Ironically, it is considered that the need 
for surgery is inversely proportional to the 
general medical condition of these usually 
frail, elderly patients, and that surgery 
should not be delayed longer than 24 to 
48 hours.9
Historical Perspective10
The technique and internal fixation 
devices used to manage intertrochanteric 
fractures have evolved from a crude to a 
sophisticated level, since Von Langen- 
beck11 first reported the use of a nail to 
fix a fractured hip in 1878. Senn,12 in 
1881, was the first to use a screw, but 
treatment at that time usually consisted 
of a body cast, because of the increased 
dangers of infection and of corrosion or 
breakage of the implant.
Smith-Petersen’s13 contributions sub­
stantially changed the management of 
intertrochanteric fractures. His incision 
was refined, making exposure of the frac­
ture site a matter of careful anatomic dis­
section and his tri-flanged nail (Fig. 1), 
used initially in 1925, was the first implant 
expressly designed for the fixation of hip
fractures. Johanson,14 in the hope of 
reducing avascular necrosis and nonun­
ion, pioneered a technique of closed 
reduction and blind insertion of the fixa­
tion device.
The tri-flanged nail remained in use for 
almost 50 years but, although it was an 
excellent device, it alone was not enough 
to control rotation adequately or prevent 
the tendency of the femoral head to drift 
into varus. Also, it tended to “ back out” 
of the bone with subsequent loss of fixa­
tion. Thus, Preston introduced a side
FIG. 1—Tri-flanged nail.
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plate to overcome these difficulties.10 
However, this required bending the device 
to fit the shaft of the femur. Thornton’s 
plate (Fig. 2) was the first attachable to 
the Smith-Petersen nail and McLaughlin’s 
nail-plate (Fig. 3) eliminated the need for 
bending because of its variable-angle 
design.
Another device in use was the one-piece 
nail designed by Jewett in 1941 (Fig. 
4 ).15 This became the most popular 
method of fixing these fractures for 
nearly 30 years. Then, in 1964, 
Clawson16 reported his experience with a 
new and innovative device, the compres­
sion screw and side-plate combination, 
produced by the Richards Manufacturing 
Company of Memphis, Tenn. (Fig. 5). 
This versatile, high-strength system 
allowed compression of the fracture site 
at operation, as well as gradual impaction 
of the fragments with weight bearing. 
Acting as an internal splint, it sufficiently 
stabilized the femur to allow early ambu­
lation of the patient, which is precisely the 
goal of treatment. With these important 
advantages, the Richards compression 
system rapidly gained widespread accep­
tance and remains the current standard 
of treatment for intertrochanteric frac­
tures in most North American hospitals.
Recently, a “ challenger” , the con-
FIG. 2—Nail-plate combination with fixed 
angle.
dylocephalic nail, has gained popularity 
in North America (and is already widely 
used in Europe). Lezius17 in 1950 was the 
first to promote the idea of fixing frac­
tures of the trochanteric region by 
introducing a curved nail from the distal 
femur. The operative technique is simple, 
involving minimal exposure of the femur 
medially, just proximal to the knee. A 
small cortical window is made and three 
to five flexible metal rods are introduced 
into the region of the femoral head, 
thereby maintaining and sometimes even 
improving on a previously performed 
closed reduction. No incision is required 
in the region of the fracture. Kiintscher18 
in 1967 and Harris19 in 1973 introduced 
a single semi-rigid nail for this purpose. 
In 1970, Ender and Simon-Weidner 
described multiple, flexible pins20 (Fig. 
6). The intramedullary position of the 
implant allows it to be more medial and 
therefore closer to the compression side 
of the femur. This provides a biomechan­
ical advantage as the result is a decreased 
bending moment of the fixation 
device.21’22 Also, “ dynamic controlled 
motion” occurs; this concept, put forth 
by Pankovich and Tarabishy,23 describes 
the favourable amount of motion of the 
fracture fragments that promotes healing. 
The net result is early weight bearing for 
the patient after a simpler, smaller, oper­
ative procedure.24
FIG. 3—Variable-angle nail-plate combi­
nation.
Both Richards’ compression-screw fix­
ation and Ender’s nailing procedures 
allow early mobilization of the patient. 
Ender’s nailing is a smaller procedure, 
remote from the fracture site and claims 
lesser operative morbidity. This attractive 
advantage stimulated us to carry out a 
retrospective review and comparison of 
two similar groups of patients who had 
undergone either Richards’ compression- 
screw fixation or Ender’s nailing for inter­
trochanteric hip fractures.
Patients and Methods
Between January 1980 and August 
1982, 58 Ender’s nailings were performed 
in 57 patients with intertrochanteric frac­
tures (group 1). This group was compared 
to a group of 51 patients with similar frac­
tures treated by compression-screw fixa­
tion between February 1977 and Novem­
ber 1979 (group 2).
Data were obtained from review of the 
patients’ charts and roentgenograms with 
a follow-up of at least 6 months for all 
patients. All pathologic fractures were 
excluded. Fractures were classified and 
matched according to Tronzo’s classifi­
cation of intertrochanteric fractures.25
Variables examined included age, sex, 
volume of blood lost and transfused,
FIG. 4—One piece nail-plate combination.
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duration of operation and anesthesia, 
time to weight bearing, morbidity, mor­
tality and roentgenographic findings at 
follow-up.
Findings
Fifty-three patients in the Ender’s nail­
ing group (group 1) and 51 patients in the 
Richards’ compression-screw group 
(group 2) were available for study. The 
mean ages for the two groups were 80.2 
and 80.0 years respectively. There were 
slightly more men in group 2 (Table I).
The duration of both operation and 
anesthesia was less in group 1 and the 
amounts of blood lost and transfused 
were approximately half in this group. 
Group 1 patients were able to weight bear 
in similar to slightly less time than group 
2 patients (Table I).
Complications
There was only one intraoperative com­
plication, a supracondylar fracture of the 
femur in a patient who underwent 
Ender’s nailing.
FIG. 5—(Left) Richards’ compression screw, showing individual components: threaded 
lag screw, side plate with barrel, compression screw. (Right) Device assembled.
T a b le  1 - F a c t o r s  C o m p a re d
G r o u p  1 G ro u p  2
F a c t o r (n  =  5 3 ) (n -  5 1 )
A g e , y r
M e a n 8 0 .2 8 0 .0
R a n g e 5 2 - 9 6 5 1 - 9 5
M a le , n o . (% ) 8 (1 5 .1 ) 11 (2 1 .6 )
F e m a le , n o . (% ) 4 5  (8 4 .9 ) 4 0  (7 8 .4 )
D u r a t io n  (m in ) o f
o p e r a t io n ,  m e a n  (ra n g e ) 5 5  ( 3 3 - 1 4 5 ) 81 ( 4 0 - 1 8 5 )
a n e s t h e s ia ,  m e a n  (ra n g e ) 1 0 2  ( 6 3 - 2 2 5 ) 1 2 3  ( 7 5 - 2 4 5 )
A m o u n t  (m L ) o f  b lo o d
lo s t ,  m e a n  (ra n g e ) 2 3 3  ( 1 0 0 - 5 0 0 ) 4 5 3  (1 0 0 - 1 5 0 0 )
t r a n s f u s e d ,  m e a n  (ra n g e ) 24 1 ( 0 - 7 5 0 ) 4 8 0  ( 0 - 1 7 5 0 )
T i m e  (d) t o  w e ig h t
b e a r in g ,  m e a n  (r a n g e ) 5 ( 1 - 1 1 ) 7 ( 1 - 9 2 )
Postoperatively, there was a difference 
in the infection rate, 13.7% in group 2 
compared with 0% in group 1. There 
were slightly more cardiovascular compli­
cations in the Ender’s nailing group but 
a similar incidence of other postoperative 
problems (Table II).
The number of deaths was somewhat 
higher in group 1, especially those due to 
cardiovascular disorders (Table III).
Technical failures again were slightly 
more frequent in the Ender’s nailing 
group, particularly those due to varus 
deformity and shortening, but there were 
no instances of nonunion or implant 
failure in this group (Table IV).
Discussion
A review of the literature21"24,26’32 rev­
ealed that intertrochanteric fractures fixed 
with Ender’s nails are generally associated 
with minimal blood loss, a low postoper­
ative complication rate and a low mor­
tality. An increased incidence of external 
rotation deformity has been reported with 
Ender’s nails but this is not important 
clinically in elderly patients.23 On the
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Table II—Postoperative Complications
Group 1, no. (%) Group 2, no. (%)
Complication (n -  53) (n = 51)
Infectious
Superficial
Deep
0
0
5 ](1 3 .7 )
Cardiovascular 8 (15.1) 5 (9.8)
Pulmonary 2 (3.8) 2 (3.9)
Thromboembolic 4  (7.5) 5 (9.8)
Gastrointestinal 1 (1.9) 3 (5.9)
Genitourinary 5 (9.4) 7 (13.7)
M iscellaneous 5 (9.4) 2 (3.9)
Table I ll-C a u se s  of Death
Group 1, no. (%) Group 2, no. (%)
Cause of death (n -  53) (n = 51)
Sepsis 0 2 (3.9)
Cardiovascular disorders 4 (7.5) 1 (2.0)
Pneumonia 1 (1.9) 0
Cerebrovascular accident 1 11.9) 0
Chronic lymphocytic leukemia 1 (1.9) 0
Tota ls 7 (13.2) 3 (5.9)
Table IV—Technical Failures
Group 1, no. (%) Group 2, no. (%)
Cause (n -  53) (n = 51)
Nonunion 0 1 (2.0)
Proximal migration 1 (1.9) 1 (2.0)
Implant failure 0 1 (2.0)
Varus and shortening 7 (13.9) 2 (3.9)
Tota ls 8 (15.1) 5 (9.8)
other hand, an increased incidence of 
reoperation after Ender’s nailing is 
reported, due to migration of pins and 
knee pain. Our study confirmed most of 
these findings. In addition, we found a 
slightly increased incidence of cardiovas­
cular complications and a higher mortal­
ity than in the group managed by 
Richards’ compression-screw fixation, 
but this might have resulted from patient 
selection as some of the surgeons in the 
study may have chosen the lesser opera­
tion for the higher-risk patients.
In considering the technical complica­
tions encountered with Ender’s nailing, 
we note that no surgeon had had previ­
ous experience with this technique. Com­
plications were highest early in the series 
and diminished as each surgeon’s 
experience with the procedure increased. 
In contrast, all surgeons had had con­
siderable experience with the com­
pression-screw method.
Conclusions
Modern technology has provided 
today’s orthopedic surgeon with a wide 
choice of excellent internal fixation 
devices. Both Ender’s condylocephalic 
nail and Richard’s compression screw 
achieve the goals of surgical stabilization 
of the fracture and early mobilization of 
the patient. On the basis of this study and 
a review of the literature, no clear-cut 
superiority of one method over the other 
could be demonstrated (Fig. 7). Ulti­
mately, the method of treatment chosen 
should be based on the surgeon’s 
experience, in conjunction with the needs 
of the individual patient.
i
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Ectopic pregnancy is no longer depen­
dent on laparotomy for definitive diagno­
sis. When patients present with massive 
hemoperitoneum, the diagnosis is usually 
obvious; but most patients do not 
present this way, so diagnostic aids are 
required. Culdocentesis is associated 
with unusually high false-negative and 
false-positive results. Laparoscopy is 
accurate but is an invasive procedure 
unwarranted in most cases for diagnosis. 
Although it is unusual to make the diag­
nosis of unruptured ectopic pregnancy 
by ultrasonography alone, when 
ultrasonography is combined with quan­
titative beta-subunit determinations of 
human chorionic gonadotropin, many 
ectopic pregnancies can be diagnosed 
before rupture occurs. The treatment of 
the woman with a ruptured ectopic preg­
nancy and in shock is immediate 
laparotomy and salpingectomy. Salpin­
gostomy with removal of the ectopic 
mass and preservation of the tube may 
enhance a patient’s subsequent fertility 
and may be useful in carefully selected 
women.
De nos jours, le diagnostic d§finitif de 
grossesse ectopique ne depend plus de 
la laparotomie. Quand une patiente pre- 
sente un hemoperitoine massif, le 
diagnostic, habituellement, ne fait pas de 
doute. Toutefois, la plupart des patientes 
n'arrivent pas dans cet etat, d'ou la 
n£cessite de disposer d'aides diagnosti- 
ques. La ponction du cul-de-sac de 
Douglas donne un nombre anormalement 
eleve de faux n6gatifs et de faux posl- 
tifs. La laparoscopie est exacte mais il
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Ectopic Pregnancy
s'agit d'une intervention invasive, non 
justifiee a des fins diagnostiques la plu­
part du temps. Bien qu'il soit inhabituel 
d'etablir un diagnostic de grossesse 
ectopique non ruptur6e par echographie 
ultrasonique seulement, plusieurs gros- 
sesses ectopiques peuvent etre diagnos- 
tiquees avant rupture quand on associe 
echographie ultrasonique et determina­
tion quantitative des sous-unites beta de 
la gonadotrophine chorionique humaine. 
Le traitement d'une grossesse ectopique 
rupturee avec choc necessite une laparo­
tomie immediate et une salpingectomie. 
Dans certains cas bien choisis, une sal- 
pingostomie avec interruption de la gros­
sesse ectopique et conservation de la 
trompe peut ameiiorer les chances de la 
patiente de redevenir enceinte.
One hundred years ago, Tait1 first 
described the operative treatment of five 
women who had ruptured ectopic preg­
nancies. A difficult, cantankerous gyne­
cologist from the English Midlands, Tait 
described both the diagnosis and treat­
ment of this condition. He commented on 
the diagnosis in these trenchant words; 
“ Only a fool would await the diagnosis 
with certainty” and he advised early 
laparotomy and excision of the uterine 
appendage. In the succeeding 80 years, 
diagnosis and therapy have remained 
essentially unchanged. During the course 
of this essay, I shall describe the use of 
new diagnostic aids that permit diagno­
sis early in the development of the con­
dition before rupture occurs. I shall 
describe the diagnosis, which does not 
require recourse to laparotomy. With 
early diagnosis, surgery that conserves 
rather than removes the fallopian tube 
becomes an option. As this article will 
make clear, there has been notable 
progress in the treatment of ectopic preg­
nancies.
Diagnosis
The most dramatic clinical picture seen
on gynecologic wards is that of a patient 
with a massive hemoperitoneum due to 
a ruptured ectopic pregnancy. The 
patient, who is in her reproductive years, 
presents in shock with a history of 
abdominal pain and menstrual upset. The 
diagnosis is clearly that of a ruptured 
ectopic pregnancy; laparotomy to control 
the hemorrhage must be undertaken 
immediately. The need for immediate sur­
gery without delay or attempt at labora­
tory confirmation cannot be overstated.
However, in developed countries the 
majority of ectopic pregnancies do not 
present in this fashion; in the absence of 
rupture, diagnosis is much more difficult. 
The symptoms of pelvic pain and men­
strual irregularity are nonspecific and the 
principal physical finding of a pelvic mass 
is often absent. Unruptured ectopic preg­
nancies will be diagnosed only when 
sought, and suspicion alone is not suffi­
cient for definitive diagnosis. Clinically, 
such disparate conditions as threatened 
abortion, pelvic inflammatory disease, 
endometriosis and a variety of medical 
and surgical conditions mimic ectopic 
pregnancy.
Since clinical methods alone are 
unreliable in diagnosing this condition 
with accuracy, ancillary diagnostic aids 
are required. The measure of the effi­
ciency of these aids is their ability to diag­
nose an ectopic pregnancy before rupture 
occurs and without operative inter­
vention.
Culdocentesis, a technique that in­
volves the insertion of a reasonably wide- 
bore needle into the cul-de-sac, has been 
used for many years to assist in diagno­
sis. However, culdocentesis has fallen into 
disrepute. Those who oppose the proce­
dure believe that the high false-positive 
rate (26%) and the frequent absence of 
blood in the cul-de-sac when the ectopic 
pregnancy has not ruptured (35%) make 
the test so unreliable that management is 
rarely augmented by the findings of the 
culdocentesis.2,3 On the other hand, 
those who do use the procedure point out 
that the test can be done quickly and with
VOLUME 28, NO. 5, SEPTEMBER 1985 /  THE CANADIAN JOURNAL OF SURGERY 397
little discomfort, and thus eliminates the 
delay and expense of further investiga­
tion. Although recent literature supports 
its continued use, the procedure is seldom 
performed in our clinic.4
Laparoscopy has been suggested as a 
screening device when the presence of an 
ectopic pregnancy is suspected.5 There is 
no question that laparoscopy can provide 
accurate diagnosis of various pelvic dis­
orders. Furthermore, its increased use is 
associated with the ability to diagnose an 
increasingly large number of ectopic preg­
nancies before rupture.6 In spite of its 
undoubted accuracy, the use of the 
laparoscope as a screening device is ques­
tioned. Even when its use is limited to 
patients whose positive pregnancy tests 
make them suspect, nearly one out of 
every three women will be found to have 
no ectopic pregnancy.7 The risk and 
expense of a frequently unnecessary oper­
ative procedure are such that its 
indiscriminate use for this purpose can­
not be recommended. This view must be 
balanced by the recognition that, when 
the diagnosis is in doubt, laparoscopy will 
ease the mind of both the physician and 
the patient.
In the past few years a laboratory test 
(beta-subunit pregnancy test) and an 
echographic technique (pelvic ultrasono­
graphy) have radically changed our diag­
nostic approach to these patients. The 
beta-subunit pregnancy test is a new and 
remarkably sensitive pregnancy test.8 It 
permits the physician to diagnose preg­
nancy within 9 days of conception. A 
negative test rules out the possibility of 
pregnancy of any sort. This degree of cer­
tainty is in contrast to former pregnancy 
test results, including hemagglutination 
tests, which all too often gave negative 
findings when the patient did in fact have 
an ectopic pregnancy. Human chorionic 
gonadotropin (HCG) (secreted by placen­
tal tissue) consists of an alpha and beta 
portion. The alpha portion is common to 
the glycoprotein hormones, follicle 
stimulating hormone, luteinizing hor­
mone and thyroid stimulating hormone, 
secreted by the anterior pituitary, whereas 
the beta portion is specific to placental 
chorionic gonadotropin. Commercial 
radioimmunoassay kits are now available 
that permit such diagnosis within an 
hour.9 Furthermore, it is now possible 
not only to give a qualitative determina­
tion of the presence of /3-HCG but also 
to determine quantitatively the precise 
concentration of /3-HCG in the blood. In 
effect, we can now predict the length of 
gestation from such blood concentra­
tions. Furthermore, the increasing con­
centration of /3-HCG in early pregnancy 
can now be determined. The rate of 
increasing concentration of /3-HCG in the 
circulation is found to vary both with the 
implantation site and the viability of the 
pregnancy. When implantation is in the
uterine cavity and the pregnancy is nor­
mal, the /3-HCG level increases by 100% 
within 2 days.10 The lower limit of a nor­
mal rise is 65%, but in the presence of 
ectopic pregnancy, the rise is less than 
60% (this is true in 87% of the cases). The 
subnormal production of (3-HCG in ec­
topic pregnancy is thought to be the result 
of reduced blood supply to the conceptus. 
Reduced /3-HCG secretion may also result 
from an abnormal pregnancy with a dead 
or dying trophoblast in a normal intra­
uterine location, as happens in threatened 
or missed abortion; these conditions are 
the most common cause of a falling /3- 
HCG level.
Diagnostic ultrasonography is also 
most useful in further delineating this vex­
ing clinical problem. There is no question 
this method can rule out ectopic preg­
nancy by demonstrating that the preg­
nancy is intrauterine. In this case, the 
diagnosis of pregnancy is made by visuali­
zation of the fetus itself or, at an earlier 
stage, the fetal amniotic sac. Although the 
visualization of the fetus is a definitive 
sign, there may be some confusion about 
the diagnosis of an amniotic sac. In some 
ectopic pregnancies (20%) the ultrasonic 
picture of the uterine cavity resembles the 
picture seen in an early pregnancy.11,12 
The usefulness of ultrasonography is fur­
ther limited because most patients with 
ectopic pregnancy present early in preg­
nancy and are often seen before the sac 
or the fetus would be expected to develop. 
In such instances, ultrasonography is not 
helpful. When negative findings are used 
as the sole indication for diagnostic 
laparoscopy, an unacceptably high false­
positive rate (19%) results.7,13
These difficulties can be overcome and 
the usefulness of ultrasonography greatly 
increased if the findings on ultrasono­
graphy are linked directly to the quantita­
tive level of /3-HCG. It has been demon­
strated that a normal intrauterine 
pregnancy can be detected by ultrasono­
graphy when the /3-HCG concentration is 
greater than 6000 IU /L .10,12 This in­
formation can be extrapolated further. 
If the /3-HCG is over 6000 IU /L and 
no intrauterine sac can be seen, then an 
ectopic pregnancy is likely. On the other 
hand, if the /3-HCG level is less than 6000 
IU/L and ultrasonography identifies 
a sac, the combination would suggest that 
the pregnancy is a threatened or missed 
abortion. Although this information is 
useful, the number of cases where it can 
initially supply the diagnosis is limited by 
the fact that ectopic pregnancies normally 
present with /3-HCG levels that are less 
than 6000 IU /L.4
With the above information in mind, 
the following approach to the diagnosis 
of ectopic pregnancy is suggested (Fig. 1).
• Is the patient hemodynamically sta­
ble? If the patient is unstable and if the 
clinical diagnosis is that of a ruptured
ectopic pregnancy, then laparotomy 
should be undertaken. Physicians need no 
reminder that young women tolerate 
blood loss extremely well and the first and 
possibly the only sign of vascular insta­
bility is tachycardia.
• In all other cases, if the diagnosis is 
so uncertain that laparoscopy is needed 
for accurate differentiation, ultrasono­
graphy and quantitative /3-HCG should 
be requested instead of proceeding with 
immediate surgery. A number of diagnos­
tic options will then become available 
(Table I).
When the location and nature of the 
pregnancy are uncertain, the (3-HCG 
measurement should be repeated in 48 
hours; the results of the second test will 
make it clear whether one is dealing with 
a normal intrauterine pregnancy, an 
ectopic pregnancy or an abortion. In nor­
mal cases, the /3-HCG will double in 48 
hours; in the other circumstances the rise 
will be less pronounced. The diagnosis of 
ectopic pregnancy or abortion will be con­
firmed by curettage followed by 
laparoscopy if necessary. When intrauter­
ine pregnancy is diagnosed, the diagno­
sis should be confirmed within a week by 
diagnostic ultrasonography to rule out
FIG. 1—Suggested approach to diagnosis of 
ectopic pregnancy.
Table 1-Diagnostic Options Outlined by 
Ultrasonography and Beta-Human Chorionic 
Gonadotropin (/3-HCG) Measurement
Not pregnant 
/3-HCG <  10 IU/L 
Intrauterine pregnancy 
Normal intrauterine pregnancy 
Fetal heart seen
Intrauterine sac + /3-HCG >  6000 IU/L 
Abnormal intrauterine pregnancy 
Intrauterine sac + (3-HCG <  6000 IU/L 
Ectopic pregnancy
No intrauterine sac + (3-HCG >  6000  
IU/L
Complex pelvic mass + /3-HCG >  10 
IU/L
Nature and location of pregnancy uncertain 
No intrauterine sac + /3-HCG <  6000 IU/L
3 9 8 VOLUME 28, NO. 5, SEPTEMBER 1985 /  THE CANADIAN JOURNAL OF SURGERY
those rare cases in which ectopic gesta­
tion produces normal /3-HCG levels.
Use of this protocol will increase the 
numbers of ectopic pregnancies diagnosed 
before rupture and limit the numbers of 
unnecessary diagnostic laparoscopies.7 It 
has made the diagnosis of ectopic preg­
nancy a more exact science.
Management
In the hemodynamically unstable 
patient with rupture of the uterine tube, 
surgery must be undertaken without 
delay. It may not be possible to resusci­
tate the patient fully until the bleeding is 
controlled. It is therefore a grave error to 
delay surgery while vain attempts are 
made to raise the patient’s blood pressure 
to normal. The patient is best brought to 
the operating room immediately. While 
the patient is prepared for surgery, a 
bolus of intravenous fluid (Ringer’s solu­
tion) is given. A lower midline incision is 
made. The hemoperitoneum is ignored 
and the surgeon immediately identifies the 
uterus, which leads the hand to each 
appendage in turn. If a mass is felt on one 
side or the other, then that appendage is 
delivered into the wound. Over 90% of 
ectopic pregnancies occur in the outer two 
thirds of the tube and are obvious on pal­
pation. Sometimes no mass is palpated 
and in this case the uterus itself should 
be brought into the incision. An ectopic 
pregnancy may be found in the isthmical 
portion of the tube. Although these are 
often small, they are especially dangerous 
because particularly severe hemorrhage 
may occur. When the site of the preg­
nancy has been found, bleeding is con­
trolled by placing Kelly clamps across the 
mesosalpinx and the cornual portion of 
the tube. No single tube should be 
clamped until the other has been visual­
ized and found to be normal. Once the 
hemorrhage is controlled the patient’s 
condition will improve dramatically. At 
this point the blood and clot can be aspi­
rated from the peritoneal cavity, 
peritoneal toilet performed with saline 
and blood given. The tube may now be 
removed without haste. The actual tech­
nique is relatively unimportant, but may 
be neatly done if fenestrations are made 
in the mesosalpinx, and the isolated blood 
vessels are then clamped and ligated with 
fine catgut. Cornual resection of the tube 
is no longer recommended. It is unneces­
sary; not only does it fail to prevent cor­
nual ectopic pregnancies but may also 
result in localized myometrial defects that 
may well compromise a future pregnancy.
In most patients with ectopic preg­
nancy, salpingectomy is done in a way 
that is unchanged since Tait’s time. 
Although clearly life-saving, it may fail 
to prevent other problems that the patient 
with an ectopic gestation must face in the 
future. One of these is that following an
ectopic pregnancy, one half of the women 
will not conceive again and 15% are sub­
ject to repeat ectopic pregnancy. These 
disheartening figures have remained con­
stant for some years with the occasional 
exception in selective reports.14
The possibility of improving this poor 
prognosis was first addressed by Jeff- 
coate15 who suggested that the removal 
of the adjacent ovary would improve the 
tubal pick-up of the ovum by preventing 
transperitoneal migration of the fertilized 
ovum. Although the thinking was ingeni­
ous, the results of the procedure have 
remained both equivocal and controver­
sial and the procedure is no longer recom­
mended. Salpingo-oophorectomy as a 
treatment for ectopic pregnancy has never 
been subjected to proper trial.
At present, the thrust of gynecologic 
thinking is that the outcome of subse­
quent pregnancies will best be improved 
by preserving the tube. This will be pos­
sible only when the ectopic pregnancy is 
diagnosed before rupture. What remains 
controversial, however, is the question of 
whether such conservative surgery is 
worthwhile. DeCherney and Kase16 in a 
definitive study were unable to show an 
increased pregnancy rate or a decreased 
ectopic pregnancy rate. A good case for 
this surgery may be made for the young 
woman whose opposite tube is absent or 
damaged and who wishes to retain her 
fertility. DeCherney and colleagues17 
described the effect of salpingostomy for 
unruptured ectopic pregnancy in the 
presence of one tube only. The absence 
of the contralateral tube ensures that sub­
sequent pregnancy results from ovum 
transport through the tube that had had 
tubal surgery. His results were most 
worthwhile for women wishing more 
babies although there was an increased 
risk of another ectopic pregnancy. The 
pregnancy rate was 53% and the rate of 
repeat ectopic pregnancy was 20%. In 
these special instances, therefore, conser­
vative surgery does seem to be beneficial.
Microsurgery includes linear salpin­
gostomy with a needle cautery, teasing 
out of placental tissue with fine forceps, 
immaculate hemostasis with bipolar cau­
tery and the irrigation of the operative 
area with a heparin solution. The tubal 
incision may be closed with 6-0 Dexon or 
left alone with no effort at closure. 
Postoperatively, RhoGAM is given as 
required and the level of the /3-HCG is 
monitored at weekly intervals.
Summary
Ectopic pregnancy has become a com­
mon surgical emergency. The increased 
rate of ectopic pregnancy relates to the 
increased incidence of pelvic inflamma­
tory disease.18 Both history and physical 
examination, except in women with tubal 
rupture, are inconclusive. To diagnose an
ectopic pregnancy before rupture of the 
tube occurs and without invasion of the 
peritoneal cavity, quantitative /3-HCG 
measurements and diagnostic pelvic 
ultrasonography are recommended. A 
diagnostic plan has been outlined. For the 
most part, surgical therapy is limited to 
salpingectomy. The very necessary, 
although limited, place for conservative 
surgery is also outlined.
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Femoropopliteal bypass gra fting  fo r clau­
dication is a controversia l procedure.
One hundred consecutive patients so 
treated were analysed fo r ve in-gra ft 
patency, subsequent operation and sur­
vival. Initial success, trea tm ent o f 
incip ient g ra ft fa ilure and a ttrition  from  
death were the three critica l facto rs 
influencing long-term  benefit. Cumulative 
g ra ft patency, a fte r revision when neces­
sary, was 89% , 8 6 %  and 78%  a t 2, 5 
and 10 years respective ly. In assessing 
the real benefit o f surgery in th is  group, 
it  is im portant to  consider the e ffe c t of 
late deaths, as the life expectancy of 
these patients is so o ften  shortened by 
related disease; the "cu m u la tive  pallia­
t io n "  (patient alive and g ra ft patent) was 
82% , 67%  and 28%  at the same time 
intervals. The concept o f cum ulative pal­
liation sets a high standard in assessing 
results o f vascular surgery, adding 
im portant in form ation to  the usual graft 
patency rates th a t ignore the e ffec t of 
death. These results suggest a place for 
fem oropopliteal vein bypass gra fting  in 
selected claudicants.
Le pontage fem oro-pop lite  pour la claudi­
cation in te rm itten te  est controversy. Les 
dossiers de 100 patients, tra itgs con- 
secutivement par pontage veineux 
femoro-poplite pour une claudication 
im portante, fu ren t revises quant a la per­
mabilite de la g re ffe , une chirurgie subse- 
quente et la survie du patient. Le succes
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in itia l, le tra item en t d 'une throm bose 
im m inente du g re ffon et I'a ttr itio n  par le 
deces fu ren t les tro is  principaux facteurs 
qui on t in fluence le benefice a longue 
echeance. La perm abilite cum ulative du 
gre ffon , apres revision si n£cessaire, fu t 
de 89% , 86 %  et 78 % , a 2, 5 et 10 ans 
respectivem ent. En evaluant le benefice 
reel de la ch irurg ie dans ce groupe. il est 
im portant de considerer I 'e ffe t de la m or­
ta lity  ta rd ive car I'expecta tive  de vie de 
ces patients est souvent reduite a cause 
de maladies associ£es; " la  palliation 
cum u la tive " (patient v ivant avec une 
greffe permeable) fu t de 8 2 % , 6 7 %  et 
28% , aux memes intervalles. Le concept 
de palliation cum ulative a tab lit un stan­
dard yieve dans E v a lu a tio n  des resultats 
de la ch irurg ie vasculaire en a joutant une 
in form ation im portante aux taux 
habituels de perm abilite du greffon qui 
ne tiennent pas com pte des deeds. Ces 
resultats suggerent qu 'il y a place pour 
un pontage veineux fem oro-poplite  chez 
des patients bien selectionnes, presen- 
ta n t de la claudication.
Femoropopliteal grafting for claudication 
is controversial. Linton and Darling1 
published their classic paper on 
femoropopliteal vein grafts in 1962. Two 
thirds of their patients had claudication. 
However, in the succeeding 20 years, 
results and opinions have varied consider­
ably as to whether this operation is indi­
cated for claudication.2-4 This study was 
initiated to assess the long-term result, 
fate and, more importantly, what was 
actually achieved in a series o f  100 con­
secutive patients each of whom received 
a primary reversed femoropopliteal vein 
graft for claudication.
P atien ts
Initially, only patients who were una­
ble to work were selected for surgery. 
Later, we accepted patients whose life­
style was frustrated by their limitation 
and who requested surgery on that basis.
Each patient suffered symptoms of clau­
dication after walking less than 200 m, 22 
were limited to less than 50 m. They were 
not accepted for operation unless their 
symptoms had been stable for at least 3 
months or were deteriorating. Seven 
patients had received a femoropopliteal 
graft previously in the contralateral leg, 
three had been treated elsewhere for clau­
dication and four by us for ischemia. Ten 
had undergone aortoiliac “ inflow” proce­
dures previously. The mean age of these 
patients was 60 years (range from 41 to 
77 years). There were 30 women. 
Associated risk factors were standard for 
arteriosclerotic disease (Table I). Only 
five patients had never smoked. Of the 
121 limbs, 16 had only one patent tibial 
vessel to the foot, the remainder had two 
or three. The minimum follow-up was 
over 5 years for a total o f 862 limb-years.
M e th o d s
Starting in July 1964, details o f all vas­
cular operations done at St. Paul’s Hospi­
tal in Vancouver were entered prospec­
tively onto a comprehensive computer 
form.5 The first vein graft for claudica­
tion was performed in November 1964 
and the most recent, in this series, in
T a b le  1— P r e o p e r a t iv e  R is k  F a c to r s  in  
1 0 0  C la u d ic a n t s  S e le c t e d  fo r  S u r g e r y
R is k  f a c t o r
N o . o f  
p a t ie n t s *
C a r d ia c  d is e a s e  ( in c lu d e s  e le c tr o - 4 1
c a r d io g r a p h ic  a b n o r m a lit ie s )  
C e r e b r o v a s c u la r  d is e a s e 1 0
H y p e r te n s io n 2 1
D ia b e te s 1 0
P la s m a  t r ig ly c e r id e  
le v e ls  >  2 . 2 6  m m o l/L 6
P la s m a  c h o le s te r o l  
le v e l > 7 . 7 6  m m o l/L 1 5
P la s m a  u r ic  a c id  
le v e l > 4 7 6  yzm o l/L 5
T o t a l 1 0 8
* 3 5  p a t ie n t s  h a d  n o  id e n t i f ie d  r is k  f a c t o r s .
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November 1978. A two-team approach 
was used; the first author (J.G.S.) was the 
primary surgeon in all cases, usually in 
association with the second author 
(J.L.G.).
Grafts associated with common or 
superficial femoral endarterectomy, or 
arising from the superficial femoral artery 
above the adductor hiatus, were included. 
The lower end of the vein graft termi­
nated in the popliteal artery above the 
knee in 44 of the 121 grafts. We were 
more aggressive in our use of “ border­
line” vein than we would be today 
because of our lack of enthusiasm for the 
alternatives at that time. This probably 
resulted in more operations for revision. 
Patients were followed up at 3, 6, 12 and 
18 months after surgery, then annually to 
the time of death or occlusion. None were 
lost before occlusion, but one patient has 
been lost to follow-up since the graft 
occluded. The closing date for this study 
was Dec. 31, 1984. Absence of symptoms 
associated with easily palpable pulses was 
accepted as evidence of graft patency. All 
patients with grafts of questionable 
patency underwent femoral arteriography 
or the graft was considered occluded. The 
tables of cumulative patency and pallia­
tion, risk factors and cause of death were 
set up initially on an IBM personal com­
puter then confirmed on SPSS.6 '
Results, Fate and Palliation
Primary patency rates at 2, 5 and 10
years were 75%, 68% and 54% respec­
tively (Table II, Fig. 1). Thirty of our 121 
grafts had to be revised because of 
incipient failure — usually stenosis within 
the first 2 years. Graft patency including 
the positive effect of these operations 
(i.e., secondary patency) was 89%, 86% 
and 78% at 2, 5 and 10 years (Table III). 
If we assume that the grafts that were 
revised, all of which were severely 
stenosed, would have failed at an aver­
age of 3 months, then there was a signifi­
cant statistical gain from the revision (p 
= 0.003, Lee-Desu statistic).
Twenty-one of the 100 patients had a 
subsequent contralateral femoropopliteal 
vein graft for claudication and 1 for ische­
mia. Ten patients had a subsequent 
inflow procedure and in 7 serious 
abdom inal aneurysm s developed. 
Twenty-five of the 121 grafts throm­
bosed. Three of these were treated by 
thrombectomy, but only one was perma­
nently salvaged. In all, five limbs were 
amputated, all late, two of them within 
2 months of the patient’s death.
Cumulative survival for the 100 
patients was 79% at 5 years and 39% at 
10 years. This is compared with the life 
expectancy curve for 60-year-old persons 
in Fig. 2. Smoking-related diseases of the 
vascular and pulm onary systems 
accounted for 36 of the 42 deaths of 
known causes (Table IV).
To assess what was actually achieved 
in this series, we considered a live patient 
with patent grafts as the criterion for suc-
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FIG. 1—Cumulative graft patency. Primary 
patency (solid line) ends with reoperation (revi­
sion or thrombectomy), regardless of outcome, 
and graft failure. Secondary patency (broken 
line) reflects effect of maintenance operations 
and ends with graft failure only. Average num­
bers of limbs at risk during interval are noted 
below curves which were calculated from limb 
data base (N = 121).
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FIG. 2—Cumulative survival of 100 patients 
after femoropopliteal bypass for claudication 
(average age 60 years) (solid line) compared to 
sex-adjusted life expectancy at age 60 (broken 
line).
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7 41 1 0 3 6 3 8 9 2 6 0 .1 5 .2
8 2 8 4 2 6 1 4 9 6 5 7 .8 5 .5
9 2 3 1 0 1 8 1 6 9 4 5 4 .5 6 .1
T a b le  I I I - L im b  D a ta  B as e. C u m u la tiv e  S e c o n d a ry  P a te n c y
In te rv a l N o . en terin g N o. N o . a t No.
In te rv a l, % C u m u la tiv e S tan d ard
s ta r t ,  yr in te rv a l w ith d ra w n risk fa ilu re s Failure S uccess su ccess, % erro r, %
0 12 1 0 121 1 1 9 9 9 9 .2 0 .8
3 0  d 1 2 0 4 1 1 8 5 4 9 6 9 5 .0 2 .0
1 11 1 7 1 0 7 .5 7 7 9 3 8 8 .8 2 .9
2 9 7 2 9 6 1 1 9 9 8 7 .9 3 .0
3 9 4 6 91 0 0 1 0 0 8 7 .9 3 .0
4 8 8 11 8 2 .5 1 1 9 9 8 6 .8 3 .2
5 7 6 9 7 1 .5 2 3 9 7 8 4 .4 3 .5
6 6 5 6 6 2 3 5 9 5 8 0 .3 4 .1
7 5 6 1 6 4 8 1 2 9 8 7 8 .6 4 .3
8 3 9 7 3 5 .5 0 0 1 0 0 7 8 .6 4 .3
9 3 2 1 4 2 5 0 0 1 0 0 7 8 .6 4 .3
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cess. Thus, patients who had bilateral 
femoropopliteal bypass grafting for clau­
dication were considered palliated until 
the first graft occluded or the patient 
died. On this basis, the palliation rates at 
5 and 10 years were 67% and 28% respec­
tively (Table V, Fig. 3). Five patients with 
patent grafts were to some extent disabled 
before death (one by stroke, one by renal 
failure and three by “ old age” ). Disabil­
ity is a “ soft” end point and accounted 
for only 7 of a total of 760 patient-years 
of follow-up. For this reason we used 
only occlusion and death as criteria for 
failure of palliation. Each of the follow­
ing groups was analysed and compared 
with its counterpart for graft patency and 
palliation: age older than 64 years and 
older than 69 years, female, claudication 
at less than 50 m, single-vessel outflow
FIG. 3—Secondary graft patency (ability to 
maintain patent grafts) and cumulative palli­
ation (patient alive and grafts patent) were cal­
culated from patient data base (N = 100). Lat­
ter gives critical additional information in 
assessing patient benefit from operation. Num­
bers of patients at risk are noted below curve.
Table IV—Causes of Death *
Cause
No. of 
patients
Cardiac 30
Cerebrovascular (stroke) 6
Vascular 1
Lung cancer 2
Other 7
Unknown 17
*37 alive.
and the lower end of the graft below the 
knee. The group with single-vessel out­
flow fared worst but the difference was 
not statistically significant in this small 
sample.
Discussion
Early results in vascular surgery depend 
upon case selection and technical exper­
tise. There was only one early failure 
(within 30 days of operation) and no 
operative deaths in this series. A two- 
surgeon approach is advocated to shorten 
the procedure and to allow more flexibil­
ity in time if a difficult technical situation 
is encountered. The graft patency results 
presented here are surprisingly similar to 
those of Donaldson and Mannick4 and 
appear to be reproducible. The late ampu­
tation rate, 0.6% per year at risk, com­
pares favourably with the natural history 
for claudicants of 1.4% amputations per 
year7 but certainly does not, in itself, 
justify operation.
Selecting claudicant patients for sur­
gery is a challenge, but there are bench­
marks. Within 10 years of the onset of 
symptoms 25% of claudicants will die, 
the annual mortality from cardiovascu­
lar causes being about four times higher 
than normal.8 If we select claudicants 
with angina or those who smoke, the risk 
of death rises to six or seven times nor­
mal.8 Stated another way, the annual 
mortality in patients with angina is about 
4% and is about 5% after a nonfatal 
myocardial infarction.9 However, claudi­
cation by itself has little effect on 5-year 
mortality if we eliminate the cardiovas­
cular risk factors and smoking.10 We 
stressed the risk of smoking to our 
patients and nearly all stopped before sur­
gery. Unfortunately, many resumed the 
habit but usually at a lower level. Finally, 
if we are to expand our indications in 
femoropopliteal surgery to include some 
claudicant patients, life-style becomes 
critical. Patients must be selected on their 
need, wish and ability to lead a more 
active life.
We did not operate on claudicants with 
poor outflow. For this reason, graft
failure was almost always due to graft- 
related stenosis. The consequences of 
femoropopliteal graft occlusion are seri­
ous, even when the original grafting was 
done for claudication.11 Five of our 25 
thrombosed grafts resulted in amputation 
of the limb. Incipient graft failure must 
be diagnosed and treated promptly if the 
graft is to be saved.12 The hallmarks of 
graft stenosis are return of claudication, 
weakening pulses and a bruit over the 
graft. Patients must be prewarned to 
report any recurrence of claudication. A 
drop of 0.2 in the ankle index is seri­
ous.13 The bruit occlusion test12 is very 
useful in localizing graft stenosis clini­
cally, and the diagnosis is confirmed by 
careful angiography.14
Reporting results in vascular surgery by 
the life-table method is mandatory. The 
standard life table of graft patency is very 
helpful in comparing grafts, groups of 
patients or surgeons. Comparing primary 
and secondary patency rates gives a good 
indication of the operation’s durability. 
However, as death is dropped out of 
cumulative patency results, these curves 
bear little relation to what the surgeon or 
patient can expect from the operation. 
Previous reports have stressed the late 
mortality after peripheral vascular sur­
gery, reporting patient survival and 
cumulative survival.15'16 The fact that 
most of these patients die of related vas­
cular and pulmonary disease is well 
documented.10'17 The key to a true 
reflection of treatment is to combine the 
cumulative effect of graft failure and 
death. We have named this curve 
“ cumulative palliation” . With the use of 
in-situ vein grafts, long-term graft 
patency in the femoropopliteal area may 
improve, but it is noteworthy that the pal­
liation curve in this series followed the 
survival curve; 80% of the surviving 
patients were palliated at 5 years and 70% 
at 10 years, leaving a relatively small 
increment to be gained by improved graft­
ing procedures. The concept of “ cumula­
tive palliation” is very useful in assess­
ing the success of vascular surgery, adding 
important information to the usual graft- 
patency curves which neglect the effect of
Table V-Patient Data Base. Cumulative Palliation
Interval 
start, yr
No. entering 
interval
No.
withdrawn
No. at 
risk
No.
failures
4-------
Failure
Interval, %
Success
Cumulative 
success, %
Standard 
error, %
0 100 0 100 1 1 99 99.0 1.0
30 d 99 0 99 7 7 93 92.0 2.7
1 92 0 92 10 11 89 82.0 3.8
2 82 0 82 4 5 95 78.0 4.1
3 78 1 77.5 3 4 96 75.0 4.3
4 74 0 74 8 11 89 66.9 4.7
5 66 0 66 9 14 86 57.8 5.0
6 57 4 55 5 9 91 52.5 5.0
7 48 3 46.5 11 24 76 40.1 5.0
8 34 1 33.5 5 15 85 34.1 5.0
9 28 3 26.5 5 19 81 27.7 4.8
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death. The fact that about two thirds of 
these patients were alive with patent 
femoropopliteal vein grafts 5 years after 
operation indicates that there is a group 
o f claudicant patients who can be well 
palliated by this operation. The surgeon’s 
challenge is to identify these patients and 
keep their grafts functioning.
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Statistical Prediction of Cardiac Risk in Patients 
Who Undergo Vascular Surgery
Since A ugust 1982, an extensive com ­
puterized data base has been developed 
on all patients adm itted to  the Division 
o f V ascu lar Surgery at the O ttaw a Civic 
H osp ita l. For each patient, 180 variables 
are recorded, including in form ation about 
preoperative  risk factors and postopera­
tiv e  com plications. Since cardiac com pli­
ca tions are a major cause o f m orta lity  
and m orb id ity , the data file  has been 
used to  study postoperative cardiac com ­
p lica tions in patients who undergo 
arteria l reconstructive operations.
Betw een August 1982 and December 
1 9 8 3 , 3 5 3  artery repairs were per­
fo rm ed , excluding ruptured aneurysms. 
Cardiac com plications developed fo llo w ­
ing surgery in 56 patients. Risk facto rs 
w ere  in itia lly  studied using contingency 
tab le  analysis. Four of these factors 
w ere  found  to be sign ificant: elec­
trocard iograph ic evidence o f previous 
m yocard ia l in farction (p = 0 .0 00 3 ), non-
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specific ST-segment changes (p = 
0 .0007 ), New York Heart Association 
classification o f sym ptom s (p = 0 .0003 ) 
and age (p = 0 .01).
A  further sta tistica l study was based 
upon m ultip le  logistic regression. The 
authors believe that the identifica tion of 
a high-risk group, using these criteria, is 
helpful in selecting patients for intensive 
preoperative investigation, including 
coronary arteriography.
Depuis aout 1982, une vaste banque de 
donnees sur ordinateur a ete generee a 
partir de tous les patients repus au Ser­
v ice de chirurgie vasculaire de I'hop ita l 
Civique d 'O ttaw a . Ont §te enregistr^es 
pour chaque patient, 180 variables dont 
I'in fo rm ation  concernant les facteurs de 
risque preoperatoires et les complications 
postoperatoires. Comme les complica­
tions cardiaques representent une cause 
majeure de m ortalite et de m orbidity, le 
fich ie r de donnee a 6t§ utilisee pour etu- 
dier les com plications postoperatoires 
chez les patients qui subissent une ope­
ration de reconstruction arterielle.
Entre aout 1982 et decembre 1983, 
35 3  reparations art^rielles ont ete effec- 
tuees si I'on excepte les ruptures d'ane- 
vrisme. Des com plications cardiaques 
postoperatoires sont survenues chez 56 
patients. Les facteurs de risque ont to u t 
d 'abord 6te etudies par analyse des 
tables de contingence. Quatre de ces 
facteurs se sont averts  im portants: les 
signes electrocardiographiques d 'un 
in farctus du myocarde ancien (p = 
0 .0 00 3 ), des m odifications non specifi-
ques du segment ST (p = 0 .0 00 7 ), la 
classification des symptomes de la New 
York Heart Association (p = 0 .0 00 3 ) et 
I'age (p = 0 .01).
Une seconde analyse sta tistique par 
regression logistique m ultiple a ete effec- 
tuee. Les auteurs croient que I'identifica- 
tion , a I'aide de ces criteres, d 'un  groupe 
a risque eleve, permet de choisir les 
patients qui devraient etre soumis a un 
examen preopSratoire pousse compre- 
nant une arteriographie coronarienne.
Cardiac complications are the commonest 
cause of death following peripheral 
arterial reconstruction. If we could relia­
bly identify preoperatively, using simple 
criteria, the patients most likely to suffer 
such complications, we might be able to 
reduce the incidence of cardiac death 
postoperatively. The present study was 
carried out in an attempt to predict 
cardiac risk in patients requiring 
peripheral arterial repair, using statistical 
methods.
Method
In 1982 we began an ongoing statisti­
cal study of all patients admitted to the 
Vascular Surgical Service of the Ottawa 
Civic Hospital. This involved the develop­
ment of a coded questionnaire contain­
ing 180 variables that was filled out on 
each patient. Following validation, the 
information was entered into the Univer­
sity of Ottawa mainframe computer, 
creating a large data base that provided 
a detailed profile of each patient, includ-
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ing the clinical findings, preoperative 
investigations, operative procedure and 
postoperative course. We decided to use 
this data base to investigate postoperative 
cardiac complications in patients who 
underwent peripheral arterial repair.
Potential cardiac risk factors identified 
for the study were: arteriosclerotic heart 
disease, diabetes, hypertension, obesity, 
smoking, hyperlipidemia, previous vascu­
lar surgery and age. Assessment of arteri­
osclerotic heart disease included informa­
tion about previous documented myo­
cardial infarction, previous coronary ar­
tery repair, angina, arrhythmias and elec­
trocardiographic abnormalities. Symptom 
severity was assessed according to the 
New York Heart Association (NYHA) 
classification. Resting admission elec­
trocardiograms were read independently 
and coded according to the presence of 
rhythm other than sinus, bundle branch 
block, evidence of previous myocardial 
infarction, ST-segment and T-wave 
changes, and left ventricular hypertrophy. 
Previous infarction was determined by the 
presence of Q waves greater than 0.04 
seconds in duration and 2 mm in depth. 
ST-segment depression of 1 mm or more 
was considered abnormal.
Postoperative cardiac complications 
studied were: acute myocardial infarc­
tion, acute congestive heart failure and 
arrhythmias requiring treatment. Acute 
myocardial infarction was diagnosed by 
electrocardiographic evidence of new ST- 
segment elevation, corroborated by the 
finding of elevated cardiac enzyme levels. 
Congestive failure was diagnosed by clin­
ical evidence of acute pulmonary edema 
with jugular venous distension or a third 
heart sound, and by hemodynamic 
criteria with pulmonary capillary wedge 
pressure greater than 18 mm Hg and a 
cardiac index of less than 2.2.
All patients who underwent arterial
reconstruction were included except those 
with ruptured aneurysms. They were 
excluded since the need for immediate 
surgery prevented adequate preoperative 
evaluation of their cardiac status. The 
study was retrospective, and involved an 
18-month period from August 1982 
through November 1983.
The results were subjected to statisti­
cal evaluation. In the first part of the 
analysis, we considered each factor 
individually, and constructed a contin­
gency table to study the relation between 
each risk factor and postoperative cardiac 
complications.
Further study focused on all risk fac­
tors and attempted to assess the individual 
and joint effects of the variables. In order 
to investigate these effects, we fitted a 
logistic model to the data. The logistic 
model specified that the probability of 
cardiac complications depends upon a set 
of risk factors. The selection of each 
predictor variable was done by stepwise 
logistic regression,1-2 adding those varia­
bles to the model that maximized the 
likelihood of cardiac complications.
Results
During the study period, arterial recon­
struction was done in 353 patients; 56 
(15.9%) of them suffered cardiac compli­
cations and 19 (5.4%) died. Twenty-three 
suffered myocardial infarction, with 16 
(70%) deaths (Table I).
Contingency table analysis indicated 
that four factors were significant in 
predicting cardiac risk. These were non­
specific ST-segment changes on the rest­
ing electrocardiogram (p = 0.0007), elec­
trocardiographic evidence of previous 
myocardial infarction (p = 0.0003), sym­
ptom severity as classified by the NYHA 
(p = 0.0003) and age (p = 0.01). There 
were no other significant risk factors.
Further analysis was carried out by mul­
tiple logistic regression.
ST-Segment Changes
Sixty-one patients had abnormal ST 
segments on their resting electrocardio­
gram. Nineteen (31.1%) suffered cardiac 
complications postoperatively. Thirty- 
seven of 291 patients with normal ST seg­
ments (12.7%) suffered cardiac compli­
cations. This difference was significant (p 
= 0.0007). The tracing for one patient 
was not available.
Myocardial Infarction
The degree of risk involved when there 
was electrocardiographic evidence of 
previous myocardial infarction depended 
upon the location of the infarct (Table II). 
The risk was greatest when there was evi­
dence of an anterior myocardial infarct 
(33.3% had complications) or both 
anterior and inferior infarcts (57.1% had 
complications).
NYH A Class
The New York Heart Association clas­
sification of symptom severity was the 
third significant predictor of postopera­
tive cardiac complications, the risk being 
highest for patients with class III sym­
ptoms — 33.3% suffered cardiac compli­
cations (Table III).
Age
Age was the least important of the sig­
nificant risk factors (p = 0.01) (Table 
IV). The patients ranged in age from 34 
to 94 years. There were no cardiac com­
plications in patients under 40 years of 
age, and the risk was highest over age 70. 
The introduction of age as a predictor did 
not alter the significance of electrocardi­
ographic changes or symptom severity.
In the second part of the analysis, a 
logistic regression model was fitted to the 
data. The results of step-wise logistic 
regression showed that the likelihood of 
cardiac complications was increased 9% 
by the presence of ST-segment changes on 
the electrocardiogram, 10% by evidence
Table Il l -N e w  York Heart Association 
Classification and Cardiac Complications
NYHA class No.
Complications,
no.(%)
1 170 25 (14.7)
II 55 15 (27 .3)
III 21 7 (33.3)
IV 7 2 (28.6)
0 * 99 6 ( 6.1)
‘ No symptoms, normal electrocardiogram, 1 pa­
tient was not classifiable, 
p = 0.0003.
Table 1-Postoperative Cardiac Complications
Complication No. Survived
Died, 
no. (%)
Acute myocardial infarction 23 7 16 (70 )
Acute congestive failure 5 4 1 (20)
Arrhythmias 21 19 2 (1 0 )
Severe angina and hypotension without myocardial infarction 7 7 0 (  0)
Table II—Electrocardiographic Evidence of Myocardial Infarction 
and Cardiac Complications for 352 Patients*
Electrocardiographic findings No.
Complications, 
no. (%)
No infarction 257 3 3 (12 .8 )
Inferior myocardial infarction 52 7(1 3 .5 )
Anterior myocardial infarction 36 12 (33 .3)
Inferior and anterior myocardial infarctions 7 4 (5 7 .1 )
* Tracing for 1 patient was not available, 
p -  0.0003.
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of previous infarction, 7% by the NYHA 
symptom classification and 4% by age. 
The total number of complications that 
could be predicted by these four signifi­
cant variables was thus 30%.
Discussion
The importance of acute myocardial 
infarction as a cause of death following 
peripheral artery repair has been well 
documented by Hertzer.3 Of 273 con­
secutive patients who underwent lower 
extrem ity revascularization at the 
Cleveland Clinic between 1969 and 1973, 
myocardial infarction caused 52% of the 
early postoperative deaths and 55% of 
late deaths up to 11 years. Since 19784 
routine preoperative coronary angiogra­
phy has been recommended for all 
patients in his institution who required 
lower limb arterial repair. Significant cor­
rectable coronary artery lesions were 
found in 54% of patients with aortoiliac 
disease who had preoperative evidence of 
coronary artery disease and in 13% of 
patients with no such evidence.4 Early 
results indicated a low risk following 
preliminary coronary artery repair. In a 
subsequent report of 1000 patients, 
presenting with peripheral vascular dis­
ease who had coronary arteriography, 
Hertzer and associates5 carried out 
preliminary cardiac procedures in 226, 
with 12 postoperative deaths (5.3%); 130 
of these patients had subsequent 
peripheral vascular operations and 1 of 
them died. It has also been suggested by 
Crawford and associates6 that the risk of 
noncoronary operations is decreased fol­
lowing successful coronary bypass 
surgery.
While careful assessment of cardiac 
risk is most important before carrying out 
peripheral vascular reconstruction, the 
appropriate extent of this evaluation may 
be difficult to determine in an individual 
case. All of our patients were assessed 
clinically by a consultant cardiologist. 
Recording of one or more resting elec­
trocardiograms was routine. Exercise 
stress testing was not possible in many 
patien ts , since their claudication 
prevented them from walking far enough 
on a treadmill to produce cardiac symp­
toms. Coronary artery catheterization
T a b le  IV - -A g e  and  C ard iac  C o m p lic a tio n s
C o m p lic atio n s ,
A g e, y r N o . n o .(% )
<  4 0 3 0101
4 0 - 4 9 2 0 2 ( 1 0 !
5 0 - 5 9 6 8 3  (4 .4 !
6 0 - 6 9 1 2 2 21 (1 7 .2 )
7 0 - 7 9 9 8 21 (2 1 .4 )
>  8 0 4 2 9 ( 2 1 . 4 )
p -  0 . 0 1 .
was used selectively, and we are reluctant 
to advise it as a routine procedure without 
additional evidence that its use would 
markedly lower the incidence of postoper­
ative cardiac complications, as well as 
reduce overall mortality.
Goldman’s group7'9 have produced a 
good deal of statistical information about 
cardiac complications following 1001 con­
secutive operations, subjecting the data 
to multivariate analysis. Factors that cor­
related independently with cardiac deaths 
were: clinical evidence of congestive 
failure, myocardial infarction within 6 
months, rhythm other than sinus or 
premature atrial contractions on the 
preoperative electrocardiogram, more 
than five premature ventricular contrac­
tions a minute, significant aortic steno­
sis, age over 70 years, emergency surgery 
and type of operation. While Goldman’s 
patients underwent a wide variety of 
thoracic, abdominal, gynecologic, uro- 
logic and breast operations, there were 80 
procedures for abdominal aortic aneu­
rysms and he noted an increased cardiac 
risk following abdominal aortic surgery. 
The usefulness of Goldman’s cardiac risk 
index has been confirmed by others.10
Congestive heart failure preoperatively 
is known to increase surgical risk, and the 
increment is proportional to the degree of 
hemodynamic compromise. Skinner and 
Pearce,11 in a study of cardiac patients 
who underwent general surgical proce­
dures, found that mortality increased 
directly with the NYHA functional class: 
class I, 4.3%; class II, 10.6%; class III, 
25%; and class IV, 67%. In our patients, 
the preoperative NYHA classification 
predicted an increasing number of cardiac 
complications postoperatively from class 
I (14.7%) to class III (33.3%). However, 
only two of the seven patients in class IV 
(28.6%) suffered cardiac complications. 
This is at variance with reported data11 
and may be related to the small number 
of patients in class IV who were operated 
upon.
The most significant electrocardio­
graphic finding was the presence of signs 
of previous myocardial infarction of 
indeterminate age (p = 0.0003). The risk 
of complications depended upon the loca­
tion of the infarct, being greatest when 
both anterior and inferior infarction had 
occurred (58%) and less with anterior 
(30%) or inferior (14%) infarction alone. 
History of a remote, clinically docu­
mented infarction previously was not sig­
nificant. The increased risk within 6 
months of acute infarction is well known 
and patients were not operated upon 
under these circumstances.
The second most important predictor 
was the presence of nonspecific ST- 
segment changes (p = 0.0007). Goldman 
noted that nonspecific or nonclassifiable 
ST changes and flat or negative T waves 
were associated with an increased
postoperative cardiac mortality (4% to 
8%) by univariate but not multivariate 
analysis.7 T-wave changes were not sig­
nificant in our series. Age was the least 
significant predictor of cardiac risk in our 
patients. The incidence of cardiac com­
plications postoperatively increased from 
0% under age 40 to 21.4% among those 
over age 80. Cardiac risk began to 
increase at age 60, and was greatest over 
age 70. A striking increase in patients over 
70 years has been reported in a number 
of other series.9 It is also of interest in 
this series to note that age itself did not 
alter the significance of other predictors 
(electrocardiographic, NYHA class).
Conclusions
Patients who undergo vascular surgery 
run a substantial risk of cardiac compli­
cations following operation. Among 
patients requiring peripheral artery repair, 
it is possible to identify a high-risk group 
based on routine preoperative elec­
trocardiographic findings, NYHA clas­
sification of symptom severity and age. 
We believe that patients in this high-risk 
group should undergo intensive cardio­
logic investigation before operation, 
including cardiac catheterization and 
coronary artery repair where appropriate.
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Intraoperative Bacterial Contamination of 
Vascular Grafts: a Prospective Study
The establishment of graft infection 
depends on host response, an appropri­
ate field and bacterial contamination. 
Intraoperative bacterial contamination of 
prosthetic graft material was studied 
prospectively in 77 patients. Vascular 
reconstruction was indicated for abdomi­
nal aortic aneurysm (15%), claudication 
(42%), rest pain (25%) and ulceration or 
gangrene (18%). In 78% of cases the 
procedure was elective. Staphylococcus 
epidermidis was isolated in 80% of cul­
tures; mixed flora were more frequent in 
patients with rest pain (60%) and ulcera­
tion or gangrene (45%) than in those 
with aneurysms (22%) or claudication 
(16%). Grafts became contaminated in 
56% of cases using standard techniques; 
this was lowered to 35% when the sur­
geon changed gloves before preclotting 
the graft. There was no significant differ­
ence with respect to the surgeon who 
performed the operation, the indication 
for operation, primary versus secondary 
repair or the use of skin barriers. One 
patient (1.3%) had an established graft 
infection. It is concluded that the inci­
dence of contamination is high but may 
be decreased by glove changing.
L'infection d’une greffe depend de la 
rgponse de I'hote, de la presence d'un 
champ favorable et d'une contamination 
bactgrienne. On a etudie de fagon pros­
pective, chez 77 patients, la contamina­
tion bact6rienne peroperatoire d'un 
greffon prothetique. II s'agissait de 
reconstruction vasculaire pour angvrisme
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de I'aorte abdominale (15%), claudica­
tion (42%), douleur au repos (25%) et 
ulceration ou gangrene (18%). Dans 
78% , il s'agissait d'interventions diffe- 
rees. Du Staphylococcus epidermidis a 
ete isole dans 80% des cultures; une 
flore mixte etait plus fr£quente chez les 
patients souffrant de douleur au repos 
(60%) et d’ulceration ou de gangrene 
(45%) que chez ceux qui presentaient un 
anevrisme (22%) ou de la claudication 
(16%). Avec les techniques convention- 
nelles, il y a eu contamination du greffon 
dans 56% des cas. Ce chiffre a ete 
abaisse a 35% lorsque le chirurgien a 
change de gants avant la precoagulation 
du greffon. On n'a constate aucune dif­
ference significative attribuable au chirur­
gien, a I'indication operatoire, au fait 
qu'il s'agisse d'une reparation primaire 
ou secondaire, ou a I'utilisation de barrie- 
res cutanees. Un patient (1.3%) a vu 
I'etablissement d'une infection de gref­
fon. On conclut que la frequence des 
contaminations est grande mais qu'elle 
peut §tre reduite par un changement de 
gants.
Infection of a vascular prosthetic graft is 
associated with substantial morbidity and 
mortality that ranges from 25% to 75%, 
depending on the location of the graft.1 
Those who survive must spend a 
prolonged period in hospital at consider­
able cost, many must undergo multiple 
procedures and 36% to 40% will lose a 
limb.2’3 Improved supportive measures, 
potent broad-spectrum antibiotic therapy 
and aggressive surgical management have 
not improved the results in established 
infections.2 Despite our awareness of the 
problem, careful surgical technique and 
antibiotic prophylaxis, the incidence of 
graft infection still ranges from 2% to 
5% . 1-4
An appropriate field, a bacterial 
challenge and the patient’s host response 
are factors in the establishment of a graft 
infection. The open operative field is 
clearly unavoidable. Increasingly, patients 
with an inadequate host response due to 
age, diabetes mellitus or malnutrition can 
be recognized and, where possible, their
host response can be improved preoper- 
atively. Bacterial contamination may 
occur in the operating room or in the 
early or late postoperative period.
Intraoperative contamination of 
prosthetic graft material was assessed 
prospectively in this study to address the 
following questions: What is the incidence 
of graft contamination intraoperatively? 
What organisms are involved? Are there 
identifiable factors associated with con­
tamination? and Can such contamination 
be minimized intraoperatively?
Patients and Methods
A prospective study was conducted of 
all patients who underwent vascular 
reconstruction with a prosthetic graft 
over an 18-month period at St. Joseph’s 
Health Centre in Toronto. There were 77 
patients; 4 were excluded because of 
incomplete culture collection. Two groups 
of patients were studied: group 1, 30 
patients in whom operative care was rou­
tine (i.e., no glove changing) and group 
2, 43 patients for whom the operating 
team changed gloves before preclotting 
the graft. The indications for surgery 
included abdominal aortic aneurysm 
(15%), claudication only (42%), rest pain 
(25%), gangrene or ulceration, or both 
(18%) (Table I); secondary procedures or 
revision surgery were included unless 
established graft infection was present.
Of the 73 patients forming the study 
population, 50 (68%) were men. The 
patients’ mean age was 65 years (ranging 
from 48 to 94 years). Six patients had 
undergone previous vascular reconstruc­
tion. The operations performed included 
axillofemoral bypass, femorofemoral 
bypass, aortic tube grafting, aor- 
tobifemoral bypass and femoropopliteal 
bypass. The procedures were elective in 
78% and emergency in the remainder. All 
patients were managed in a standard 
fashion by two vascular surgeons. All 
received cefazolin (1 g intravenously) 60 
to 90 minutes before operation; no sup­
plemental antibiotics were given system- 
ically or locally during surgery. In elec­
tive cases, the skin was shaved using a
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blade 12 to 18 hours before operation; in 
emergency cases, the patient was shaved 
immediately preoperatively. Skin scrubs 
were done using povidone iodine. Sterile 
reusable cloth drapes and gowns were 
used in all cases. A plastic skin barrier 
(Op-Site; Smith & Nephew Inc., Lachine, 
PQ) was used by one surgeon (D.L.W.) for 
part of the study period. External velour 
grafts (Meadox Medicals, Inc., Toronto, 
Ont.) were used; preclotting was per­
formed in a standardized fashion with the 
patient’s own blood using repeated flush­
ing and stripping of the graft.
Cultures were taken from the patient’s 
skin before scrubbing, the surgeon’s 
gloves at the time of glove changing and 
before preclotting the graft, the dry graft 
before preclotting, the graft immediately 
after preclotting and at the last anasto­
mosis. A brain-heart-infusion (BHI) 
medium was used for all cultures. Speci­
men handling was supervised by one 
microbiologist (SK).
Routine in-hospital, clinic and office 
follow-up for 18 months was used to 
detect established graft infection.
Statistical evaluation was performed 
using the paired Student’s /‘-test.
Findings
There was no significant difference in 
age, sex, indication for surgery or opera­
tions performed between the two groups.
All skin cultures taken before skin 
preparation yielded positive cultures. 
Of these, 80% grew Staphylococcus 
epidermidis. The other 20% grew 
Staphylococcus aureus, Staphylococcus 
saprophyticus, diphtheroids, anaerobic 
Streptococcus, micrococci, Klebsiella sp 
and Proteus sp. The incidence of organ­
isms other than S. epidermidis was sig­
nificantly (p<0.01) higher in patients 
with rest pain (60%) and ulceration or 
gangrene (45%) than in those with 
aneurysms (22%) or claudication (16%).
The incidence of graft contamination 
with the same species of organisms as 
found on the patient’s skin in each study 
group is shown in Table II. Most con­
tamination occurred at preclotting in both 
groups, but glove changing decreased the 
incidence of contamination in group 2 by 
10%. The surgeon’s gloves were contami­
nated with the same species of organisms 
as found on the patient’s skin in 53% of 
cases. Although glove changing lowered 
the contamination rate at preclotting, 
ongoing contamination was evident in 
both groups (Table II).
The incidence of contamination did not 
differ with either surgical team (37% 
versus 36.5%) or with the use of the plas­
tic skin barrier (36% versus 37%). A posi­
tive culture was obtained in 5 of 14 
patients in whom no skin barrier was used 
and in 6 of 16 with a skin barrier. There 
was no correlation with the patient’s age
or sex or with the type or duration of 
operation. There were no gross breaks in 
technique in any procedure and no addi­
tional concomitant intra-abdominal 
procedures were performed with the vas­
cular repair.
One established graft infection was 
identified in follow-up to 18 months. The 
patient had had three revisions for graft 
failure before signs of graft infection 
developed; the offending organism (S. 
aureus) belonged to the same species by 
biotyping and antibiogram as that cul­
tured at the initial procedure.
Discussion
The incidence of graft contamination 
with glove changes (25% to 35%) and 
without (37% to 56%) was remarkably 
high but the incidence of established graft 
infection was 1.4%. While long-term 
follow-up over many years is needed to 
rule out graft infection, infection from 
intraoperative contamination should 
become evident within 18 months of 
grafting. Cruse and Foord5 showed base­
line infection rates for “clean” operations 
of 1.81% and for “ clean vascular” pro­
cedures of 3.7%; few studies report on 
graft contamination alone. Ernst and 
colleagues6 found that in 20% of 
patients who underwent abdominal 
aneurysm repair, the bowel bag or 
aneurysm wall was contaminated, but 
they did not culture the graft material 
itself intraoperatively. Blomgren and 
associates7 reported that 43% of wounds 
and prostheses became contaminated dur­
ing total hip procedures in conventional 
operating rooms; Lidwell’s group8 found 
a correlation between airborne contami­
nation and joint sepsis in orthopedic 
cases. Furthermore, they showed a 
decrease in joint sepsis with prostheses if 
contamination was decreased by using 
“ ultraclean air systems” .9 Kluge and 
colleagues10 noted similarly high rates of 
contamination of tissues during cardiac 
surgery.
Our study reports only the incidence of 
contamination and, as quantitative 
studies were not available, we cannot indi­
cate the number of organisms present or 
if a critical level of contamination was 
reached. Foreign material has been shown
to initiate complex bacteria-graft-host 
response interactions thereby potentiat­
ing infection.11 Clinical composition, 
shape and surface characteristics of the 
graft and mechanical factors may all play 
a ro le .11 Whereas some laboratory 
models fail to show this potentiation of 
infection,2 these results may be mislead­
ing due to contrived bacterial chal­
lenges12,13 or excessive numbers of 
organisms.14 Bennion and colleagues14 
have shown with small, graduated 
challenges that different types of grafts 
have varying patterns of resistance to 
infection. Clearly, graft material renders 
normally innocuous bacterial contamina­
tion significant and infection by organ­
isms of low pathogenicity may have seri­
ous consequences.6
Many intraoperative sources of bac­
teria are present. They include the patient, 
nurses, surgeons and anesthetists, equip­
ment in the operating room, the operat­
ing room air and gross breaks in tech­
nique. Contamination from staff is 
generally episodic and associated with one 
organism; in this study there was no con­
sistent pattern of contamination despite 
many personnel and the use of different 
operating rooms. No gross breaks in tech­
nique were identified, no patients were 
systemically septic and graft cultures cor­
related well with the flora found on the 
patients’ skin. Therefore, the patient’s 
skin was the most likely source of con­
tamination. This is consistent with the 
findings of sternotomy infections in 
cardiac surgery.15 Further studies, using 
endonuclease restriction analysis in order 
to trace the organism from skin to graft, 
are in progress.
In 80% of samples, S. epidermidis was 
identified; this is consistent with the find­
ings of this organism in 60% of patients 
in the series of Ernst and colleagues.6 In 
our series, the remaining 20% of samples
Table II—Contamination of Graft 
With Same Organism as Found on Patient's Skin
Cultures obtained
Contamination, % 
Group 1 Group 2
After preclotting 35 25
At last anastomosis 56 35
Table I—Indications and Operations
Indication/operation
Group 1,
no. <%) 
(n -  301
Group 2, 
no. (%) 
(n -  43)
Aneurysm 7123) 5(12)
Claudication 14(47) 16(37)
Rest pain 6(20) 12(28)
Ulcer 3(10) 10(23)
Aortobifemoral bypass grafting 18(60) 21 (49)
Extra-anatomic bypass grafting 9(30) 13(30)
Femoropopliteal bypass grafting 3110) 9(21)
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grew other organisms, which correlated 
with those cultured from ulcers or skin 
flora in patients with rest pain. Although 
it is evident that patients with the gross 
skin breakdown of ulceration and gan­
grene will have a more varied flora, the 
correlation with rest pain in 60% of 
instances is striking and unexpected; no 
similar reports are available in the litera­
ture. It is proposed that patients in whom 
perfusion is so borderline as to produce 
rest pain are susceptible to minor and 
unnoticed areas of skin breakdown or 
cracking as well as a decreased immune 
response, allowing overgrowth of such 
organisms. This finding may be impor­
tant when selecting antibiotics for 
prophylactic use in patients with rest pain. 
Rather than one drug given routinely to 
all patients with aneurysm, claudication 
and rest pain, patients with ulceration 
should receive prophylactically antibiotics 
specific to the organisms grown in pre­
operative cultures. Further studies are in 
progress to address this issue.As the incidence of contamination, 
sometimes with unexpected organisms, is 
high, are there any factors that can be 
identified and controlled to limit such 
contamination? All patients were shaved 
the night before surgery for elective cases 
and immediately preoperatively for emer­
gency procedures; there was no difference 
in the rate of contamination in these two 
subgroups. We recognize that shaving in 
the operating room or use of depilatory 
agents decreases the incidence of infection 
in clean cases;5 however, the present ser­
ies does not address that issue. Routine 
skin preparation with an effective 
agent16 was used in all patients. The use 
of plastic skin barriers has been impli­
cated in high rates of contamination in 
orthopedic procedures7 but in this study 
there was no difference with or without 
its use. No special ventilation or 
“ ultraclean air” devices were used.
The incidence of contamination imme­
diately after preclotting using a standard 
technique of flushing and stripping the 
graft with their patient’s blood was 37%. 
With glove changing this was reduced to 
25%. Ongoing contamination during 
anastomosis of the graft adds an addi­
tional 19% if gloves are not changed and 
10% with glove changing. Considerable 
contamination remains even with glove 
changing; a “ no-touch” preclotting 
procedure may decrease this but will not 
eliminate contamination. Other graft han­
dling changes such as protecting the graft 
from contact with the skin edge or other 
tissues may decrease contamination but 
were not studied here.
It is unlikely that all bacteria will ever 
be excluded from intraoperative contact 
with a graft, hence antibiotics should be 
used prophylactically. Antibiotics given 
before surgery and for a brief period after 
have been shown to decrease the incidence
of wound infections and pneumo­
nia.2’11'15,17 Szilagyi and associates3 and 
Fry and Lindenauer18 have shown low 
incidences of graft infection with no 
antibiotics and Fry and Lindenauer18 
found no difference with antibiotics. 
Kaiser and associates16 in a randomized 
double-blind study showed a decrease in 
all infections with antibiotics; all graft 
infections occurred in the group not given 
antibiotics. Antibiotic soaks and topical 
agents are ineffective.2 Recent animal 
studies with antibiotic bonded grafts show 
good protection against infection in 
experimental settings with Dacron,19 
human umbilical vein14 and poly- 
tetrafluoroethylene.20 The selection of 
the best antibiotic for such grafts is still 
under study.
In view of the high incidence of con­
tamination of vascular grafts with the 
standard operative technique, antibiotics 
should be given prophylactically. 
Methods to decrease contamination by 
variations in operative technique are 
being investigated.
Conclusions
This study demonstrated a high inci­
dence of contamination of prosthetic 
material during vascular reconstructive 
surgery. This contamination is indepen­
dent of the indication for surgery, 
whether a primary or secondary repair is 
performed, the surgeon involved, the skin 
preparation used and the use of plastic 
barriers. The organisms identified are 
consistent with the patient’s skin flora 
and may include a wide range of organ­
isms in patients with rest pain or ulcera­
tion. Contamination occurs prominently 
at preclotting and can be decreased but 
not controlled by changing gloves. Ongo­
ing contamination occurs throughout the 
handling and placement of the graft. 
Antibiotics should be used in an attempt 
to control established infection due to this 
contamination.
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ROYAL COLLEGE SYMPOSIUM
Symposium on the Controversial Aspects 
of Colonic and Rectal Carcinoma
Introduction
i h
<
Carcinoma of the large bowel is one of 
the most common visceral malignant 
lesions seen in the West. Worldwide inci­
dence is also high with geographic varia­
tions. In North America, the age-adjusted 
mortality per 100 000 population shows 
the highest rates in Canada (19.5), fol­
lowed by the United States (17), then 
Mexico (2.9). The diagnosis and manage­
ment of patients affected with carcinoma 
of the large bowel is therefore of great 
concern to physicians and surgeons in 
these countries.
This symposium has brought together 
a distinguished panel of speakers to share 
with us their practice and recommenda­
tions in dealing with this common car­
cinoma.
There is a saying that we should learn 
from the mistakes of others, for we can­
not live long enough to make them all 
ourselves. This adage should be 
paraphrased for our panel of specialists 
so that “ we should learn from the 
experiences of others for most of us as 
general surgeons cannot have the volume 
or live long enough to have them all our­
selves” .
Our first speaker, Professor John 
Goligher, is well known for his many arti­
cles and his up-to-date complete text­
book, “ Surgery of the Anus, Rectum and 
Colon” . Professor Goligher will present 
a paper on sphincter-saving operations 
for rectal carcinoma.
Surgery must still be the principal treat­
ment for malignant tumours of the large 
bowel. The 5-year survival rates have not 
really improved over the past 30 years. 
Technically, surgery may have advanced 
as far as it can, so we require other 
modalities to assist us in extending treat­
ment. The word “ adjuvant” is defined as 
assisting, aiding or assisting another. Dr. 
Norman Wolmark’s paper on the role of 
adjuvant chemotherapy in colorectal car­
cinoma will help to do that.
The first two contributors deal with 
what is hoped, initially, to be a curative 
approach to colonic and rectal carcinoma. 
To deal with the real spectre of recurrence 
of the disease, which will occur in approx­
imately 50% of patients, regardless of 
stage, Dr. Bernard Langer will present his 
views and recommendations on the 
management of metastatic disease secon­
dary to colorectal carcinoma and Dr. 
Alfred Ketcham will discuss the manage­
ment of recurrent rectal carcinoma.
We know that in 50% of patients who 
have recurrent disease after an operation 
for cure, the recurrence will appear in the 
first 18 months and the remainder within 
4 to 6 years of the operation. Since there 
is approximately 50% 5-year survival, 
regardless of stage, how can we tell which 
patients will have recurrent tumour? This 
places a considerable commitment for 
after-care and follow-up on the physician 
and patient alike. Dr. James Langevin of 
Calgary will tell us what he considers to 
be the appropriate follow-up for patients 
with colorectal carcinoma.
R obert  H. T h o r la k so n , m d ,
FRCS, FRCSC, FACS
Symposium chairman
Professor of Surgery,
University of Manitoba,
Winnipeg Clinic,
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1. Current Use of Sphincter-Saving Excision 
in the Radical Treatment of Rectal Cancer
The author examines the recent 
increased use of sphincter-saving forms 
of excision to treat carcinomas of the 
middle third and upper part of the lower 
third of the rectum. This trend has been 
due chiefly to technical innovations — 
especially the introduction of the circular 
stapler, which has extended the down­
ward reach of low anterior resection — 
and the willingness to accept a distal 
margin of clearance in resections of 2.0 
to 2.5 cm instead of 4 to 5 cm.
Published data show that these inno­
vations are associated with a low opera­
tive mortality and that satisfactory 
anorectal function can be retained. 
Insufficient length of follow-up, however, 
has made it impossible so far to calcu­
late valid long-term survival rates and the 
high incidence of local recurrence in 
some reports has been disturbing.
L'auteur examine I'augmentation r6cente 
du recours b des formes d'excision 
visant a sauvegarder le sphincter dans le 
traitement des cancers du tiers moyen et 
de la partie superieure du tiers inferieur 
du rectum. Cette tendance est due prin- 
cipalement a des innovations techniques 
— tout sp6cialement a I'av&nement de la 
brocheuse circulaire et etend la portee 
vers le bas de la resection anterieure 
basse — et (’acceptation pour la resec­
tion d'une marge distale de 2.0 £ 2.5 cm 
plutot que 4 a  5 cm.
Les publications r£v£lent que ces inno­
vations sont reliees a une faible mortalite 
peroperatoire et qu'elles permettent de 
conserver une fonction anorectale ade-
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quate. Le peu de recul du suivi fait tou- 
tefois qu'il est impossible de calculer un 
taux de survie a long terme valable, et la 
frequence eievee des recidives locales 
signaiee dans certaines publications est 
inquietante.
In a patient with carcinoma of the rec­
tum, it is a very pleasant bonus to be able 
to excise or destroy the tumour in such 
a way that a permanent colostomy is not 
necessary — provided that this does not 
increase the operative mortality, lessen the 
prospects of ultimate cure or leave 
anorectal function so impaired as to 
represent little better than a perineal 
colostomy.
For virtually all carcinomas of the 
upper third of the rectum, this ideal can 
be readily attained by conventional 
anterior resection.1,2 It is when we apply 
sphincter-saving resection to cancers of 
the middle and lower parts of the rectum 
that controversy arises. At one time most 
surgeons were reluctant to use this oper­
ation for such lesions for various reasons 
(Table I). Over the past 6 or 8 years, there 
has been a revival of interest in more con­
servative surgery for malignant disease of 
the middle and lower thirds of the rectum. 
This has been due mainly to technical 
advances.
Before discussing these innovations, I 
want to emphasize that what makes it 
possible even to contemplate sphincter­
saving resection, certainly for cancers of 
the middle and lower segments of the rec­
tum, is the fact that when the lateral liga­
ments are divided at operation and the 
rectum is mobilized down to the anorec­
tal ring, the anteroposterior and lateral 
curvatures of the rectum are abolished 
and the bowel straightens out and 
lengthens (Fig. 1). Consequently, a 
tumour seen preoperatively at sig­
moidoscopy to be 5 to 6 cm from the anal 
verge moves proximally to 7 to 8 cm so 
that it can be resected together with a dis­
tal margin of clearance of 2.0 to 2.5 cm 
— now considered adequate by most,2-5 
but not all,6 surgeons — and yet leave 
the anal canal and sphincters intact, often 
with a small fringe of rectal ampulla. The
FIG. 1—When lateral ligaments are divided 
and bowel is mobilized down to anorectal ring, 
rectum straightens out and lengthens, so that 
tumour 5 to 6 cm from anal verge on preoper­
ative sigmoidoscopy rises to 7 or 8 cm, allow­
ing resection to be performed with distal mar­
gin of clearance of 2 to 3 cm, yet leaving intact 
not only anal canal and sphincters but also 
small fringe o f rectal ampulla (after 
Goligher2).
Table 1-Choice of Radical Operation in 100 Consecutive Unselected Patients 
With Rectal Carcinoma
No. of
Site of tumour Operation patients
Upper and middle thirds Anterior resection with hand suture 55
Difficult growths of middle 
third and some of lower third
Extended low anterior resection with stapler 
Abdominoanal or abdominosacral resection 
Hartmann's procedure or abdominoperineal excision 
with colostomy
20
Remaining growths of lower 
third or anal canal
Abdominoperineal excision with colostomy 25
In addition 2 or 3 very early tumours in the lower third might be deemed suitable for local excision
or destruction instead of abdominoperineal excision, according to the philosophy of the surgeon.
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problem then is whether and how colorec­
tal continuity can be restored.
Much depends on the site of the 
growth, on the sex and physique of the 
patient (low resections are much easier in 
women than men and in thin than obese 
subjects) and on the technical methods 
that the surgeon can deploy. If standard 
anterior resection is the only sphincter­
saving method he can offer, some of his 
patients (mainly men with tumours of the 
lower middle third of rectum), though 
eligible on pathological grounds for a 
sphincter-saving resection, will be denied 
that opportunity and instead be treated 
by abdominoperineal excision and crea­
tion of a permanent colostomy.
Alternative Methods of Sphincter- 
Saving Excision (or Treatment)
Abdominoanal (Pull-Through) Resection
Originally, this technique achieved
Fig. 2b
FIG. 2—Roentgenograms after small cau­
tiously administered Gastrografin enemas, 12 
days following low anterior resection in very 
obese men with carcinomas of lower middle 
third of rectum. Sites of anastomoses are indi­
cated by metal staples. There is no leakage 
(after Goligher2).
union between the resulting colonic stump 
and the anorectal remnant simply by 
drawing the colon through the latter, to 
protrude for 7 to 10 cm beyond the anus. 
After 2 or 3 weeks the excess colon was 
amputated. Later versions have been 
more elaborate, as in Parks’s method,7 
which provides for a sutured endocavitary 
coloanal anastomosis. Abdominoanal 
resection was once popular in certain 
clinics in the United States but its 
popularity has declined.2
Abdominosacral (or Abdominoposterior 
Transsphincteric) Resection
In abdominosacral resection,2 after a 
thorough mobilization of the left colon 
and rectum down to the anorectal junc­
tion during an initial abdominal phase, 
resection and anastomosis are performed 
through a sacral incision. Currently, the 
leading exponent of this technique is 
Arthur Localio of New York,8 who has 
had most impressive results with it. In 
Britain, Mason9 has been an equally 
staunch advocate of a modification of the 
operation in which the sacrococcygeal 
approach is replaced by a posterior trans­
sphincteric one. Despite the enthusiastic 
reports of these two advocates, neither 
version of the procedure has attracted 
much support.
Extended Low Anterior Resection 
Using the New Circular Staplers
From personal experience2 with 
abdominoanal and abdominosacral resec­
tion, I know that both are eminently prac­
ticable methods, but unquestionably far 
simpler to perform and much more popu­
lar is the extended low anterior resection
Table II—Characteristics of a Sessile Rectal 
Cancer, Suggesting That it May Be an Early or 
Entirely Submucosal Lesion
Not more than 3 cm in diameter 
Protuberant or not deeply ulcerating 
Mobile on underlying muscle coat 
No palpable pararectal lymph nodes 
At least moderately well differentiated on biopsy
Table Ill-Satisfactory Findings on 
Histopathological Examination of Disc-Removal 
Specimen of Rectal Carcinoma
Confirms that in no part of the tumour on 
multiple sections is the lesion of less than 
average differentiation
Shows that the tumour is confined to the 
submucosa or at most invades only the most 
superficial part of the muscle coat 
Reveals a margin of 0 .5 -1 .0  cm of normal 
bowel wall at all parts of the periphery of 
the lesion
using the new circular staplers.2'10 The 
great attraction of the circular stapler is 
not that it constructs anastomoses more 
quickly or securely than hand suturing but 
that it makes possible from above some 
anastomoses that would be impossible 
without it, especially in heavily built men 
with tum ours of the low middle 
third2'10'11 (Fig. 2). With the aid of the 
stapler, about 15% of patients requiring 
operation for cancer of the rectum can 
now have an anterior resection.
Local Disc Excision o f  the Primary 
Tumour Through a Perianal or Posterior 
Transsphincteric Approach,2 or Its Des­
truction by Diathermy Fulguration'2-'3 
or Endocavitary Contact Irradiation'4
The rational use of these measures 
depends on two conditions. The first is 
that on pathological examination of 
excised specimens, some rectal cancers are 
found to be confined strictly to the rec­
tal wall (Dukes’ class A); 15% of tumours 
are in this category with 3% actually lying 
entirely within the submucosa.2 The 
second is that it is possible to recognize 
with a high degree of accuracy (although 
not 100%) on clinical examination which 
carcinomas are in this category. To les­
sen the risk of error, most surgeons try 
to select for purely local treatment not 
just Dukes’ class A cases but also those 
with submucosal lesions, using the clini­
cal criteria listed in Table II. But I stress 
that, even if the surgeon is correct in 
determining that direct spread of a 
tumour is confined to the submucosa, 
there is still an 11 % risk of nodal 
metastases being present,15 for which 
purely local therapy is quite ineffective. 
To compensate for this weakness, local 
treatment carries virtually no operative 
mortality, even in poor-risk patients, as 
against an immediate mortality for rec­
tal excision in such unfit subjects of 8% 
to 10%. In other words, local excision or 
destruction is best reserved for patients 
with early favourable lesions, who are 
also unfavourable candidates for formal 
rectal excision.
Relative Use of Sphincter-Saving 
Techniques for Cancers of the Middle 
or Lower Thirds of Rectum
In Table III, I have attempted to put 
the indications for the recently favoured 
sphincter-saving procedures for carci­
nomas of the middle and lower part of 
the rectum in proper perspective in the 
overall management of rectal cancer. As 
many as 75% of patients with rectal 
cancer may npw be treated by a sphincter­
saving type of resection—in about 55%, 
a conventional anterior resection with 
hand suture may be used, while in 20% 
other forms of sphincter-saving resection 
are required for lesions in the middle or
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Table IV-Comparison of 5-Year Survival Rates After Abdominoperineal Excision and Abdominoanal 
Resection for Carcinomas of the Middle Third of the Rectum
Type of operation
Level above 
anal verge, cm
No. patients 
treated
No. (%) alive 
>  5 yr
Abdominoperineal excision 6-10 182 93 (51)
Abdominoanal resection 5-10  (in 81% of cases) 131 69 (53)
Hospital deaths and palliative cases were excluded. Adapted from Waugh and Turner.21
Table V-Incidence (%) of Local Recurrence After Abdominoperineal 
Excision for Rectal Carcinoma According to Various Authors
Series
Stearns and Morson and
Binkley23 Gilbert sen24 associates25
Site of lesion (N = 369) (N = 117) (N -  1596)
Upper third 14 ? 5
Middle third 20 ? 8
Lower third 30 ? 14
All sites 22 24 10
Table VI—Incidence of Local Recurrence After Anterior Resection With Hand Suture for Rectal Cancers 
in the Upper and Middle Thirds of the Rectum
Series
Deddish and Stearns, 196126 Cullen and Mayo, 196327
Site of lesion No. No. (%) No. No. (%)
in rectum treated recurrences treated recurrences
Upper third 99 5 (5) 158 20(13)
Middle third 51 6112) 81 19(23)
All sites 150 11(7.3) 239 39(16)
Of 50 local recurrences, 32 were anastomotic, 18 pelvic.
lower thirds. Purely local treatment is 
reserved for as few as 2% to 3% of 
patients with growths in the lower third.
Results of the Newest Sphincter-Saving 
Forms of Resection for Cancers of the 
Middle and Lower Thirds of the Rectum
Operative Mortality and Morbidity
There are many published re­
ports2'8,11'16'20 showing that the operative 
mortality after the three forms of resec­
tion has been roughly similar, about 3% 
to 4%. The average incidence of anasto­
motic leakage after low stapled anasto­
moses has been about lWo2'10’11'16'17 and 
a similar figure is quoted in the literature 
for abdominoanal and abdominosacral 
resections,8'18'19 although my modest 
experience2 of the latter two procedures 
has been less favourable, with more com­
plications from dehiscence, pelvic sepsis 
and hematoma formation than after low 
anterior resection with the stapler.
Functional Results
Recent experience with very low resec­
tions has shown conclusively that after 
colorectal anastomoses as low as 4 and 
5 cm from the anal verge or even after 
coloanal anastomoses, anal control can 
eventually often be normal.2,17 The rele­
vant word is “ eventually” , because func­
tion is at first usually greatly disturbed, 
with frequency and urgency of defeca­
tion; often the patient has 8 to 12 bowel
Table VII--Incidence of Local Recurrence After Sphincter-Saving Resection for Carcinomas 
Mainly of the Middle Third of the Rectum in Recent Years
Series Operative method
Period of 
follow up, yr
No. patients 
treated
No. (%) of 
recurrences
Goligher, 19821 Abdominosacral 2 -5 18 2(11)
Localio and associates, 19838 Abdominosacral 5 + 89 13(15)
Parks and Percy, 198219 Abdominoanal 1-5 73 6(8)
Keighley and Matheson, 198020 Abdominoanal 1-3 7 3(43)
Hurst and associates, 198228 Anterior resection with stapler 0.5-2 34 11 (32)
Luke and associates, 198329 Anterior resection with stapler 2.5-5 44 10(23)
Anderberg and associates, 198330 Anterior resection with stapler ? 39 9(23)
Lasson and associates, 198431 Anterior resection with stapler 0.5-3 40 8(20)
Reid and associates, 198432 Anterior resection with stapler 2 -6 29 8(28)
Heald, 1984 (personal communication) Anterior resection with stapler 0.5-4 110 3(3)
Oates, 1984 (personal communication) Anterior resection with stapler 0 .5-4 60 4(7)
Goligher, 1984 (unpublished data) Anterior resection with stapler 2 -7 120 11(9)
Table VIII—Outcome of Local Excision for Small Early Frank Sessile Rectal Cancers According to Various Authors
Series Method
No. of 
patients
Early reoperation 
for suspected 
incomplete 
removal, %
Length of 
follow­
up, yr
No. (%) of 
recurrences
No. (%) 
of cancer 
deaths
Hawley and Ritchie, 198033 Mostly peranal 42 14 1-30 7 (20)* 216)*
Hermanek and associates, 198034 Peranal 48 20 Mean 3 5(13)* 1 (3)*
Mason, 1983 (personal communication) Posterior trans sphincteric 36 ? 5-15 5(14) 2(6)
“ Patients having early rectal excision were excluded from the calculation of local recurrence.
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movements in 24 hours that cannot 
always be completely controlled. 
However, over the next 3 to 6 months, 
there is usually gradual improvement, the 
frequency of bowel movements is reduced 
to four or fewer daily and full continence 
is regained.
Ultimate Cure
Five-year survival.—Unfortunately, 
not enough patients with growths of the 
middle and lower thirds of the rectum 
have yet been treated by the newer 
sphincter-saving resections or followed up 
for long enough to enable worthwhile 
5-year survival rates to be calculated; in 
another 2 or 3 years sufficient data should 
emerge. Meanwhile, some older statistics 
from the Mayo Clinic warrant attention. 
There, in the 1940s and 1950s, John 
Waugh did many abdominoanal resec­
tions for tumours of the middle third of 
the rectum. He used the Bacon-Babcock 
technique2 which gave poor functional 
results and has since been abandoned; 
nevertheless, insofar as excision was con­
cerned, this technique did not differ sig­
nificantly from the more recent tech­
niques of sphincter-saving resection now 
in favour. Admittedly, Waugh and 
Turner’s21 comparison of abdominoanal 
resection with abdominoperineal excision 
(Table IV) was not properly controlled, 
but it did suggest that the two operations 
were almost equally effective in the cure 
of middle-third tumours. A similar study 
recently from St. Mark’s Hospital, Lon­
don,22 reached the same conclusion.
Incidence or absence o f  local recur­
rence.—As is well known, local recur­
rence is a not-infrequent sequel to 
abdominoperineal excision for rectal 
cancer, being commoner the more 
advanced the growth and the lower it is 
located in the rectum (Table V23'25). It 
might have been expected that recurrence 
would be at least as frequent after 
sphincter-saving resections. That this is 
not so is presumably owing to a degree 
of selection of patients for these opera­
tions with rejection of those who have 
really low growths or particularly exten­
sive spread. But the incidence of local 
recurrence after sphincter-saving resection 
also increases the more advanced the 
lesions are and the deeper they lie in the 
rectum (Table VI26,27). Some of the 
recurrences are closely related to the 
anastomotic site, others are more 
diffusely situated in the pelvis. The data 
in Table VI relate to patients treated in 
the late 1950s. As the tendency in the 
recent revival of sphincter-saving resec­
tions has been to take on even lower 
growths, a still greater incidence of local 
recurrence would be a reasonable conse­
quence. Some recent reports (Table 
y j j i t8,i9,20,28-32) have jn fact recorded
recurrence rates of the order of 30% after 
extended low anterior resection using the
circular stapler, but fortunately several 
other workers, who have used the stapler 
a great deal for this purpose, have not so 
far encountered any large number of local 
recurrences. Obviously, these recurrence 
rates need to be monitored closely. It is, 
however, hard to understand how the 
method of joining two segments of bowel 
together should affect the incidence of 
recurrence.
Results of Local Excision of the Primary 
Tumour
Some of the more important published 
reports on the results of local removal are 
shown in Table VIII. It should be empha­
sized that the lesions dealt with in all these 
cases were small, frank, sessile carci­
nomas and not just apparently benign 
polyps removed by snaring and found on 
histologic examination to be malignant. 
The series of Hawley and Ritchie33 and 
Hermanek and colleagues34 represented 
the collective efforts of St. Mark’s Hospi­
tal, London and the University Surgical 
Clinic, Erlangen, respectively, while the 
report from Mason (personal communi­
cation, 1983) refers to an entirely personal 
series. In the first two series note the 
resort to early reoperation in 14% and 
20% of the cases, when the pathologist 
found that the growth in the excised disc 
specimen was more deeply invasive or 
more active than had been thought on the 
preoperative clinical examination and 
biopsy. A 10% to 20% recurrence rate 
may not seem excessive, but it must be 
remembered that nearly all the cases in 
these series had Dukes’ A or super A 
(entirely within the submucosa) lesions, 
which makes it somewhat less creditable.
Conclusions
Evidence has accumulated to show 
that, in the recent wave of sphincter­
saving excisions for cancers of the mid­
dle and lower parts of the rectum during 
the past decade, most of the objections 
hitherto levelled at this type of operation 
for such tumours seem to have been over­
come. However, there is still uncertainty 
as to the precise incidence and mechan­
ism of local recurrence after their use for 
very low lesions and continued close scru­
tiny of this issue is of paramount impor­
tance.
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2. Adjuvant Chemotherapy in Colorectal Cancer
The current status of adjuvant therapy 
for colorectal cancer is reviewed using 
examples from selected, recently com­
pleted, randomized, prospective, clinical 
trials. Although adjuvant systemic ther­
apy is of limited therapeutic efficacy in 
cancer of the colon, there have been 
examples of beneficial effects in specific 
patient subsets. The rationale and cur­
rent status of adjuvant portal vein 
hepatic perfusion suggest that it 
represents a potentially promising 
approach that must be evaluated in a 
large prospective randomized study. 
Finally, the value of adjuvant radiother­
apy and chemotherapy for carcinoma of 
the rectum is assessed. Although one 
study has demonstrated increased 
disease-free survival for patients receiv­
ing a combination of chemotherapy and 
radiotherapy, the small numbers in the 
study preclude any definitive conclu­
sions. The current National Surgical 
Adjuvant Breast Project, rectal protocol 
R-01, the largest rectal cancer study 
with a concomitant "untreated" control, 
is reviewed and discussed.
La situation actuelle des traitements 
d'appoint du cancer colorectal est etu- 
diee a la lumiere d'exemples tires 
d'essais cliniques prospectifs randomises 
qui ont ete termines recemment. Bien 
que le traitement systemique d'appoint 
soit d'une efficacite therapeutique limitee
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dans le cancer du colon, on a constate 
des exemples d'effets benefiques parmi 
des sous-groupes specifiques de mala- 
des. Les raisons et la situation presente 
de la perfusion veineuse porte utilisee en 
traitement d'appoint indiquent que cette 
approche represente possiblement une 
m£thode prometteuse valant la peine 
d'etre evaluee dans un vaste essai ran­
domise. On examine finalement I'interet 
de la radiotherapie et de la chimiothera- 
pie d'appoint pour le cancer du rectum. 
Bien qu'une etude ait montre une prolon­
gation du temps de survie exempt de 
maladie chez des patients qui ont regu 
une association de chimiotherapie et de 
radiotherapie, le petit nombre de sujets 
compris dans I'etude ne permet aucune 
conclusion definitive. Le protocole R-01 
du National Surgical Adjuvant Breast Pro­
ject pour le cancer du rectum, la plus 
vaste etude du cancer du rectum ayant 
un groupe temoin "non traite," est 
decrit et commente.
The emphasis placed on studies in adju­
vant therapy depends on the natural his­
tory of the disease under consideration. 
Survival data for colorectal cancer indi­
cate that a complacent attitude towards 
surgery alone is unjustified. The belief 
that microdissemination is present at the 
time of surgery has led to current efforts 
in assessing systemic therapy as an 
adjunct to operative resection. The 
greatest drawback to the use of adjuvant 
chemotherapy for colorectal cancer is the 
failure to identify agents that are partic­
ularly effective in patients with advanced 
disease. Colorectal cancer is particularly 
resistant to chemotherapeutic manipula­
tions. The early promise of such combi­
nations as methyl-cyclohexyl-chloroethyl- 
nitrosourea (MeCCNU), 5-fluorouracil 
(5-FU) and vincristine (VCR) for 
advanced colorectal cancer has been 
dampened by the subsequent demonstra­
tion that these combinations have no 
advantage over 5-FU alone.1'2 The previ­
ous generation of randomized prospective 
trials in adjuvant chemotherapy for 
colonic cancer has been based mostly on 
the nitrosourea-fluorinated pyrimidine
baseline, but the anticipated synergism 
between the two agents was found to be 
specious in the setting employed. Even 
though the premise for those adjuvant 
trials was erroneous, it was essential to 
review the data objectively.
Adjuvant Clinical Trials of 
Multiple Agents
Selected representative examples of 
adjuvant clinical trials will provide a 
reasonable overview of the whole. It is 
regrettable that some studies did not 
include a concurrent “ untreated” control, 
thus eliminating the ability adequately to 
analyse the data and to assess the natural 
history of the disease in a controlled set­
ting. The following three studies illustrate 
the current efforts being made to treat 
colonic cancer.
Veterans’ Administration Surgical Oncol­
ogy Group (VASOG), Protocol 27 A 3
This trial (Table I), which studied 653 
patients between 1973 and 1979, deserves 
special mention because it provides the 
longest follow-up of any study of com­
bination chemotherapy, nearly all 
patients having been studied for 5 years. 
Patients randomized to receive chemo­
therapy were given 5-FU intravenously, 
9 mg/kg daily for 5 successive days, along 
with a single oral dose of MeCCNU, 120 
mg/m2, on day 1. Cycles were repeated 
every 7 weeks for 12 months. Of the 653 
patients, 645 were available for evalua­
tion. When the data were analysed in all 
patients without regard for nodal status, 
no significant differences in survival were 
found.3 However, when the presence or 
absence of regional nodal metastases were 
considered, patients with positive nodes 
demonstrated prolonged survival that was 
attributable to the chemotherapy. This 
statistically significant difference (p = 
0.004) in survival was derived exclusively 
from patients with one to four nodes posi­
tive for malignant disease. This study 
represents one of the few instances in 
which com bination chemotherapy 
appears to have altered the natural his-
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tory of colonic cancer, although the alter­
ation was limited to a specific subset of 
patients.
Gastrointestinal Study Group (GITSGJ, 
Protocol 6175 4
This study was started in 1975 and 
completed in 1979 after 621 patients had 
been randomized (Table I). It was a four- 
arm study evaluating combination 
chemotherapy (MeCCNU and 5-FU) and 
immunotherapy (methanol-extractable 
residue of bacille Calmette Guerin [MER- 
BCG]). It included only patients with car­
cinoma of the colon (more than 12 cm 
from the anal verge) with full-thickness 
penetration and positive nodes (Dukes’ 
classes B and C). Patients were stratified 
according to the number of positive 
nodes; a C, lesion was defined as a 
tumour associated with fewer than five 
histologically positive nodes and a C2 
lesion as being associated with five or 
more positive nodes. It is interesting that, 
unencumbered by the results from the 
VASOG study, the G1TSG trial 6175 has 
been cited as indicative of the failure of 
adjuvant chemotherapy to prolong 
disease-free survival.4 The data indicated 
that after more than 5 years of follow-up, 
no significant differences were apparent 
for either recurrence or survival. The 
prolonged time to recurrence previously 
reported for com bined chemoim- 
munotherapy was no longer significant in 
the most recent analysis. A critically 
important aspect of this study was the 
demonstration that 29% of the patients 
receiving chemotherapy suffered grade 2 
or worse hematologic toxicity and seven 
patients were noted to have acute non- 
lymphocytic leukemia, presumably drug- 
related. This information stresses the need 
to assess any putative benefits in the light 
of potential risk.
National Surgical Adjuvant Breast 
Project (NSABP), Protocol C-OI
This protocol (Fig. 1, Table I) was 
initiated in 1977 and was terminated in 
1983 after 1166 patients with Dukes’ class 
B or C tumours had been entered; this 
was the largest number accumulated in 
the current series of clinical trials. 
Patients were randomized into three 
arms: (a) control, no further treatment 
after curative resection, (b) chemotherapy 
and (c) BCG. Eligibility was limited to 
patients with standard Dukes’ class B 
lesions (Kirklin B2) and those patients 
with Dukes’ class C tumours. A colonic 
tumour was defined by the protocol as 
any lesion that did not require opening 
of the pelvic peritoneum to identify the 
distal margin. The chemotherapy differed 
from the other cooperative groups in that 
three drugs were used: 5-FU, MeCCNU 
and vincristine. The results of this study 
have taken on a greater importance in the 
light of the apparently conflicting conclu­
sions obtained from the VASOG and 
GITSG studies. Preliminary results (an 
average study period of 41 months) indi­
cate that the chemotherapy cohort 
demonstrates a small but significant 
(p = 0.05) prolongation in disease-free 
survival independent of the Dukes class.
The differences noted with adjuvant 
combination chemotherapy are clearly of 
limited therapeutic application. With the 
documented risk of acute non-lympho- 
cytic leukemia attributable to MeCCNU, 
it is inappropriate to use nitrosourea com­
binations in the adjuvant setting. From 
a biologic standpoint, however, it may 
very well be that colonic cancer, like 
breast cancer, is manifesting a heter­
ogeneous response to adjuvant therapy in 
that certain subsets may demonstrate a 
response to adjuvant chemotherapy.
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Adjuvant Clinical Trials of Local 
and Regional Therapy
Before discounting studies in which the 
therapy is regionally oriented, I must 
point out that the most intriguing prelimi­
nary results have been provided by just 
such a study. In 1975, Taylor and associ­
ates, in Liverpool, initiated an adjuvant 
trial in which the portal vein was infused 
with 5-FU following resection of the 
primary tumour.5'7 The logic for this was 
based on the contention that in a substan­
tial proportion of patients with colorec­
tal cancer, metastases will develop in the 
liver as the first and only site of recur­
rence. Although the exact incidence of 
hepatic metastasis is difficult to establish, 
it has been argued that a therapeutic regi­
men which could effectively decrease 
hepatic metastasis would alter the natural 
history of the disease and result in 
improved survival. Although most evi­
dence suggests that established hepatic 
metastases are supplied predominantly by 
the hepatic artery, the portal vein has 
been found to play an important role, 
particularly in supplying smaller tumours. 
Thus, in the trial undertaken by Taylor’s 
group, patients were randomized after 
resection to receive portal vein hepatic 
perfusion through the umbilical vein or 
no further treatment. 5-fluorouracil was 
given on 7 successive days (1000 mg/d) 
starting postoperatively; heparin (5000 
units/d) was also given. Between 1975 
and 1981,212 patients entered the study; 
97 were evaluated in the control group 
and 90 in the perfusion group. Hepatic 
metastases developed in 17 control 
patients compared with 5 treated patients; 
however, the incidence of local and 
regional recurrences appeared unchanged. 
The patients who seemed to sustain the 
greatest benefit from therapy were those 
with Dukes’ class B tumours; those with 
class C lesions derived minimal benefit.
FIG. 1—National Surgical Adjuvant Breast 
Project, protocol C-01. 5-FU = 5-fluorouracil, 
MeCCNU = methyl-cyclohexyl-chloroethyl- 
nitrosourea (semustine), VCR = vincristine, 
a = 325 mg/m2 intravenously, days 1 to 5, 
375 mg/m2, days 36 to 40. b = 130 mg/m- 
orally, day 1. c = 1 mg/m2 (max 2 mg) 
intravenously, days 1 and 36. a, b and c every 
10 weeks for eight courses, d = scarification 
every week for 12 weeks, then every 2 weeks, 
28 times.
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These results were achieved with very lit­
tle toxicity.
The design and patient randomization 
in this study have been criticized. The 
5-FU dose was constant and was not 
determined by the patient’s surface area. 
Moreover, the effect of adding heparin 
to the infusate was not controlled and it 
is possible that the heparin may have had 
a tumour-inhibiting effect. The criteria 
for eligibility were such that some patients 
with Dukes’ class D tumours were 
entered, making data interpretation more 
difficult. In spite of these criticisms, the 
study provided preliminary results that 
warrant optimism. If nothing else this 
treatment regimen is certainly worth test­
ing on large numbers of patients in a 
cooperative group setting.
In an effort to assess the propriety of 
portal vein hepatic perfusion, the NSABP 
initiated protocol C-02 in March 1984. 
Patients with colorectal carcinomas in 
Dukes’ classes A, B and C are ran­
domized to receive portal vein hepatic 
perfusion with 5-FU, 600 mg/m2, and 
5000 units of heparin on 7 successive days 
or no further treatment following colonic 
resection carried out for cure. To date, 
over 300 patients have entered the study. 
This trial represents a definitive test of 
regional hepatic perfusion in the adjuvant 
setting and will be instrumental in assess­
ing a potentially innovative adjuvant 
therapy.
Adjuvant Trials in Rectal Cancer
Two studies have satisfactorily  
addressed the propriety of adjuvant ther­
apy in rectal cancer (Table II).
Gastrointestinal Study Group,
Protocol 7175
In this study a beneficial effect has been 
claimed for adjuvant therapy. Because of 
the important influence that these find­
ings may have and have already imparted, 
it is essential to review the data carefully 
and in detail. This study was started in 
1975 and terminated in September 1980 
after 227 patients had been randomized; 
202 were available for evaluation. The
study defined a rectal cancer as being 
within 12 cm of the anal verge. Patients 
were randomized into four arms after 
resection of the primary tumour (Table 
II): (a) control — no further treatment, 
(b) chemotherapy consisting of MeCCNU 
and 5-FU, (c) radiotherapy consisting of 
4000 to 4800 rad delivered in 4 Vi to 5 Vi 
weeks and (d) a combination of b and c. 
The initial projected sample-size estimates 
were for 520 patients to be evaluated in 
order to detect a 50% increase in median 
survival time for 2 to 3 years. In Febru­
ary 1980, it was noted that one of the ran­
domized arms was inferior to the other 
three; as a result, that arm was unblinded. 
The inferior group proved to be the con­
trol group and as a result randomization 
into this arm was discontinued and the 
protocol was terminated shortly there­
after. Consequently, the number of 
patients in each group is small: of the 202 
patients, 58 were untreated, 48 received 
chemotherapy, 50 radiotherapy and 46 
combination therapy. Results of this 
study after a median follow-up of 80 
months have recently been disclosed.8 
They indicated that 55% of the control 
group had recurrent tumour compared 
with 46% for chemotherapy alone, 48% 
for radiotherapy and 33% for the com­
bined regimen.8 A significant (p = 0.009) 
pair-wise difference in disease-free sur­
vival was noted when the control group 
was compared with the combined therapy 
group. The strongest therapeutic benefits 
were evident in patients with Q  lesions 
(fewer than five affected nodes) in whom 
significant differences were evident 
among the treatment arms. Analysis of 
site of recurrence information again sug­
gested an advantage in favour of the com­
bined treatment arm. There was no sig­
nificant difference in survival for any of 
the treatment arms over operation alone. 
Two treatment-associated deaths in the 
combined treatment arm were attributed 
to radiation enteritis. The long-term inci­
dence of radiation enterocolitis has yet to 
be determined. The toxicity of this regi­
men has been addressed by a subsequent 
rectal protocol initiated by the GITSG in 
1980 (GITSG 7180). This study represents 
a retreat from GITSG 7175 in that the
identical combined radiotherapy-chemo­
therapy arm is compared to one in which 
the MeCCNU has been eliminated in fa­
vour of the 5-FU only.
The data from the GITSG protocol 
7175 must be regarded as a major con­
ceptual advance. They must be viewed as 
an important initial indicator of the value 
of adjuvant therapy in patients with 
Dukes’ class B and C rectal cancers. 
However, with only 46 patients available 
for analysis in the group demonstrating 
the greatest benefit and with the magni­
tude of major toxicity encountered, it is 
premature and inappropriate to extrapo­
late these results to the treatment of 
patients outside the context of clinical 
trials. The GITSG results must await con­
firmation from trials now in progress in 
which adequate sample sizes are available.
National Surgical Adjuvant Breast 
Project, Protocol R-01
The final study that merits review is 
that of the NSABP. This study was 
initiated in 1977 and to date over 500 
patients with Dukes’ class B or C rectal 
lesions have been randomized after resec­
tion into three treatment arms: control 
with no further treatment, chemotherapy 
consisting of 5-FU, MeCCNU and VCR 
and postoperative radiotherapy with a 
central midline dose of 3200 to 4000 rad 
delivered in 18 to 22 fractions (Fig. 2). A 
rectal tumour is defined by this study as 
one that requires the intraoperative open­
ing of the pelvic peritoneum in order to 
define the distal margin of the lesion. This 
protocol, which has presently accrued the 
largest number of patients, is the only 
study currently in a position to compare 
the results of adjuvant chemotherapy and 
radiotherapy to a concomitant untreated 
control. Consequently, the results of this 
study are of pivotal importance. As of the 
middle of 1984 with 41 months’ mean 
time in the study, there appear to be 
differences in men younger than 65 years. 
Since the groups remain blinded with 
respect to identity, conclusions on the 
efficacy of the treatment modalities can­
not be formulated. Until the results of this 
study become available, adjuvant therapy
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FIG. 2—National Surgical Adjuvant Breast Project, protocol R-01. a, b and c as in Fig. 1.
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either in the form of chemotherapy, radi­
otherapy or the combination of the two 
must be regarded as experimental in car­
cinoma of the rectum.
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3. Colorectal Cancer: Managing Distant Metastases
The best opportun ity  fo r cure in colorec­
tal cancer is early diagnosis and com ­
plete excision o f the primary disease. 
Currently, m etastatic disease develops in 
about 50%  o f patients, m ost o ften  in the 
liver. Resection o f so lita ry liver 
metastases is warranted, and a 5-year 
survival o f a t least 25%  can be 
expected. Patients w ith  lim ited unilobar 
m ultiple metastases may also benefit 
from  resection. Extensive m etasta tic 
disease to  the liver may respond to  sin­
gle or combination chem otherapy. 
Response rates are highest w ith  hepatic 
artery infusion chem otherapy, bu t 
im provem ent in survival has no t clearly 
been shown. Solitary or lim ited lung 
metastases, when unassociated w ith  
other m etastatic disease, should also be 
resected. M ultiorgan invo lvem ent may 
respond to system ic chem otherapy but 
results are generally poor. Palliation is an 
im portant objective o f therapy, involving 
not only anticancer treatm ent (surgery, 
chemotherapy, radiotherapy) bu t also 
general supportive care.
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La meilleure chance de guerison du can­
cer co lorecta l repose sur un diagnostic 
precoce et I'excision com plete de la 
tum eur prim itive . Dans I'e ta t actuel des 
choses des metastases apparaissent 
chez environ 50%  des patients, la plu- 
part du tem ps au foie. La resection des 
m etastases hepatiques solita ires est indi- 
quee et on peut s 'a ttendre a une survie a 
5 ans de 25% . Les patients qui presen- 
te n t des m etastases m ultip les lim itees a 
un seul lobe peuvent aussi p ro fite r d'une 
resection. Les metastases hepatiques 
etendues peuvent repondre h une chim io­
therapie simple ou d is s o c ia tio n . Les 
meilleurs taux de reponse son t obtenus 
par chim iotherapie adm inistree en perfu­
sion dans I'artere hepatique mais on n'a 
pu dem ontrer d 'am elioration nette de la 
survie. Les metastases pulmonaires soli­
ta ires ou lim itees, quand elles ne sont 
pas reliees a d 'autres a tte in tes m etastati- 
ques, devraient aussi etre resequees. Les 
a tte intes de plusieurs organes peuvent 
repondre a une chim iotherapie system i- 
que mais les resultats sont gendralement 
mauvais. Un e ffe t pa llia tif constitue  un 
ob jec tif im portan t du tra item en t e t sup­
pose non seulement le tra item en t anti- 
cancereux (chirurgie, chim iotherapie, 
radiotherapie), mais dgalement des soins 
de soutien generaux.
The 5-year survival rate for resected 
primary colorectal cancer is approxi­
mately 50%, with prognosis being related 
to the stage of the disease. The liver is the 
commonest site of hematogenous spread 
and is involved in over 80% of patients 
who have metastatic disease.1’2 One third 
of these patients have liver involvement 
only, the rest have widespread disease. 
Pulmonary involvement occurs in only 
about 10% to 15% of patients with
metastases and is commoner in those with 
rectal cancer than in those with more 
proximal colonic lesions. Isolated single 
liver metastases are seen in 4% to 5% of 
these patients, and lung metastases in 1 % 
to 2%. Considerable controversy remains 
regarding both the selection of treatment 
for metastatic colonic cancer and the 
expected results from such treatment.
Metastases to the Liver
In patients whose liver metastases are 
a part of widespread secondary disease, 
regional treatment of the liver other than 
for control of symptoms is inappropriate. 
When metastases are confined to the liver, 
regional therapy, consisting of either 
resection or hepatic infusion chemother­
apy, can be considered. To assess the 
results of such therapy, detailed informa­
tion on the natural history of the 
untreated disease is needed.
The expected survival of patients with 
liver metastases from colorectal cancer
Time a fte r m etastases (years)
FIG. 1— Survival of 39 patients with solitary 
(solid line) hepatic metastases, 31 patients with 
multiple unilateral (broken line) hepatic 
metastases and widespread (dotted line) liver 
m etastases, reported  by W agner and 
associates.5
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varies, depending on the extent of liver 
involvement and presence or absence of 
other metastatic disease. The older 
reported data3 4 suggest survival times of 
6 to 9 months for such patients and have 
been used to support claims for effective­
ness of new therapies that produce bet­
ter mean survival in uncontrolled series. 
Clearly, the use of such unselected, 
unstaged historical data is inappropriate, 
since patients who are selected for either 
resection or infusion are usually those 
with regional disease and most often less 
advanced disease as well. If historical data 
are to be used for comparison, the dis­
ease must at least be staged; when this is 
done,5 a difference in survival between 
patients with solitary, unilobar multiple, 
and widespread liver metastases is noted 
(Fig. 1). These data also show that 
without resection even patients with soli­
tary metastases rarely survive for 5 years.
Resection of Liver Metastases
Prim ary and secondary hepatic 
tumours were resected as early as 1888.6 
Reports in the 1950s and 1960s indicated 
survival rates following resection for 
metastatic disease of approximately 
20%.7
The technique of liver resection has 
been improved to the point at which 
major resections can be carried out with 
a mortality of 5% or lower.8’9 It is also 
now widely accepted that the results of 
resection of liver metastases are as good 
with adequate regional resection as with 
formal anatomical lobectomy. The latter 
is performed only to obtain adequate 
tumour clearance and leave viable tissue. 
Critical to achieving this low morbidity 
and mortality are a good understanding 
of hepatic vascular and ductal anatomy, 
and sufficient experience in surgery of the 
liver.
Although many authors now report 
5-year survival rates after resection of 
liver metastases ranging from 25% to 
30%,8,9 there remain differences of opin­
ion regarding the results of synchronous 
versus m etachronous excision of 
metastases, the importance of positive 
lymph nodes related to the primary dis­
ease, and the advisability of resecting 
multiple liver metastases. Virtually no one 
recommends liver resection in the 
presence of uncontrolled primary disease
or other metastatic disease outside the 
liver.
In the past, the tradition was that 
metastases to either lung or liver should 
not be resected until the primary tumour 
was demonstrated to have been controlled 
and other metastases had not ap­
peared.10 Although many still hold this 
view with regard to lung metastases, liver 
metastases are usually treated more 
aggressively. In the extensive review of 
Foster and Berman,8 no significant 
difference in survival was found between 
patients having resection of metastases 
discovered at the time of primary colonic 
resection or of those that appeared later. 
Wilson and Adson9 did note better sur­
vival in metachronously resected secon­
dary lesions but the results from both syn­
chronous and metachronous excision 
were encouraging enough to warrant an 
aggressive approach in both situations.
The survival of untreated patients with 
solitary liver metastases is clearly better 
than in those with multiple metastases.5 
One would expect the same difference in 
the results of resection in these two groups 
of patients. However, the reported data 
do not clearly support this. Five-year sur­
vival reported by Wilson and Adson9 
clearly favours patients with solitary 
metastases. However, the data accumu­
lated by Foster and Berman8 showed no 
clear difference in 5-year survival between 
patients who underwent resection of sin­
gle versus multiple metastases. Their 
study did not clearly separate the unilo­
bar from bilobar multiple metastases and 
this may account for the favourable 
results.
Our experience with resection of 
hepatic metastases from various primary 
cancers, reported in 1983,11 is outlined in 
Table I. The large number of formal ana­
tomical resections reflects in part our 
earlier belief that lobectomy was the 
preferred operation for malignant disease 
of the liver. We are currently doing more 
segmental and wedge excisions wherever 
we can include adequate margins (at least 
3 cm) of normal tissue.
Our actuarial survival curves (Fig. 2) 
are in keeping with data reported in the 
literature. We found a clear difference in 
outcome between solitary and multiple 
metastases, and we currently only resect 
multiple metastases if they are unilobar 
or, if multilobar, if they require only sim­
ple wedge excision. We found no differ­
ence in survival between patients with syn­
chronous or metachronous metastatic 
disease.
Theoretically, about 2 of every 100 
patients who undergo colonic resection 
for cancer have, or will have, solitary liver 
metastases and probably an equal num­
ber with unilobar multiple metastases will 
be suitable candidates for resection. It is 
therefore important to look carefully for 
such patients at the preoperative assess­
ment, at operation for the primary 
tumour and during follow-up. Serial 
determinations of carcinoembryonic anti­
gen and alkaline phosphatase levels, along 
with physical examination, are used in the 
follow-up of all patients who have cancer 
of the colon. If liver tumours are sus­
pected, either ultrasonography or com­
puterized tomography are carried out. 
When a tumour is deemed suitable for 
resection, nuclear scanning is also done, 
since it sometimes identifies multiple 
lesions missed by the other modalities. 
Angiography is always done preopera- 
tively in patients thought to have resec­
table metastases, to show the vascular 
anatomy of the liver, and because it occa­
sionally identifies patients with unresec- 
table m ultiple lesions. When the 
metastatic tumour is large and centrally 
placed, hepatic venography is also used 
to show the position of the hepatic veins 
and to ensure that they can be cleared sur­
gically.
Hepatic Infusion Chemotherapy
Because of the generally discouraging 
results of systemic chemotherapy in 
metastatic colonic cancer, the technique 
of infusion chemotherapy was developed 
to allow higher drug concentrations to be 
administered to the tumour area without 
a comparable increase in systemic toxic­
ity. Hepatic artery infusion has been used 
since the 1950s, and in spite of technical 
improvements in drug delivery systems 
and the development of numerous regi-
FIG. 2—Actuarial survival of 16 patients 
with colorectal cancer who had single (solid 
line) or multiple (broken line) hepatic 
metastases and underwent resection. 
(Reproduced from Taylor B, Langer B, Falk 
RE, Ambus U: Can J Surg 1983; 26: 215-7.)
T a b le  1 - R e s e c t i o n  o f  H e p a t ic  M e t a s t a s e s  a t  t h e  T o r o n to  G e n e ra l H o s p ita l  F ro m  1 9 7 4  to  1 9 8 2
S it e  o f  p r im a ry
N o . o f  
p a t ie n t s E x t e n t  o f  re s e c t io n
N o . o f  
p a t ie n ts
C o lo re c tu m 1 6 E x te n d e d  r ig h t  lo b e c to m y 3
A d re n a l 2 R ig h t lo b e c to m y 8
T e r m in a l ile u m  (c a rc in o id ) 1 L e f t  lo b e c to m y 2
T h y r o id 1 L e f t  la t e r a l  s e g m e n te c to m y 1
P a n c re a s  ( is le t -c e ll  tu m o u r ) 1 W e d g e  e x c is io n 8
A b d o m in a l w a l l  ( le io m y o s a r c o m a ) 1
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mens of combination chemotherapy there 
is still no good evidence that infusion 
chemotherapy prolongs life in patients 
with liver metastases. Many authors 
report response rates of 50% or more, but 
most comparisons are with “historical” 
controls, and controlled trials have 
yielded equivocal results.12 Infusion 
chemotherapy should be reserved for 
patients in whom systemic chemotherapy 
has failed, or for patients entering con­
trolled trials.
Metastases to the Lung
The first collected series of cases in 
which metastatic disease of the lung was 
resected was reported in 1947.13 Since 
then, many have confirmed that 
prolonged survival can be obtained fol­
lowing removal of lung metastases.14,15 
Secondary tumours from colon and rec­
tum make up only about 20% of pulmo­
nary metastases suitable for resection, 
unlike the liver where they are by far the 
commonest source of metastatic disease.
With modern surgical techniques and 
conservative segmental or wedge exci­
sions, the morbidity and mortality of pul­
monary resection for metastatic disease 
are low. Control of the primary disease 
and absence of other metastatic disease 
are necessary. Some still believe that 
patients with a long disease-free interval 
do better than those with synchronous 
metastases, but others have found no 
difference. Most workers are resecting 
multiple metastases in selected patients 
providing the lesions are few in number 
and resectable with little loss of lung 
parenchyma. In such patients there is no 
significant difference in survival com­
pared with patients who undergo resec­
tion of solitary metastases. Five-year sur­
vival rates of about 25% can be expected 
after resection of colorectal metastases 
using the above criteria.
Unresectable Metastases
Aside from a small number of patients 
with isolated metastases to liver or lung, 
or with early local recurrences, surgical 
excision for cure is not possible in the 
majority of patients with colorectal 
metastases. The status of these remain­
ing patients varies from the healthy 
asymptomatic individual with small mul- 
tilobar metastases to the liver only to the 
moribund patient with widespread peri­
toneal, hepatic and other disseminated 
disease. In selecting from among treat­
ment options in this heterogeneous group 
of patients, a number of principles should 
be kept in mind.
• Treatment is palliative only. There 
are many reports of excellent responses 
in symptomatic patients to a variety of
therapies that in the individual case seem 
to prolong life as well as relieve symp­
toms; however, there is no good evi­
dence that any given treatment regimen 
can predictably prolong survival.
• Treatment of asymptomatic 
patients with known disease, or patients 
with unproven metastatic disease but at 
a high risk for recurrence, can only be 
justified as part of a controlled clinical 
trial, because there is no good evidence 
that treatment of such asymptomatic 
patients either delays the onset of symp­
toms or prolongs life.
• Palliative treatment of the sympto­
matic patient should be based on detailed 
information of the natural history of the 
untreated disease, the side effects and 
risks of the proposed therapy, and relia­
ble information regarding the expected 
response from the chosen therapy.
• The patient should participate fully 
and in an informed way in decisions 
regarding such therapy, with as full an 
explanation of the expected benefits and 
risks of medical therapy as one would 
carry out in patients who undergo surgi­
cal therapy.
The treatment options available for 
patients with unresectable metastatic dis­
ease include the following:
• Observation and supportive care. 
This is required in all, but particularly in 
those for whom specific antineoplastic 
treatment is not thought to be worth­
while. Therapy other than antineoplastic 
agents for relief of symptoms is as impor­
tant in such patients as the antitumour 
therapy itself.
• Surgery should remain an option, 
even in incurable disease, when required 
for complications that can be corrected 
with a reasonable expectation of pallia­
tion, such as intestinal obstruction, bleed­
ing and certain types of intractable pain.
• Radiotherapy is occasionally useful 
to control pain, especially in bony or pel­
vic recurrence.
• Systemic chemotherapy is indicated 
in patients with symptomatic, systemic, 
nonresectable disease, in patients who are 
in satisfactory nutritional state, and in 
those who are infection-free. Patients 
over the age of 70 years tolerate such 
chemotherapy poorly and selection of 
such treatment in this group of patients 
should be made with care. Acceptable 
drug regimens in order of increasing 
effectiveness, and also increasing toxic­
ity, are 5-fluorouracil, 5-fluorouracil and 
mitomycin C, and 5-fluorouracil, 
mitomycin C and Adriamycin.
• Experimental therapy should be 
used only under carefully controlled con­
ditions and as part of organized clinical 
trials. These include new combinations of 
chemotherapy, immunotherapy and 
hyperthermia.
Conclusions
The best opportunity for cure in 
colorectal cancer is through early diagno­
sis and adequate surgical excision. Care­
ful follow-up of all patients is imperative 
since in a small number of those in whom 
recurrent disease develops, especially in 
the liver, the cancer may still be curable 
by surgical resection. The role of adju­
vant therapy is still being defined. 
Chemotherapy for symptomatic unresec­
table metastatic disease should be selec­
tive, remembering that the objective is 
palliation, so that benefits may be max­
imized and morbidity minimized.
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4. The Management of Recurrent Rectal Carcinoma
Rectal carcinoma remains an enigma to 
surgical and medical oncologists. The 
chemo- and radiotherapeutic approaches 
have been fraught with failure, and when 
this happens the patient is left to the 
challenge of the surgical oncologist who 
sometimes must perform extensive re­
resection to include adjacent structures. 
Experienced surgical judgement is 
assisted by preoperative and intraopera­
tive criteria, which are contraindications 
to resection: preoperatively, they include 
metastases, fixation of tumour to pelvic 
wall, sciatica, obstruction of both ureters 
and leg edema. Intraoperatively, 
metastases within aortic nodes or 
beyond the pelvis and extension of dis­
ease laterally or deep to pelvic wall or to 
multiple loops of bowel are all contraindi­
cations. These tumours are often slow to 
metastasize so that aggressive local sur­
gical resection is warranted to minimize 
the morbidity prone complications 
associated with low-lying perineal or pel­
vic recurrence of rectal cancer.
Le cancer du rectum demeure une 
enigme pour les oncologistes chirurgi- 
caux et medicaux. La chimio et la radio- 
therapie debouchent trop souvent sur 
Techec, et quand cela survient, le patient
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est laisse aux tentatives du chirurgien 
oncologiste qui doit parfois proceder a 
une deuxieme resection large, touchant 
les structures adjacentes. Le jugement 
chirurgical experiments considere les cri- 
teres preoperatoires et opSratoires qui 
determinent les contre-indications de 
resection: en preoperatoire on recher- 
chera, les metastases, Tadherence de la 
tumeur a la paroi pelvienne, une sciati- 
que, I'obstruction des deux ureteres et 
un oedeme des membres inferieurs. 
Durant I'operation, les metastases des 
ganglions aortiques ou au-dela de la 
cavite pelvienne, et Textension laterale 
ou profonde du cancer a la paroi pel­
vienne ou a plusieurs circonvolutions de 
Tintestin sont autant de contre- 
indications. Ces tumeurs sont souvent 
lentes a se metastasier de sorte qu'il est 
justifie de faire une resection locale 
aggressive pour reduire la morbidity et 
les complications des recidives pelvien- 
nes ou perineales basses du cancer du 
rectum.
Carcinoma of the colon and rectum is the 
only malignant lesion of the gastrointes­
tinal tract to be associated with a substan­
tial cure rate. However, it is distressing 
that the overall 5-year survival rate for 
colorectal cancer patients approximates 
only 42%. If the disease is diagnosed 
before symptoms develop, then the sur­
vival rate may reach 90%. It is difficult 
to understand how there can be only a 
42% survival rate from a disease that is 
characterized early in its course by change 
in the diameter, colour or consistency of 
the stool, with or without associated 
dietary gastrointestinal disturbances. This 
failure of early recognition rests both with 
the patient and the physician. Certainly 
the American Cancer Society and other 
health-oriented groups have publicized 
the signs and symptoms of colonic cancer 
to the extent that the reading and view­
ing public should be aware that rectal 
bleeding may arise from something other 
than hemorrhoids. From the oncologist’s 
standpoint, it is uncomfortable to realize 
the number of patients who, upon leav­
ing the physician’s office, have not had
a digital rectal examination, or a guaiac 
test for occult blood in the stool.
Late recognition with an overall sur­
vival of less than 50% following primary 
treatment leads next to the problem of 
local failure. The recurrence of rectal 
cancer is, in part, due to lack of early 
recognition, but equally important, to 
inadequate or less than optimal initial 
treatment. Failure to recognize the extent 
of the disease, locally within the bowel, 
and the potential for spreading to other 
areas at the time of the original surgery, 
presents the surgeon with the challenge of 
treating recurrent disease as if it can be 
cured, not as if he will fail in 50% of 
patients. It is equally important that the 
extent of local disease or the identifica­
tion of distant disease be recognized 
before the surgeon decides on the 
management techniques for proven recur­
rent cancer of the rectum. If the goal is 
symptomatic palliation because of pain, 
bleeding or tenesmus, then the expense, 
inconvenience and morbidity associated 
with a metastatic work-up may not be 
indicated. Before expensive and debilitat­
ing local surgery is undertaken, it is 
appropriate to establish the potential for 
cure by ruling out, if possible, the 
presence of liver, lung or distant lymph- 
node metastases. Computerized axial 
tomography, liver scanning, hepatocellu­
lar and hematochemical profiles and pos­
sibly lymph-node biopsy of groin or 
supraclavicular areas might all allow a 
better understanding of the state of the 
disease process.
Role of Therapy
The first question, then, must be 
related to the role of therapy for the 
recurrent colorectal cancer. Is it for 
potential cure? Is it for palliation (in the 
sense of relieving local symptoms)? Is it 
to delay the expected local recurrence, 
knowing that eventually metastases will 
develop if the disease process is allowed 
to continue unchecked? The final ques­
tion that must be asked, particularly in 
the academic environment, is: Is therapy 
for study accrual based upon a ran­
domized investigative protocol? It is with
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these questions in mind that the surgeon 
must approach the local recurrence either 
with local resection, cauterization, fulgu- 
ration, chemotherapy, radiotherapy, 
immunotherapy or the multidisciplinary 
use of two or more of these modalities.
Today there is a trend towards conser­
vatism in treating many cancers, partic­
ularly in the lower colon and rectum. This 
trend has been associated with an alarm­
ing increase in recurrent disease being 
identified at intervals that in no way allow 
an opportunity for ultimate cure no mat­
ter how aggressive the therapy might be. 
It must be remembered that primary 
abdominoperineal resection can be per­
formed with a mortality of 0% to 2%. 
Admittedly, the morbidity rates may 
reach 50%, but morbidity can be toler­
ated when one is dealing with a curative 
procedure. Unfortunately, colorectal 
cancer often extends laterally, requiring 
removal of the endopelvic fascia and the 
lymphatic and vascular structures 
associated with the lateral pelvic walls, 
and requires meticulous cleansing of the 
iliac vessel system. Posterior extension of 
the rectal tumour encroaching upon the 
sacrum may require primary or secondary 
partial sacrectomy. Unrecognized 
penetration anteriorly into the vagina or 
the prostate, bladder or urethra contrib­
utes to failure in patients being treated 
both primarily and secondarily. While 
there is great reservation about the value 
or need to remove the vaginal wall or the 
prostate at the time of primary colorec­
tal surgery, there should be no hesitation 
in doing so when treating recurrent dis­
Table I— Criteria Contraindicating 
Exploration for Recurrent Rectal Cancer
Metastases beyond the pelvis 
Tumour fixation to pelvic wall or frozen pelvis 
unless there has been previous radiotherapy 
Sciatic distribution of leg pain 
Bilateral ureteral obstruction 
Unilateral leg edema
Table II— Intraoperative Criteria 
Contraindicating Resection
Aortic node metastases 
Lateral or deep pelvic wall extension 
Direct extension to multiple loops of bowel 
Metastases beyond the pelvis
Table Ill-Clinical Prognostic Findings
Finding Survival
One ureter involved Decreased
Unilateral leg edema Markedly decreased
Sciatic pain Markedly decreased
Pelvic wall fixation Markedly decreased
Both ureters involved None
ease. I would minimize the role of local 
intervention with cauterization, fig u ra ­
tion or local resection in the absence of 
identified metastatic disease. It is only the 
experienced “ conservatist” surgeon, 
using these techniques frequently, who 
can successfully obtain disease control 
through fulguration and other topical 
local therapy regimens.
Adjuvant Therapy
Trends in treatment suggest that adju­
vant radiotherapy with aggressive local 
surgery results in a lower local recurrence 
rate, but when the disease does recur, the 
morbidity from repeat local resection is 
overwhelming. It is therefore mandatory 
that when adjuvant chemotherapy or 
radiotherapy is used primarily or secon­
darily, the surgeon must expect morbidity 
associated with progression of the disease, 
fistulization and urinary and bowel infec­
tion. When one uses adjuvant radiother­
apy, chemotherapy or even immunother­
apy to convert the nonresectable lesion 
into one that is potentially resectable, one 
is dealing in the realm of the unknown. 
Ordinarily, the extent of the procedure 
needed to bring disease under control 
after tumour shrinkage by adjuvant 
chemotherapy or radiotherapy should be 
identical to that required to bring about 
total tumour removal without adjuvant 
therapy. The diagnosis and management 
of recurrent cancer of the pelvic structures 
presents problems that do not have satis­
factory solutions. The diagnosis is usually 
tentative as histologic confirmation may 
be difficult. The treatment is ineffective 
in producing cure in many cases. Pelvic 
recurrence occurs along the bony walls of 
the pelvis but seldom invades the bone 
until late in its development and causes 
pain by pressure, particularly on the 
nerves radiating usually down one leg. 
Pain associated with recurrent pelvic 
perineal cancer suggests non-resectable 
recurrence. Seldom is perineal or radiat­
ing pain associated with radiation fibro­
sis alone. Few studies have authoritatively 
documented any increase in survival 
associated with the treatment of recurrent 
rectal cancer using radiotherapy. Pallia­
tion may be obtained but survival related 
to distal disease is seldom altered. Distant 
metastases remain the major cause of
death in patients with recurrent colorec­
tal cancer.
Surgery for Cure
In the patient who is free of identified 
metastatic disease, the surgeon may 
decide to perform extensive local pelvic 
surgery that almost never preserves 
anorectal continence and seldom allows 
preservation of the bladder and prostate. 
The patient must be prepared for urinary 
diversion with an abdominally placed 
conduit as well as the usual colostomy for 
fecal diversion if necessary. This exten­
sive surgery necessitates removal of all 
lymph-node-bearing tissue of the pelvic 
structures and often resection of the 
sacrum. When sacral resection must be 
undertaken, the surgeon should not tran­
sect above S3, for the dural sac extends 
to the middle or lower portion of S2. For­
tunately, if the bladder can be left intact, 
bladder function is seldom impaired fol­
lowing partial sacrectomy. Urinary com­
petence may be delayed, but eventually 
all patients will void normally.
Tables I and II briefly outline the 
preoperative and intraoperative criteria 
contraindicating surgical intervention and 
operative resection for cure. Table III 
outlines the prognostic significance of 
specific clinical findings when dealing 
with patients who have recurrent disease 
of the pelvic structures. While these 
criteria and prognostic findings are of 
great help, they must be interpreted selec­
tively, depending upon other clinical 
manifestations in the individual patient.
Factors Contributing to Success
Several factors will contribute to suc­
cess of surgery (Table IV). Cancer cells 
can be disseminated within the wound by 
instruments, gloves and rough operative 
technique. It is therefore essential that the 
wounds and adjacent structures be pro­
tected from tumour-cell contamination by 
one of the many new innovations in plas­
tic wound drapes. Instruments must be 
adequately cleaned or changed fre­
quently. The washing of one’s gloves in 
a wash basin beside the operating table 
only leads to cells being washed off the 
gloves and potentially picked up by cross­
contamination to the assistant’s gloves
Table IV— Factors Contributing to Successful Resection
Wound protection Elastic stockings
Instrument cleansing Gastrostomy?
Absence of glove and Appendectomy?
instrument wash basins Experience
Antibiotics Hemostasis (no packing)
Bowel sterilization Obliteration of dead space
Pulmonary toilet precautions Adeguate drainage
Fresh blood? Peritonealization
Early ambulation Careful tissue handling
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when he or she washes blood off. 
Minimizing infectious complications by 
thorough bowel preparation and ade­
quate pulmonary precautions, with 
efforts to prevent thromboembolism, will 
all give a better opportunity for success. 
Technically, the obliteration of all dead 
space is mandatory, particularly in the 
surgical field that has been irradiated. 
Adequate drainage is essential and 
peritonealization is ideal but is seldom 
obtained. It has often been said that there 
is no right way to do the wrong thing. So
often in the pelvic surgical intervention 
for recurrent cancer, poor judgement has 
been used in determining the feasibility 
of cure. Surgical aggressiveness in the 
irradiated lateral walls of the pelvis can 
lead to unrelenting immediate or delayed 
hemorrhage, particularly in the hands of 
the uninitiated surgeon.
Conclusions
While the median survival of 15 
months is the accepted life span after
diagnosis of local recurrence of cancer in 
the pelvis, this can be extended sometimes 
indefinitely to the point of cure, by selec­
tive surgical intervention. Surgeons 
should approach perineal recurrence 
aggressively for it is often curable. Pel­
vic recurrence, however, is seldom cura­
ble and it is never curable without a selec­
tively aggressive attempt at resection. It 
is unfortunate that surgeons sometimes 
forget that the best way to avoid radical 
surgery is to perform major surgery at the 
first opportunity.
James M. Langevin, md, frcsc;* W. Douglas Wong, md, frcsc, FACst
5. What Is Appropriate Follow-up for the Patient 
With Colorectal Cancer?
Overall recurrence rates after curative 
resection for colorectal cancer average 
30% . The value of intensive follow-up 
protocols is assessed from a review of 
the literature, which reveals that recur­
rent colorectal cancer can be detected at 
an earlier stage (average 3 months) and 
that repeat resection rates for cure can 
be increased (twofold or more) by inten­
sive follow-up. Despite this, no improve­
ment in survival has been documented. 
As nonsurgical modalities of therapy for 
recurrence become further refined, earlier 
detection of recurrent tumour will 
become increasingly important. An inten­
sive follow-up regimen is therefore pro­
posed, based on a knowledge of the pat­
terns and timing of recurrence, the 
relative merits of the investigational 
modalities available and the assumption
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that at some point earliest detection and 
subsequent therapy will improve survival.
Dans I'ensemble, le taux de recidive 
apres resection a visees curatives d'un 
cancer du colon ou du rectum est en 
moyenne de 30%. On evalue a travers la 
litterature medicale, I'interet des protoco­
les comportant des examens de surveil­
lance intensifs; on y constate que les 
recidives du cancer colorectal peuvent 
6tre deceives a un stade plus precoce 
(en moyenne de 3 mois) et que le nom- 
bre de deuxi&mes resections a visees 
curatives peut etre augmente (pouvant 
etre double ou davantage) grace a des 
examens de controle frequents. Nean- 
moins, on n'a pu demontrer aucune ame­
lioration de la survie. Avec le 
perfectionnement du traitement non chi- 
rurgical des recidives, ('importance d'une 
detection precoce ira en augmentant. En 
consequence, on propose un programme 
intensif d'examens de controle 
s'appuyant sur revolution et le delai 
caracteristiques des recidives, la valeur 
relative des difterents examens disponi- 
bles et I'hypothese, qu'eventuellement, 
une detection tres precoce et le traite­
ment subsequent amelioreront la survie.
Colorectal cancer is the second leading 
cause of cancer deaths in North 
America.1 In Canada, the mortality 
from this disease has not changed over the 
last decade.2 Approximately 6000 Cana­
dians die annually of colonic and rectal 
cancer and in a further 6000 the disease 
is diagnosed.2 Although two thirds of 
the latter group will undergo a curative 
resection, recurrent tumour will develop 
in about one third of them. The overall
cure rate for colorectal cancer therefore 
is approximately 50%.
At present, adjuvant treatment has had 
no major impact on survival following 
curative resection. Early detection and 
surgical excision of recurrence currently 
offer the best hope for improved survival. 
What constitutes appropriate follow-up 
to detect recurrence at the earliest possi­
ble stage and of what value early detec­
tion is, are controversial.
This paper will focus on four basic 
aspects of follow-up. Where to look, 
when to look, how to look and why to 
look. A follow-up protocol is also recom­
mended.
Risk, Pattern and Timing 
of Recurrence
The first two aspects of follow-up 
(where and when to look) must be based 
on our current knowledge of the risk fac­
tors, patterns and timing of recurrence.
Overall recurrence rates after curative 
resection for colorectal cancer average 
about 30% (Table I3'6). Stage at resec­
tion, site of the lesion, size of the tumour 
and patient age have consistently been 
found to correlate with an increased risk 
of recurrence. Those patients whose 
tumour has spread through the bowel wall 
are at greatest risk of recurrence. Of 285 
patients who underwent curative resection 
at the Peter Bent Brigham Hospital in 
Boston, Malcolm and associates4 
reported an overall recurrence rate of 
27%. Lesions penetrating the bowel wall, 
with or without positive lymph nodes, 
had the highest recurrence, 56% and 37% 
respectively. In this study patients less 
than 60 years old and those with tumours
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larger than 4 cm in diameter were also at 
greater risk of recurrence.
A striking relation between the site of 
the primary tumour and recurrence rate 
has been demonstrated, with lesions in the 
sigmoid colon and rectum at greatest risk 
for recurrence.4,7 In addition to having a 
higher overall rate of recurrence, patients 
with rectal and rectosigmoid lesions have 
a higher rate of local recurrence compared 
with those who have lesions of the prox­
imal colon.47-8 In a study of tumour 
recurrences demonstrated at “ second- 
look” operations, Gunderson and Sosin8 
found that nearly 50% of recurrences 
from rectal cancer were local or regional 
failures alone. Local failure was a com­
ponent in 92% of failures with only 8% 
having distant recurrences alone. Of the 
129 patients with cancer of the large 
bowel located proximal to the sigmoid 
colon, Malcolm and associates4 found 
no isolated local recurrence, but 88% dis­
tant recurrences. A similar difference in 
the pattern of recurrence between prox­
imal and distal large-bowel cancers was 
demonstrated by Welch and Donald­
son.9 They found no isolated local recur­
rences in lesions proximal to the sigmoid 
colon but local failure was a component 
in 75% of patients with recurrence from 
sigmoid and rectal cancer. This increased 
recurrence rate is unrelated to stage, 
although local failure rates also correlate 
with the stage of the disease, increasing 
with advanced stage and occurring 
primarily in the tumour bed and adjacent 
structures.10
The timing of recurrence after curative 
resection is relatively constant; 40% to 
50% of recurrences will be manifest dur­
ing the first year after resection, 70% by 
the second year and 90% or more by the 
fourth year (Table II6’8’9). The high early 
recurrence rate in rectal cancer as demon­
strated by Gunderson and Sosin8
resulted from earlier detection by second- 
look operation, which was carried out in 
a high-risk group.
Late recurrence after curative resection 
for colorectal cancer is low and is primar­
ily distant. Welch and Donaldson9 found 
that only 7% of recurrences occurred 
after 5 years. Cass and associates" 
found only 6% of local recurrences after 
that time. Late recurrence also occurs in 
patients whose primary tumour is more 
confined. In the series of Welch and 
Donaldson, 33% of late recurrences 
occurred in patients whose primary 
tumour was classified as Dukes’ A; this 
compared with an overall late recurrence 
• rate of 14%.
In addition to late recurrence, follow­
up programs must be designed to incor­
porate surveillance for metachronous 
lesions, which develop in approximately 
3.5% of patients surviving resection for 
colonic and rectal cancer. The mean inter­
val to detection of this tumour is about 
11 years.12
Follow-up
A plethora of tests and examinations 
are available for screening patients who 
have undergone a curative resection for 
colonic and rectal cancer. To maximize 
their usefulness, the decision to carry out 
these tests must be based on what is 
known about location and timing of 
recurrence.
History and Physical Examination
History-taking and physical examina­
tion are essential in follow-up, since 
approximately 60% of patients will be 
symptomatic when the recurrence is diag­
nosed, even when the follow-up has been 
intensive.13 A detailed history is more 
sensitive than physical examination in 
diagnosing recurrence. Of the 48 patients 
with recurrent cancer found at follow-up
by Beart and O’Connell,3 41 (85%) had 
symptoms before or at the time the recur­
rent tumour was detected by physical 
examination, or biochemical or radiologic 
abnormalities. Only 16 (33%) had posi­
tive physical findings.5 The value of the 
history and physical examination is 
limited by the fact that the recurrence is 
diagnosed late and only rarely can sym­
ptomatic patients have their lesion 
resected for cure. In a prospective study, 
assessing the value of intensive follow-up 
after curative resection for colonic and 
rectal cancer, Tornqvist and associates13 
found that in only 8% of symptomatic 
patients was the recurrence resectable for 
cure, compared with 39% of asympto­
matic patients.
Hemoccult Test
Stool testing for occult blood is simple 
and inexpensive and is useful for detect­
ing anastom otic recurrence and 
metachronous lesions. In terms of detect­
ing recurrence, however, the yield from 
this test is low, because overall 90% of 
recurrences are non-mucosal.3’13
Endoscopy
The endoscopic procedures available 
for surveillance of recurrence are more 
sensitive for mucosal recurrence than 
either hemoccult test or barium enema 
examination.14 They are both diagnostic 
and potentially  therapeu tic  for 
metachronous lesions, but they carry the 
same limitation as the Hemoccult test in 
that the majority of recurrences are non- 
mucosal. Of the 240 patients followed up 
through colonoscopy by Nava and 
Pagana,14 only 17 (7.1%) had mucosal 
recurrence. Fifty-one patients (21%) had 
a benign tumour resected and in 4.6% of 
them a metachronous cancer developed 
in the 4-year follow-up period.14 Beart 
and O’Connell3 found that in only 3 
(23%) of 13 patients with pelvic recur­
rences after anterior resection could the 
recurrent lesion be detected by proc­
toscopy.
Biochemical Tests
These are used primarily to detect 
hepatic m etastases. Kemeny and 
colleagues15 evaluated prospectively the 
usefulness of several biochemical tests of 
hepatic function and carcinoembryonic 
antigen (CEA) levels in identifying 
patients with hepatic metastases. They 
found no single laboratory test that gave 
more than 65% accuracy in detecting 
hepatic metastases and no combination of 
tests increased this accuracy. Carcinoem­
bryonic antigen, lactic dehydrogenase, 
alkaline phosphatase and alanine 
aminotransferase levels were, in that 
order, the most accurate of 13 laboratory 
tests studied. No patient with obvious 
liver metastases on physical examination 
was included in this study.15
Table 1—Overall Recurrence Rates After Curative Resection 
for Colorectal Carcinoma
Series No.
Recurrence 
no. (%)
Beart and O'Connell, 19833 168 48 (29)
Malcolm and colleagues, 19814 285 76 (27)
Cochrane and colleagues, 1980s 180 71 (39)
Berge and colleagues, 19736 639 217(34)
Table 11-Rates (%) of Recurrence at Various Intervals 
After Curative Resection for Colorectal Carcinoma
Interval, mo
Series 6 12 24 48
Welch and Donaldson, 19789 18 41 69 89
Berge and colleagues, 19736 - 48 70 92
Gunderson and Sosin,* 1974s 42 - 80 99
‘ Rectal cancer only.
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Radiologic Investigations
Of the conventional radiologic proce­
dures, chest roentgenography continues 
to play an important role in detecting 
metastases. Approximately 50% of lung 
metastases detected on the chest film are 
asymptomatic and, of these, 50% or more 
will be resectable for cure with a 5-year 
survival of about 30%.13,16 Intravenous 
pyelography in the past was used to deter­
mine pelvic recurrence but is of no value 
because by the time abnormalities are 
detected, recurrence is advanced and non- 
resectable. Double-contrast barium 
enema examination is of value in detect­
ing anastomotic recurrence or meta­
chronous lesions. It is most sensitive when 
a baseline study is available for compari­
son; however, it is less sensitive than 
colonoscopy.14 It is a recommended 
procedure when colonoscopy is not avail­
able or is incomplete.
Imaging Techniques
Body imaging techniques are inap­
propriate for screening as they are expen­
sive and time-consuming. Liver scanning 
and ultrasonography are both about 80% 
accurate in demonstrating liver meta­
stases.17 Computerized tomography is 
slightly more accurate18 but its major 
impact has been in identifying pelvic 
recurrence.
Tumour Markers
Tumour markers will play an increas­
ingly important role in the early detection 
of recurrence. Carcinoembryonic antigen 
is the most specific and sensitive of the 
tumour markers, levels being elevated in 
75% of recurrences.19 It is the first evi­
dence of recurrence in 33% of patients 
when done on a monthly basis after cura­
tive resection and levels are elevated in 
45% of patients before there is clinical 
evidence of recurrence.19,20 In fact, this 
elevation can be detected as early as 6 
months before there is any clinical evi­
dence of recurrence.21 Carcinoembryonic 
antigen, however, is a poor indicator of 
local recurrence.22,23 It is most sensitive 
for disseminated disease and gives a high 
rate of both false-negative and false­
positive results. At present, its greatest 
potential is in identifying patients who 
would benefit from a second-look oper­
ation.
Various other tumour markers are 
being investigated as alternatives or 
adjuncts to CEA. They include acute- 
phase reactive proteins,24 Tennessee anti­
gen,25 carbohydrate 19-9 antigen26 and 
tissue polypeptide antigen.27 So far, 
none of these have superseded CEA. 
Although its clinical usefulness is not yet 
established,28,29 radioimmunodetection 
using labelled antibody to CEA and other 
tumour markers may prove to be more
useful in detecting recurrence than assay 
for tumour markers. An additional 
benefit is the localization of recurrence.
Second-Look Operation
The most aggressive approach aimed at 
identifying localized recurrence has been 
the second-look operation. Wangensteen 
and associates30 initiated this concept to 
improve survival of patients at high risk 
for recurrence. Despite 12% and 20% sal­
vage rates in the asymptomatic and 
symptomatic groups respectively, this 
approach did not gain wide acceptance 
because of the high false-negative 
laparotomy rate (50%) and the high mor­
tality (10%).31 By adopting a second-, 
look approach on the basis of an elevated 
CEA, the high false-negative laparotomy 
rate seen with the second-look procedure 
alone can be greatly reduced.32 Such 
operations have been shown to increase 
repeat resection rates for cure but, 
although selectivity is enhanced by deter­
mining the CEA level, the false-negative 
laparotomy rate is still about 12%.33 
Follow-up as yet is too short to demon­
strate any increase in survival by this 
approach.
Rationale and Protocol for 
Intensive Follow-up
The prime rationale for intensive 
follow-up of the patient with colorectal 
cancer is to identify recurrences at a stage 
when they may be resected for cure and 
thus to improve overall survival. Repeat 
resection rates for cure vary in the litera­
ture from 2% to 20% but average about 
10%.13 This can be increased substan­
tially by identifying recurrences early at 
an asymptomatic stage.13,32 Increased 
survival by early detection of recurrence, 
however, has yet to be demonstrated. The 
5-year survival following resection of 
recurrence for cure, detected by routine 
follow-up, averages about 30%.9 Car­
cinoembryonic antigen-directed second- 
look operations appear to offer the 
greatest hope for increasing survival in 
patients with recurrence following cura­
tive resection. At Ohio State University, 
M artin and associates32 have been 
involved in a program of CEA-directed 
second-look operations since 1972. In 
their retrospective series of 22 patients, 
the CEA level was determined every 3 to 
6 months. Twenty-seven percent of 
patients in this group underwent resection 
for cure. This represents a twofold 
increase in the reoperation rate for cure 
over routine follow-up not using CEA.13 
In their prospective series which started 
in 1976, 38 patients underwent second- 
look operations based on a rise of the 
CEA level determined at 45 to 60-day 
intervals. Sixty-one percent of patients in 
this group had recurrent tumour resected 
for cure.
Early detection of recurrence is in itself 
important and is achievable with an inten­
sive regimen. It will become increasingly 
important as nonsurgical therapeutic 
modalities are refined. Other benefits of 
a follow-up program include detection 
and treatment of metachronous lesions, 
an increased sense of patient well-being 
and the opportunity for ongoing ther­
apeutic assessment.
Based on current knowledge of recur­
rence patterns, timing of recurrence and 
relative usefulness of available assessment 
modalities, a follow-up protocol is recom­
mended (Table III). It includes history­
taking, physical examination and Hemoc­
cult test, colonoscopy, sigmoidoscopy 
and barium enema examination and chest 
roentgenography. Liver function tests 
should be repeated at each patient visit. 
The CEA level should be determined 
every 2 months for 2 years, every 4 
months for 2 years, then every 6 months 
to 10 years. A second-look operation 
should be performed as necessary, based 
on the finding of an elevated CEA level. 
A metastatic work-up should be com­
pleted before operation to rule out incura­
ble disease.
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Chairman’s Comments
Although cancer of the colon and rectum 
has the highest cure rate of all cancers of 
the gastrointestinal tract, with an average 
5-year survival for all grades of 50%, 
there are many aspects that still confound 
surgeons in their attempt to improve the 
cure rate. Surgery, except for a few 
modifications and refinements, has prob­
ably gone about as far as it can. Consider­
able effort is going into earlier diagnosis 
with patient education and further alert­
ing the physician to the possibility of 
colorectal cancer. With the observation 
that the geographic distribution of 
colorectal cancer has changed, and the 
known deficiencies of roentgenographic 
investigation, the development and 
general use of colonoscopy has occurred 
fortuitously. Earlier diagnosis and espe­
cially the removal or identification of 
premalignant lesions should improve 
results. Time and study will show whether 
this optimism is justified.
With respect to the usual presentation 
of colorectal carcinoma, the standard 
procedures are the backbone of surgical 
treatment. In rectal carcinoma there has 
been some change with the advent of cir­
cular stapling devices, enabling more 
anterior resections to be carried out
without the associated use of a colostomy 
so that multiple procedures and a perma­
nent stoma have been eliminated in a sub­
stantial number of patients with rectal 
carcinoma.
Recurrence, of course, is still the 
spectre that looms in the wings following 
surgery for “ cure” . In about 50% of the 
patients with recurrence, the tumour will 
appear in the first 18 months after resec­
tion of the primary tumour and the 
remainder in 4 to 6 years. Much has been 
written on follow-up regimens that will 
improve earlier detection of recurrence. 
The initial optimism of tumour markers 
has not been borne out. The most univer­
sally used, carcinoembryonic antigen 
(CEA), has been found wanting because 
of false-negative and false-positive results 
of over 30% at some centres. It has been 
stated that by the time the CEA value 
reaches significantly positive levels — 
some 6 months before a clinical diagno­
sis can be made — the recurrence is 
unresectable. Even if attempted resection 
is accomplished, it seldom produces a 
cure. A search for more accurate and sen­
sitive markers is necessary. In “ second- 
look” procedures, the risk, cost and 
disease-free period has not been realized.
Although much has been made regarding 
follow-up regimens, with early and 
repeated visits, and extensive investiga­
tion, the detection of early recurrence is 
generally disappointing and recurrent 
lesions so found are usually inoperable.
Computerized tomography provides 
more accurate information on extramural 
extension of postoperative malignant 
tumours in the pelvic region and may also 
give useful preoperative information on 
the extent of the tumour, nodal involve­
ment and degree of invasion.
To approach the problem with meas­
ures other than surgery, adjuvant modal­
ities such as chemotherapy, radiotherapy 
and immunotherapy have not really made 
significant changes in survival except in 
a palliative sense. Much work still is to 
be done before the possible benefits of 
such agents are realized. Thus, in spite of 
refinements in surgery and adjuvant ther­
apy, the cure rate for cancer of the large 
bowel has not increased appreciably.
Early diagnosis, meticulous technique 
and standardization of surgical proce­
dures may produce the best initial results. 
A great deal must still be done in the field 
of adjuvant therapy to increase the sal­
vage rate.
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With the advent of the stapling gun, 
more patients can undergo restorative 
resection without needing a colostomy, 
temporary or permanent, as Professor 
Goligher has noted. The upper one third 
of the colorectum presents no problem. 
But when the tumour lies in the middle 
and lower thirds, there is controversy over 
the procedure of choice. With the stapling 
technique, continuity can increasingly be 
restored.
Goligher has reviewed the various 
sphincter-saving operations and opts for 
the circular stapling device. Up to 75% 
of patients with rectal cancer can be 
treated by sphincter-saving resection; of 
these, 55% of procedures can be accom­
plished by hand-sewn techniques and 
20% can be done only by stapling tech­
niques.
Combined adjuvant chemotherapy in 
the form of local and regional chemother­
apy, portal vein infusion chemotherapy 
and combined chemotherapy and radi­
otherapy has limited application in 
prolonging survival of patients with 
colorectal cancer, as Wolmark has 
pointed out. He reviews and analyses 
selected papers and protocols in adjuvant 
therapy for cancer of the large bowel. 
Although he draws no specific conclu­
sions, it is apparent that the results have 
not improved statistically. Much work has
yet to be done but at present colorectal 
cancer is resistant to this type of therapy.
The liver is the most common site of 
hematogenous spread of colorectal 
cancer. As Langer notes in his paper, it 
is involved in over 80% of patients with 
metastatic disease. One third have liver 
involvement exclusively, others have 
widespread dissemination, 4% to 5% 
have an isolated single metastasis of the 
liver and pulmonary metastasis occurs in 
10% to 15%. Liver resection, when there 
is no other disease, can now be performed 
with approximately 4% to 5% mortality. 
The outcome in patients with solitary 
lesions is better than in those with multi­
ple tumours. At one time the preference 
was a formal lobectomy but more seg­
mental and wedge excisions are being per­
formed, provided adequate margins of 
normal tissue can be obtained, and there 
are reports of 5-year survival after resec­
tion for liver metastasis ranging from 
25% to 30%. Hepatic perfusion chemo­
therapy has given discouraging results. 
There is no good evidence that it prolongs 
life. In secondary pulmonary lesions in 
selected patients, the survival rate can be 
up to 25%. The author gives an excellent 
review of surgical options and require­
ments for the treatment of distant 
metastasis to liver and lung, as well as 
guidelines for the management of 
unresectable disease.
Dr. Ketcham recommends an aggres­
sive approach to perineal recurrence and 
radical surgery initially but, like most sur­
geons, has found that recurrences are 
often distant and therefore incurable and 
that most local pelvic recurrences also 
have probably progressed to this state at 
the time of diagnosis.
Langevin in his paper describes the pat­
terns of recurrence, which are most 
marked in sigmoid and rectal tumours, 
especially tumours more than 4 cm in 
diameter and those in patients younger 
than 60 years; these recurrences are more 
commonly local ones. Proximally placed 
tumours are associated with more distant 
metastasis. He provides a good review of 
some of the current thoughts on the 
natural history, incidence and follow-up 
for carcinoma of the large bowel. From 
his observations he recommends a 
postoperative protocol for follow-up of 
patients with colorectal carcinoma.
Robert H. Thorlakson, md,
FRCS, FRCSC, FACS
Symposium chairman
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Winnipeg Clinic, 
Winnipeg, Man.
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Percutaneous Removal of Upper Urinary Tract Calculi: 
Experience With Ultrasonic Lithotripsy
From October 1983 to March 1985, the 
authors removed upper urinary tract cal­
culi percutaneously in 102 patients. In 
89 patients, stones required disruption 
with an ultrasonic lithotriptor before 
removal. Fifty-two patients had a stone 
in the renal pelvis and 20 had calyceal 
stones only; 21 had stones at both sites 
and 9 had a stone in the upper ureter. 
Complete removal of all stone material 
was achieved in 67 of 68 patients with 
a solitary calculus, in 13 of 26 with mul­
tiple calculi and in 6 of 8 with ureteric 
calculi. Complications were minimal; 
three patients had pulmonary edema 
postoperatively as a result of excessive 
absorption of irrigating fluid, and one 
patient sustained a perforation of the 
descending colon. The mean postopera­
tive hospital stay was 6.8 days and 
patients were able to return to work a 
few days after their discharge from 
hospital.
Percutaneous stone removal is a safe 
and effective procedure and is the surgi­
cal procedure of choice for the removal 
of upper urinary tract calculi.
D'octobre 1983 a mars 1985, les 
auteurs ont retire par voie percutanee, 
des calculs des voies urinaires superieu- 
res chez 102 patients. Pour 89 patients, 
les calculs ont du etre brises a I'aide 
d'un lithotriteur a ultrasons, avant d'etre 
enleves. Cinquante-deux patients avaient 
des calculs du bassinet rgnal alors que 
20 avaient des calculs caliciels seule- 
ment; 21 avaient des calculs loges aux 
deux sites a la fois alors que pour 9, le
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calcul etait loge dans la partie superieure 
d'une uretfcre. L'enl&vement complet de 
toute substance calculeuse a pu etre 
r6ussi chez 67 des 68 patients qui 
avaient un seul calcul, chez 13 des 26  
patients qui avaient des calculs multiples 
et chez 6 des 8 patients qui avaient des 
calculs uret£raux. Les complications 
furent rares: trois patients souffrirent 
d'un oedeme pulmonaire postoperatoire 
resultant de I'absorption excessive du 
liquide d'irrigation, et un patient a subi 
une perforation du colon descendant. La 
duree moyenne du sejour hospitalier post­
operatoire a ete de 6.8 jours et les 
patients ont pu reprendre leur travail 
quelques jours apres avoir recu leur 
conge de I'hopital.
L'enlevement des calculs par voie per­
cutanee est une intervention sure et effi- 
cace et c'est I'operation de premier choix 
dans les cas de calculs des voies urinai­
res superieures.
Removal of an intrarenal calculus 
through a percutaneous nephrostomy 
tract was first described in 1976.1 The 
subsequent development of an ultrasonic 
lithotriptor has made it possible for the 
urologist to disrupt intrarenal calculi 
before removal. Following encouraging 
early reports from Europe,2'3 percutane­
ous ultrasonic lithotripsy was introduced 
into the United States in late 1981.4,5 We 
report our experience since October 1983, 
at the Health Sciences Centre in Winni­
peg, using percutaneous techniques with 
or without ultrasonic stone destruction to 
remove renal and upper ureteric calculi.
Patients
From October 1983 to March 1985, 102 
patients (65 men, 37 women) with sym­
ptomatic upper urinary tract calculi or 
calculi associated with obstruction or per­
sistent urinary infection underwent per­
cutaneous stone removal. During the 
period of this report, no patient under­
went open surgery for an upper urinary 
tract calculus without first undergoing an 
attempt at percutaneous removal. The 
mean age of the patients was 51.1 years 
(range from 20 to 85 years).
Fifty-two patients had a stone in the 
renal pelvis and 20 had calyceal stones 
only. Twenty-one patients had stones in 
both the renal pelvis and calyces and in 
7 of these patients the stones were 
branched pelvic calculi associated with 
separate calyceal calculi. Nine patients 
had ureteric calculi. Thirteen patients had 
urinary infection with urea-splitting 
organisms; in all the calculus was thought 
to have developed secondary to the uri­
nary infection (i.e., struvite stone).
Methods
On the day before stone removal, per­
cutaneous nephrostomy is performed 
under local anesthesia. Using fluoro­
scopic control, this is done through 
the calyx, decided upon in advance as the 
most appropriate for stone removal. 
Through this nephrostomy tract a no. 6 
French angiocatheter is inserted down the 
ureter almost to the bladder and the 
exterior end is connected to a drainage 
bag. The patient returns to the ward and 
has the stone removed usually under 
general anesthesia on the following day.
Technique
For stone removal, the patient is placed 
in the prone position on a fluoroscopic 
table. A 0.038-inch torque guide wire is 
passed through the nephrostomy tube 
down the ureter into the bladder. The 
nephrostomy tube is removed and a 1-cm 
incision made adjacent to the guide wire. 
Flexible fascial dilators are used to dilate 
a tract to 12 French at which stage a dou­
ble lumen catheter is used to introduce a 
second wire down the ureter. This second 
wire is needed to provide a means of gain­
ing access back into the renal pelvis
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should the operating nephroscope be dis­
placed from the renal pelvis during the 
procedure. The tract around one of the 
guide wires is then dilated to 24 French, 
which is large enough to permit the 
introduction of the operating nephro­
scope sheath into the renal pelvis. Tract 
dilatation and nephroscope insertion are 
performed under fluoroscopic control. In 
a few patients, a balloon catheter has been 
used to dilate the tract instead of flexi­
ble fascial dilators. A special pump is used 
to inflate the balloon to 30 French at a 
pressure of 12 atmospheres and a mano­
meter is required to monitor the pressure 
and minimize the risk of balloon disrup­
tion. Despite the size of the balloon, it is 
usually necessary to pass at least one or 
two flexible dilators as well to create a 
suitable tract.
Recently, the tract has been dilated to 
between 24 French and 30 French, and 
once the largest dilator has been inserted, 
a rigid plastic sheath (Amplatz sheath), 
which fits closely over the dilator, is 
passed over it into the renal pelvis under 
fluoroscopic control. The dilator is then 
removed and the nephroscope passed into 
the renal pelvis through the sheath.
Small stones may be removed by grasp­
ing forceps under direct vision. Larger 
stones require disruption by an ultrasonic 
probe before removal. The stone may be 
broken into smaller pieces and removed 
with forceps or the stone may be com­
pletely disintegrated and the gravel aspi­
rated through the hollow core of the 
ultrasonic probe which is attached to con­
tinuous suction. During the procedure, 
the renal pelvis is continually irrigated 
with normal saline, which either passes 
down the ureter or is removed by suction 
applied to either the probe or the nephro­
scope. An accurate record of fluid inflow 
and outflow is essential because the 
irrigating fluid may be absorbed, in which 
case the procedure must be terminated to 
prevent excessive absorption.
When all stone fragments have been 
removed, a stone basket catheter is passed 
to remove any small fragments that may 
have been flushed down the ureter. A 
plain film is taken and if this shows com­
plete stone removal then a no. 20 French 
catheter is passed through the nephro­
scope sheath into the renal pelvis and the 
nephroscope is removed. A nephrosto- 
gram is obtained through the nephro­
stomy tube and, if it is satisfactory, the 
tube is sutured to the skin and connected 
to drainage. In patients who have under­
gone extensive ureteric instrumentation or 
who have sustained possible injury, a no. 
6 French polyethylene catheter is passed 
down the ureter over the spare guide wire 
which is then removed. This is also of 
value when the possibility of residual cal­
culus exists, as it will permit more ready 
access to the renal pelvis for repeat 
nephroscopy.
On the following day, a plain film of 
the kidney and a nephrostogram are 
obtained. If there is no evidence of 
residual stone, contrast extravasation or 
ureteric obstruction, and the calculus was 
uninfected, the nephrostomy tube is 
clamped. If this does not cause pain or 
fever, the tube is removed and the patient 
is usually discharged from hospital either 
on the same or the following day. No res­
trictions on activity are recommended 
apart from avoiding violent physical 
activity for approximately 6 weeks. Most 
patients can return to work within a week 
of stone removal.
In patients with infected renal calculi, 
in whom the nephrostogram shows free 
drainage of contrast down the ureter into 
the bladder, the renal pelvis is irrigated 
with Solution G (citric acid) for 48 hours 
even when stone removal is thought to be 
complete. This is done to dissolve any 
small residual fragments which, if left, 
would predispose to further stone for­
mation.
Results
Sixty-eight patients had a single renal 
calculus either in the renal pelvis or in a 
calyx. Complete removal of all calculous 
material was achieved in 67 (99%). In one 
patient with a large, branched, upper-pole 
calculus, a small fragment migrated into 
a lower calyx and could not be retrieved. 
This fragment subsequently passed down 
the ureter spontaneously and renal tomo­
grams showed no evidence of renal cal­
culi 6 months postoperatively. Twenty-six 
patients had multiple renal calculi; in 13 
of them, all calculi were removed. In 10 
others, small fragments were identified on 
plain films taken at the end of the 
lithotripsy procedure. In all these patients 
the fragments were situated in calyces that 
could not be reached with the rigid 
nephroscope or it was considered that the 
calculi were not sufficiently large to 
justify risking renal damage to remove 
them. In three patients with large 
branched calculi, a substantial amount of 
stone material remained at the end of the 
procedure. In all three patients, second 
nephrostomies were placed in an attempt 
to remove all the stone material but in 
none was it possible to clear the kidney 
completely of the stone material. Of eight 
patients with ureteric calculi, the stones 
were completely removed in six. In both 
failures, the stone could not be engaged 
in a basket in order to manipulate it into 
the renal pelvis. One of these patients had 
had three previous ureterolithotomies 
involving the affected ureter.
In 89 of our first 94 patients, ultrasonic 
stone disruption was required. In the last 
eight patients in whom an Amplatz sheath 
was inserted before removing the stone, 
disruption was not necessary.
Postoperatively, 22 patients had a fever
with body temperatures greater than 
38.5°C. In eight of these patients the fever 
was a single temperature spike and in nine 
others the calculus was associated with 
urinary infection preoperatively. Follow­
ing removal of the nephrostomy tube, 15 
patients experienced urine leakage from 
the nephrostomy tract for longer than 24 
hours. This resolved spontaneously in 14 
of them. In one patient a ureteric stent 
was required for 48 hours. Three patients 
in our series suffered from pulmonary 
edema during the procedure. None of the 
three had an identifiable pelvic rupture. 
In two of them metabolic acidosis deve­
loped with a profound drop in blood 
bicarbonate concentration. A third 
patient did not have pulmonary edema 
but did have metabolic acidosis. In one 
patient the descending colon was perfo­
rated. The perforation was detected the 
day after stone removal when a 
nephrostogram showed drainage of con­
trast into the descending colon. This 
patient required repair of her colon and 
a temporary transverse colostomy. Four 
patients experienced gross hematuria after 
their discharge from hospital. Three of 
them had a single painless episode of 
between 1 and 2 weeks after their dis­
charge from hospital, while the fourth 
patient required readmission to hospital 
6 days after discharge for hematuria that 
had persisted for 24 hours. This patient 
was treated with hydration and bed rest. 
The hematuria stopped within 48 hours 
and did not recur.
The mean postoperative hospital stay 
for all our patients was 6.8 days. Those 
with infected renal calculi required longer 
hospitalization as in these patients we rou­
tinely irrigate the kidney with Solution G 
for a minimum of 48 hours postopera­
tively to try and dissolve any remaining 
fragments even if none are identified radi- 
ologically. If the 20 patients with infected 
calculi, and the 2 who required open sur­
gery for stone removal, are excluded, the 
mean postoperative hospital stay in the 
remaining 80 patients was 5.3 days.
Stone analysis was available in 73 of the 
patients. Nineteen (26%) stones were cal­
cium oxalate, and 35 (47.9%) both cal­
cium oxalate and calcium phosphate. 
Eight patients (11%) had stones contain­
ing magnesium ammonium phosphate 
(struvite) and seven patients (9.6%) had 
pure calcium phosphate stones. One stone 
was reported as being pure calcium car­
bonate and one as calcium acid urate. 
One stone was reported as consisting of 
pure uric acid and the remaining stone 
was a mixture of calcium oxalate and uric 
acid.
Discussion
Percutaneous stone removal can no 
longer be considered experimental. Our 
success rate with the procedure is com-
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parable to that of others6’7 and we have 
found the complications associated with 
the procedure acceptable. One of our 
most serious complications, pulmonary 
edema, was likely related to systemic 
absorption of irrigating fluid, and has not 
been a problem since we adopted the 
practice of strict monitoring of fluid 
balance intraoperatively. It is important 
to note that in no patient who had pul­
monary edema was a rupture of the renal 
pelvis identified intraoperatively. Fre­
quently, at the end of one of these proce­
dures, inspection of the peripheral calyx 
through which the nephrostomy has been 
performed reveals a small rupture of the 
renal pelvic wall deep within the renal 
sinus, and it is possible that this was the 
site of fluid absorption in our patients.
In some patients early in our series, the 
guide wire was inserted on the day of 
lithotripsy under the same general 
anesthetic. In this situation, it is difficult 
to be sure that no bowel lies between the 
kidney and the skin puncture site. The 
patient who sustained a bowel perforation 
in our series had the wire placed under 
general anesthesia immediately before 
lithotripsy. All guide wires are now placed 
under local anesthesia. The patient is 
asked to rotate on the fluoroscopy table 
during the wire placement and, with the 
kidney visualized from a lateral view­
point, any bowel lying close to the kid­
ney can be avoided.
Excessive bleeding has not been a 
problem. Two patients received one unit 
of packed cells each. In one patient there 
was brisk bleeding from the nephrostomy 
tube postoperatively, so the tube was 
clamped to stop further bleeding by tam­
ponade secondary to blood clot forming 
in the renal pelvis; this maneuver was suc­
cessful.
Stone fragments were retained in few 
patients. A plain film of the kidney at the 
end of the procedure is essential since 
fluoroscopy is not sensitive enough to 
detect small fragments. If there is any sus­
picion of retained fragments, the renal 
pelvis should be reinspected carefully, and 
another roentgenogram obtained if neces­
sary. In some patients, retained fragments 
are identified postoperatively; if the frag­
ments are thought to be accessible, 
nephroscopy should be repeated.
In patients with multiple stones, 
residual stone material was identified in 
13 of 26 patients. However, 10 of these 
were considered to have a successful out­
come in that the stone causing the sym­
ptoms was completely removed and all 
associated stones considered large enough 
to cause symptoms were also removed. In 
10 of the 13 patients with residual stones, 
the fragments were considered inaccessi­
ble to the rigid nephroscope or the risk 
of renal injury was considered too high 
to justify attempting to remove the frag­
ments. In most of these patients it is pos­
sible that even with open surgical proce­
dures these stones might not have been 
removable. In recent cases use of a flexi­
ble nephroscope has made retrieval of 
small calyceal stones possible, and in one 
case use of the flexible nephroscope cou­
pled with electrohydraulic stone disrup­
tion made it possible to remove a calcu­
lus that would not have been accessible 
with the rigid nephroscope.
The nephrostomy tract may be dilated 
in various ways before removing the stone 
and the technique used may influence the 
speed and method of stone removal. For 
most of our patients (94 of 102), the tract 
was dilated to 24 French and the nephro­
scope inserted into the renal pelvis 
without using an Amplatz sheath. The 
instrumentation channel in this instru­
ment is 4.1 mm in diameter and as most 
renal calculi requiring removal are larger 
than this, ultrasonic disruption is usually 
required. The technique also carries the 
risk of fluid absorption so fluid balance 
must be carefully monitored. An advan­
tage of the technique is that the renal col­
lecting system is distended, making it eas­
ier to identify the intrarenal anatomy and 
find stone fragments. Also, the nephro­
scope is more easily maneuvered than 
when it is inside a separate sheath, and 
this may facilitate at least the initial dis­
ruption of large branched calculi. The 
Amplatz sheath system involves dilating 
the tract up to as much as 30 French and 
passing a rigid plastic sheath over the lar­
gest dilator used into the renal pelvis. The 
nephroscope or a visual grasping forceps 
can then be passed through the sheath and 
the stone either lifted out or disrupted. 
Stones up to 1 cm in diameter can be 
lifted out and in all eight patients in whom 
we have used this technique, stone disrup­
tion was unnecessary. Irrigating fluid is 
able to leak around the nephroscope, 
reducing the risk of fluid absorption and 
possible pulmonary edema. For better 
visualization of the collecting system, a 
cap can be fitted over the sheath and the 
nephroscope passed through a hole in the 
cap. This seals the system, allowing dis­
tension of the collecting system, and is 
useful particularly when performing flex­
ible nephroscopy. Balloon dilatation of 
the tract using strengthened balloons is 
relatively simple and probably less trau­
matic than serial dilators. The balloons 
are expensive and we have found them 
suitable for one or two dilatations only. 
Moreover, we have found it necessary to 
pass one or two of the larger dilators as 
well to create a suitable tract, so balloon 
dilatation does not possess any major 
advantage over flexible fascial dilators. 
Rigid metal coaxial dilators were used in 
one of our patients. A thin metal tube is 
passed over the guide wire into the renal 
pelvis and serial metal dilators of increas­
ing size are passed over the preceding one. 
This is useful in patients who have under­
gone previous renal surgery in whom 
dense scar tissue surrounding the kidney 
makes other forms of dilatation difficult.
Percutaneous stone removal is not a 
quick procedure. The average operating 
time was 101 minutes. Also, the urologist 
must be prepared to take the time to rein­
spect the renal pelvis if intraoperative 
roentgenograms suggest retained frag­
ments, and be willing to subject the 
patient to multiple procedures in order to 
achieve complete clearance of stone 
material.
Despite the difficulties associated with 
percutaneous stone removal, the proce­
dure has major advantages over conven­
tional open surgical techniques. A 1-cm 
incision is required rather than the large 
muscle-dividing incision needed for open 
surgery and postoperative discomfort 
associated with the small incision is rare. 
The duration of postoperative hospitali­
zation is substantially reduced. Patients 
are allowed to eat their normal diet as 
soon as they have recovered from the 
anesthetic and are not confined to bed 
postoperatively. A prolonged convales­
cence at home following discharge from 
hospital is not necessary and we advise 
patients that they may return to work 
within a week of stone removal. One 
patient returned to work directly from the 
hospital 72 hours after the procedure.
We consider percutaneous stone 
removal with or without stone disruption 
to be the surgical procedure of choice in 
the management of renal calculi. The 
introduction of extracorporeal shock- 
wave techniques may reduce the need for 
percutaneous stone surgery in the future. 
Nevertheless, the modest cost, availabil­
ity, effectiveness and safety of percutane­
ous stone surgery will ensure a continu­
ing role for this technique in the 
management of renal calculi.
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Pseudomembranous Colitis and Wound Infection Following 
Perioperative Use of Multiple Antibiotics
The prophylactic use of antibiotics in 
elective surgery of the colon is accepted 
practice, but it has inherent risks. The 
authors report the case of a 70-year-old 
woman who had wound infection and 
severe, relapsing pseudomembranous 
colitis due to Clostridium difficile  after a 
short course of antibiotics given orally 
and parenterally at the time of elective 
resection of the colon. Perioperatively, 
she received erythromycin base and 
neomycin orally, plus netilmicin and 
metronidazole intravenously. Although 
the concomitant administration of paren­
teral antibiotics may enhance the benefit 
of antibiotics given orally before opera­
tion, this does not entirely prevent 
wound infection. Until the relation 
between the number of drugs and risk of 
antibiotic-associated colitis is more 
clearly defined, caution should be exer­
cised in the use of multiple antibiotics in 
elective colonic surgery.
En chirurgie non urgente du colon,
I'usage prophylactique des antibiotiques 
est une pratique acceptee, mais elle 
comporte des risques inherents. Les 
auteurs decrivent le cas d'une femme de 
70 ans qui a presente une infection de 
plaie et une colite pseudo-membraneuse 
severe et recidivante a cause de Clostri­
dium diffic ile  apres avoir recu par voies 
orale et parenterale un traitement antibio- 
tique de courte duree au moment d'un 
resection non urgente du colon. En per- 
op6ratoire, elle avait regu de l'6rythromy- 
cine base et de la neomycine par voie 
orale, suivies de n£tilmicine et de 
metronidazole en intraveineuse. Meme si 
('administration d'antibiotiques par voie 
parenterale est susceptible d’ameliorer
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les effets des antibiotiques oraux donnes 
avant I'intervention, ceci ne protege pas 
entierement des infections de plaie. 
Jusqu'a ce qu'on connaisse mieux le rap­
port entre le nombre de medicaments 
administres et le risque de colite m£dica- 
menteuse, des precautions s'imposent 
dans I'emploi d'antibiotiques multiples 
lors de chirurgies coliques non urgentes.
Prophylactic administration of antibiotics 
in elective gastrointestinal surgery is a 
two-edged sword. Clarke and colleagues1 
have shown that antibiotics reduce the 
incidence of postoperative wound infec­
tions in colorectal surgery; however, there 
is a risk of drug complications that 
include antibiotic-associated colitis.2 Can 
a zero wound infection rate be achieved 
in colonic surgery and, if so, would this 
be paid for by more frequent colitis? The 
relations between the number of antibi­
otics given perioperatively, the incidence 
of wound infection and of colitis have not 
been determined. We report on a patient 
who had a wound infection and severe 
pseudomembranous colitis after receiving 
a short course of four antibiotics in 
association with elective colectomy.
Case Report
A 70-year-old woman underwent left hemi­
colectomy to remove an adenocarcinoma of the 
splenic flexure. Her past history included cho­
lecystectomy, hysterectomy and hiatal hernia 
repair. She had been taking hydrochlorothia­
zide for mild hypertension.
Preoperatively, the bowel was mechanically 
cleansed with oral magnesium citrate cathar­
sis and saline enemas. The day before opera­
tion the patient was given neomycin and 
erythromycin base orally, 1 g each at 13,00. 
16,00 and 23,00 hours; neither of these drugs 
was given postoperatively. She also received 
netilmicin (80 mg) and metronidazole (500 mg) 
intravenously 1 hour before operation. Two 
further doses of each of these drugs were admi­
nistered over the next 16 hours (netilmicin) and 
20 hours (metronidazole). The operation was 
prolonged (2 hours, 40 minutes) because of 
extensive adhesions due to previous surgery and 
diverticular disease.
The patient did well initially, but on day 9 
following operation, watery diarrhea and abdo­
minal cramps developed and she had a tempe­
rature of 39°C. Sigmoidoscopy revealed 
mucus, pus and pseudomembranes. The stool 
contained a heavy growth of Clostridium dif­
ficile and stool filtrate contained a toxin cyto- 
pathic to McCoy cells to a titre of 1:50 000 and 
neutralized by antitoxin to Clostridium sordellii 
toxin. The organism was sensitive to metroni­
dazole, one of the antibiotics that had been 
given perioperatively.
On the day that diarrhea developed, the 
patient’s wound was noted to be inflamed. 
Wound exudate contained a heavy growth of 
Staphylococcus aureus resistant to erythromy­
cin. Sensitivity to netilmicin was not tested. A 
light growth of Pseudomonas aeruginosa, sen­
sitive to netilmicin, was also cultured. The 
wound was opened and drained and did not 
cause further morbidity.
The patient was given vancomycin (500 mg 
orally every 6 hours) for 9 days. This control­
led her intestinal symptoms and eradicated 
both the C. difficile and its toxin from the 
stool. Two days after withdrawing the van­
comycin, the patient was discharged from hos­
pital. Thirteen days later she was readmitted 
because of explosive watery diarrhea, fever and 
anorexia. Barium enema revealed pancolitis. 
Vancomycin was restarted orally, followed by 
bacitracin 100 000 units orally four times a day. 
Various drug combinations, including cholesty­
ramine and metronidazole, were tried with little 
success. Over the next 2 months, toxin-positive 
diarrhea continued and was complicated by 
hypovolemia, metabolic acidosis and malnu­
trition requiring parenteral alimentation. She 
was discharged 2 months after readmission, 
still taking cholestyramine and bacitracin, but 
with the diarrhea under control.
Four months after her diarrhea began, the 
patient was admitted a third time for a right 
upper lobectomy to remove an adenocarci­
noma of the lung. This had been detected 
shortly before her colectomy. Despite conti­
nued therapy, her stool was still positive for 
C. difficile toxin. Her postoperative course was 
uncomplicated this time, and the colitis resol­
ved completely after several weeks’ further the­
rapy with bacitracin and cholestyramine.
Discussion
Colitis associated with the periopera­
tive administration of antibiotics has not 
been adequately investigated. Keighley 
and associates2 in their prospective study 
found that of 81 patients who underwent 
colorectal operations, 39 (48%) suffered 
from diarrhea postoperatively and 8
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(10%) had C. difficile toxin in the stool. 
Their report does not say how many 
patients had colitis. The actual frequency 
of this complication is unknown, and 
would require prospective analysis of a 
large number of colorectal procedures. 
Unfortunately, there is no way at present 
to predict which patients are at high risk 
for the subsequent development of colitis.
The patient in this report had two 
postoperative infections (wound and coli­
tis) caused by three bacteria. Two of these 
organisms (C. difficile and P. aeruginosa) 
were sensitive to at least one of the antibi­
otics given before operation. The S. 
aureus was resistant to erythromycin; its 
sensitivity to netilmicin was not tested. 
Although the wound infection caused lit­
tle disability, the colitis was a major 
insult.
Neomycin and erythromycin base given 
orally before operation are effective in 
reducing the number of wound infections 
following colonic surgery. However, 
Clarke and colleagues' found that these 
antibiotics do not sterilize the colonic 
lumen and do not completely prevent 
wound infection. Coppa and associates3 
showed that a parenteral agent added 
preoperatively conferred increased 
benefit. It is therefore not unreasonable 
to augment oral prophylaxis with systemic 
antibiotics. However, this means that at 
least three antibiotics must be given and,
as demonstrated by our case, they may 
still not prevent wound infection. Shapiro 
and coworkers4 found that prolonged 
surgery is as important in the develop­
ment of wound infection as the adminis­
tration of antibiotics.
It is interesting that C. difficile, the 
organism implicated in the cause of 
antibiotic-associated colitis, was sensitive 
to metronidazole. Orally administered 
metronidazole is an effective treatment 
for colitis due to C. difficile,5 and 
intravenously administered metronidazole 
is secreted into the colonic lumen.6 One 
might assume, therefore, that orally or 
intravenously administered metronidazole 
should protect against colitis. However, 
most isolates of C. difficile are sensitive 
to the drug that caused the colitis,7 and 
metronidazole itself has been implicated 
as a cause- of antibiotic-associated coli­
tis.8 In Keighley’s study,2 patients who 
suffered diarrhea associated with C. 
difficile toxin had received kanamycin 
and metronidazole (the route of adminis­
tration was not described). Metronidazole 
does not appear to protect against 
antibiotic-associated colitis.
The relation between the number of 
drugs given perioperatively and the inci­
dence of colitis requires further study. 
This case is a warning that caution should 
be exercised in the use of multiple antibi­
otics in elective surgery of the colon.
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In many patients, there is usually need for repeated 
access to body compartments for drug delivery or fluid col­
lection.
Port-A-Cath is a totally implantable drug delivery 
system, specifically designed for safe and easy repeated 
access.
Since the Port-A-Cath is implanted under the skin, it 
reduces the risk of infectious complications, spares the peri­
pheral vasculature, allows targeted drug infusion, facilitates 
ambulatory treatment and does not interfere with the normal 
daily acitivities of the patient.
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Simplified Insertion of the Port-A-Cath 
Implantable Drug-Delivery System
The increasing frequency with which 
antineoplastic drugs are being used 
demands improved vascular access for 
their administration. Venous access 
through implantable catheters facilitates 
treatment when veins are no longer 
available. Totally implantable catheters 
of the Port-A-Cath type are preferred 
because they give better performance 
and cosmetic results, and are more con­
venient for the patients.
The flexibility of these catheters makes 
their introduction difficult. The author 
describes a simplified technique, using a 
commercially available introducer that 
has been used satisfactorily in thousands 
of pacemaker implantations. The author 
has used this technique routinely with a 
50%  decrease in operative and fluoro­
scopy time and without complications.
L'usage de plus en plus frequent des 
medicaments antindoplasiques exige de 
meilleures voies d'administration vascu- 
laire. Quand les veines sont devenues 
inutilisables, I'etablissement d'un acces 
veineux grace a un catheter & demeure 
facilite le traitement. On preffere les 
catheters totalement implantables de 
type Port-A-Cath car ils offrent un meil- 
leur rendement, donnent des resultats 
cosmetiques superieures et sont plus 
commodes pour le patient.
La flexibility de ces catheters en rend 
la pose difficile. L'auteur decrit une tech­
nique simplifiee utilisant un instrument 
d'insertion du commerce qui a deja ete 
employe avec satisfaction des milliers de 
fois pour I'implantation de stimulateurs 
cardiaques. En utilisation de routine, 
l'auteur a obtenu par cette technique une 
diminution de 5 0 %  du temps d'operation 
et de fluoroscopie, et ceci sans compli­
cations.
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Advances in the development of new and 
more effective antineoplastic drugs have 
made possible the control and cure of  
several malignant neoplasms. Most of 
these agents require intravenous adminis­
tration. Drug combinations and multiple 
injections over a long period are usually 
necessary. Many of these drugs induce
local changes in the venous wall charac­
terized by inflammation followed by 
thrombosis and ultimately sclerosis. Soon 
venous access becomes a major problem. 
Pain, frustration, anxiety and expenditure 
of time increase with every treatment and 
may result in incomplete treatment or ter­
mination of therapy.
FIG. 1—J guide wire, introducer and sheath assembled after introducer and sheath have 
been inserted into subclavian vein. Note that J  wire is positioned with J portion forward for 
easy cannulation without vein damage or perforation.
FIG. 2—Silicone catheter in position before cannula is removed. Notice that J wire inside 
silicone catheter is inserted in reverse fashion. Wire does not protrude past silicone catheter 
to avoid vein injury. Insert shows portal before connection.
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Over the years some ingenious proce­
dures have been designed in an attempt 
to solve this problem. Arteriovenous 
fistulas, vascular grafts and a variety of 
“ permanent”  intravenous catheters are 
commonly used.
A totally implantable drug-delivery sys­
tem (Port-A-Cath, Pharmacia [Canada] 
Inc., Dorval, PQ) has recently been 
introduced. It allows blood sampling and 
bolus injections or continuous infusions 
of drugs. The device is composed of a 
stainless steel portal with a silicone 
catheter that self-seals by means of a 
stainless steel lock. The catheter is 
introduced usually through the cephalic 
vein and positioned under fluoroscopic 
control in a large central vein, most com­
monly the superior vena cava. The 
catheter is then connected to the portal.
Because the flexibility of the catheter 
and, in many cases, the unsuitability of 
the cephalic vein make this procedure 
difficult, I present a simplified technique 
for inserting the catheter.
Technique
Under sterile conditions in the operat­
ing room and using local anesthesia, a 
1-cm incision is made 2 cm below the 
angulation of the left clavicle, in the same 
location that normally would be selected 
for a direct subclavian vein puncture. A 
Littleford-Spector introducer (Cordis 
Corp., Miami, Fla.) has all the necessary 
items for this. First, the subclavian vein 
is punctured through the incision using 
the syringe and 18-gauge needle provided. 
Blood is aspirated and then the steel J 
guide wire is introduced and its position 
checked by fluoroscopy. The needle is 
removed and the vessel dilator and sheath 
introducer are slid into place (Fig. 1). The 
J wire is removed. A no. 10.5 French can­
nula should be used because it matches 
the portal silicone catheter best. The J 
guide wire is then introduced inside the 
catheter to prevent it from coiling and to 
speed its insertion into the superior vena 
cava. The J guide wire is best introduced 
backwards, leaving the “ J ” part outside 
because this way it slides better into the 
portal catheter. It should be lubricated 
with heparinized saline solution. The 
guide wire is advanced no further than the 
tip of silicone catheter to avoid damage 
to the venous wall during its insertion. 
The catheter is then inserted through the 
sheath and positioned (Fig. 2). The sheath 
is removed. A nonabsorbable suture is 
used to fix the catheter. The J guide wire 
should not be removed until the suture is 
tied to prevent inadvertent occlusion or 
narrowing of the lumen. This complete 
maneuver usually takes less than 5 
minutes. The catheter is then tunnelled 
subcutaneously to the area of the perma­
nent pocket and connected to the portal 
as described by the manufacturer.
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Discussion
The Littleford-Spector introducer was 
originally manufactured for the rapid 
insertion of permanent endocardial elec­
trodes for cardiac pacing.1 The tech­
nique is widely used. It is the alternative 
procedure of choice for me when the 
cephalic vein is unsuitable for cannulation 
during pacemaker insertion. I have not 
experienced any complications with this 
technique in over 300 pacemaker inser­
tions.
The original technique has been 
adapted and modified to facilitate the 
insertion of the silicone catheter of the 
portal delivery system. The silicone 
catheter is softer and more flexible than 
a pacemaker lead. Thus, it may coil inside 
the large central veins. Because of its flex­
ibility, it is also difficult to manipulate 
into position. Use of the J guide wire to 
stent the silicone catheter has several 
advantages: it provides temporary sup­
port for catheter insertion and manipu­
lation, increases the visibility of the 
catheter during fluoroscopy, reduces 
fluoroscopic time to a minimum because 
of easier manipulation and the predeter­
mined location of the introducing cannula 
and prevents inadvertent occlusion or nar­
rowing of the silicone catheter by the 
securing suture. When the no. 10.5 
French introducer is used, the inner 
diameter of the cannula matches perfectly 
the outer diameter of the silicone catheter. 
Thus, insertion is easy and blood loss is 
almost nil. This has been my procedure 
of choice for all my recent insertions. 
There have been no complications and 
time taken for insertion has been reduced 
by more than 50%.
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Thrombostat Prescribing Information
(Thrombin, USP) Bovine Origin— 
formerly: Thrombin, Topical
INDICATIONS: Thrombostat is indicated as an 
aid in hemostasis wherever oozing blood from 
capillaries and small venules is 
accessible.
In various types of surgery, 
solutions of Thrombostat may / 
be used in conjunction with 
absorbable gelatin sponge 
USP for hemostasis.
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surfaces.
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the solution should be refrigerated, 
preferably frozen, and not used 
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Delayed Intestinal Perforation After 
Nonpenetrating Abdominal Trauma
The incidence of hollow-organ injury has 
increased steadily since the use of seat- 
belts was introduced. It has become 
apparent that the clinical manifestations 
of intestinal injury may be delayed con­
siderably. Delayed perforations can pose 
a diagnostic challenge to the attending 
surgeon. The authors report four patients 
who suffered delayed intestinal perfora­
tion 6 or more days after sustaining non­
penetrating abdominal trauma in motor 
vehicle accidents while wearing passive 
seat-belt restraints. All patients had low 
severity of injury (scores ranging from 4 
to 13) but had persistent vague abdomi­
nal pain before perforation occurred. 
Three of the four patients suffered spinal 
trauma as their major initial injury. Such 
patients appear to be at higher risk for 
delayed perforation and should be moni­
tored carefully.
La frequence des blessures des organes 
creux augmente regulierement depuis 
I'avenement de la ceinture de securite. II 
est devenu evident que les manifesta­
tions cliniques des blessures intestinales 
peuvent etre considerablement retardees. 
Les perforations retardees peuvent cons- 
tituer pour le chirurgien traitant un defi 
de diagnostic important. Les auteurs 
decrivent quatre patients qui ont souffert 
d'une perforation intestinale retardee, 6 
jours ou plus apres avoir subi une contu­
sion abdominale au cours d'un accident 
de la route, alors qu'ils portaient une 
ceinture de securite. Tous les patients 
avaient subi des blessures de peu de gra­
vity (cotes variant de 4 a 13) mais souf- 
fraient de douleur abdominale vague 
persistante avant que la perforation ne 
survienne. Trois des quatres patients 
avaient subi un traumatisme spinal 
comme blessure initiate majeure. Ces 
patients semblent presenter un risque 
plus eleve de perforation retardee et
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devraient faire I’objet d'une surveillance 
attentive.
The incidence of intestinal injury secon­
dary to nonpenetrating abdominal 
trauma has increased markedly in North 
America in conjunction with the use of 
seat-belt restraints in motor vehicles.1 
Injury to hollow organs is difficult to 
diagnose even when there is perforation 
as it is not usually associated with major 
blood or volume loss. Furthermore, 
specific physical findings and definitive 
diagnostic, laboratory and radiologic 
investigations are lacking. Intestinal 
injury is usually discovered during 
exploratory laparotomy for a hemoperi- 
toneum uncovered during peritoneal 
lavage or for injury to other abdominal 
or retroperitoneal viscera. The present 
trend towards nonoperative management 
of hemoperitoneum in an effort to 
preserve splenic function will make such 
discoveries less frequent.2"4
Delayed intestinal perforation is a 
potentially lethal complication of blunt 
abdominal trauma. The surgical literature 
contains only isolated case reports or 
anecdotal mention of this pheno­
menon.5'7 We report four such cases of 
delayed intestinal perforation managed at 
this institution over the past 24 months. 
We discuss the diagnostic difficulties and 
concepts of pathophysiology and make 
recommendations for the management of 
patients with this complication.
Case Presentations
Table I documents the salient features 
of the four patients with delayed post- 
traumatic intestinal perforation referred 
to the Kingston General Hospital for 
management. All were males who were 
involved in motor vehicle accidents. All 
wore seat-belts, three of the lap type and 
one a three-point shoulder type.
The four patients demonstrated the fol­
lowing findings in common. The clinical 
manifestations on original admission sug­
gested a modest insult but there was no 
serious hypotension (injury severity scores 
4, 10, 10 and 138). The abdominal find­
ings were nonspecific. All had persistent 
abdominal complaints but no localized or 
generalized abnormalities could be found 
despite repeated physical examinations. 
There was a substantial interval between
the time of admission and the diagnosis 
of perforation (6 to 36 days). None of the 
laboratory or radiologic studies, per­
formed initially or during the period 
before operation, were diagnostic. The 
patients had resumed oral intake and had 
normal bowel movements before the full 
evolution of their intestinal perforation. 
Acute peritoneal signs eventually deve­
loped on physical examination and at 
operation localized perforation of small 
or large bowel was found.
In three patients there was evidence of 
an adjacent mesenteric hematoma and 
three had an associated spinal injury. 
After definitive treatment, these patients 
are alive and well and intestinal continuity 
has been re-established in the two patients 
who had a colostomy. Examination of the 
resected intestinal segments (Fig. 1) 
showed transmural ischemic necrosis of 
either small or large bowel in all four 
patients.
Discussion
In North America, motor vehicle acci­
dents remain the commonest cause of 
blunt abdominal traum a.1’6 Before the 
use of seat-belts became widespread, 
intestinal injury as a result of blunt 
trauma was most often reported as an 
incidental finding during laparotomy for 
hemoperitoneum due to splenic and 
hepatic injuries.9' 13 At most, 25% of 
laparotomies for blunt abdominal trauma 
have an intestinal component. Usually, 
this is either a serosal or mesenteric hema­
toma, with less than 5% of the injuries 
requiring small- or large-bowel resec­
tion.14 The incidence of injury to hollow 
organs has risen concomitantly with the 
increased use of seat-belts. In a single ser­
ies, Denis and associates5 reported that 
over 80% of their patients sustained seri­
ous intestinal injury in motor vehicle acci­
dents while wearing selt-belts. Within this 
group, 17 of 27 patients had a spontane­
ous perforation while 5 more had evi­
dence of intestinal ischemia without 
necrosis. When a patient suffers injury to 
the lumbar spine in a motor vehicle acci­
dent while wearing a seat-belt, an intesti­
nal injury should be suspected even in the 
initial absence of abdominal findings. 
Several reports have documented a sig­
nificant correlation between these inju­
ries.5’7 The clinical diagnosis of peritoni-
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tis in association with spinal trauma can 
be very difficult. Physical findings may 
be misleading because of local abdomi­
nal wall trauma or neurologic deficits 
related to the spinal injury. Moreover, 
prolonged ileus is a well-known sequela 
o f spinal fractures in the absence of neu­
rologic deficits.
The early and late diagnosis o f post- 
traumatic intestinal injury is difficult. 
Minilaparotomy (peritoneal lavage) as 
recommended by the Committee on 
Trauma of the American College o f Sur­
geons, will aid in the diagnosis of immedi­
ate intestinal perforation should Gram’s 
staining of the abdominal effluent iden­
tify organisms.5,15 Peritoneal lavage that 
contains no organisms or blood or one 
that contains 50 to 100 x  10VL erythro­
cytes, which is often found with a mesen­
teric hematoma, is of no help.
There has been a definite move to 
nonoperative management o f patients 
with a positive peritoneal lavage who are 
hemodynamically stable and have low 
injury severity scores.24'1618 This has 
been based on the observation that splenic 
or hepatic injuries, the commonest causes 
of positive peritoneal lavage, are often
not actively bleeding at the time of 
laparotomy. The development of sophis­
ticated imaging techniques has aided diag­
nosis o f intra-abdominal traumatic injury
and has spared many individuals (mostly 
children) an unnecessary laparotomy and 
splenectomy with the possibility of post­
splenectomy sepsis.19,20
FIG. 1—Photomicrograph adjacent to site of perforation. There is hemorrhage and very 
recent necrosis of muscularis propria (arrow). Inset: necrosis of this muscle (arrow) is associated 
with neutrophilic infiltrate, suggesting recent ischemic necrosis. (Hematoxylin-phloxine-safranine 
X 120; inset x 300.)
Age, 
yr Sex
~1 wf
29 M
47 M
41 M
___________________ Table I—Clinical Summary of Patients With Delayed Intestinal Perforation After Trauma________
Injury
Abdominal Peritoneal Associated severity Radiologic Laparotomy Surgical
Hypotension findings lavage injury score8 findings Course findings management
No Abdominal wall 
contusion. 
Diffuse 
tenderness
No Fracture 
dislocation 
L3—4
Yes
(crystalloid
only)
Diffuse
tenderness
only
No Fracture pubic 
rami and L3
No Abdominal wall 
contusion. 
Diffuse 
tenderness
Yes,
negative
Compression 
fracture L3 
and L4
No Abdominal wall 
hematoma
Yes, 
positive 
(100 X 109/L
None
erythrocytes)
Absent psoas Persistent mild Perforation mid- Resection with
right side. abdominal jejunum. primary
Retroperitoneal pain. Sudden Mesenteric anastomosis
signs on onset hematoma.
computerized peritoneal Seromuscular
tomogram signs on day 
6
tears proximal 
and distal to 
perforation
3 views of Day 6 — acute Perforated Jejunal
abdomen all onset of jejunum 12 resection.
normal peritoneal cm distal to primary
signs, ligament of anastomosis,
hypotension, Treitz. sigmoid
free intra- Ischemic resection,
peritoneal air sigmoid colon 
with
mesenteric
hematoma
end-colostomy 
and mucous 
fistula
Plain films Persistent Perforated Hartmann
normal abdominal fibrotic procedure,
pain. Day 36 stricture of drainage of
— large
bowel
obstruction
with flow of
barium into
abscess
cavity
mid-sigmoid, 
communicating 
w ith abscess 
cavity
abscess
3 views of Persistent mild Free perforation Colonic
abdomen all abdominal mid-transverse resection with
normal. pain. colon; double-
Computerized Discharged mesenteric barrelled
tomogram
normal
on day 7. 
Returned 12 
h later with 
acute onset 
rigid abdomen
hematoma colostomy
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Unfortunately, there are no reliable 
symptoms or signs to lead to a definitive 
diagnosis of hollow-organ injury.7’1113 
As in previous series,21 abdominal pain 
of variable severity and initially without 
notable physical findings was the only 
consistent feature. Abdominal guarding, 
rebound tenderness and auscultation of 
bowel sounds are notoriously unreliable. 
In fact, tolerance of oral intake and 
return of bowel function occurred in all 
our patients despite serious underlying 
intestinal injury.
Similarly, there are no specific labora­
tory investigations that lead to a defini­
tive diagnosis of intestinal injury. Plain 
films of the abdomen are unreliable.19 
Evidence of free intraperitoneal air is seen 
in less than 50% of patients with intesti­
nal perforation.19 Although abdominal 
computerized axial tomography is effec­
tive in diagnosing disruption of solid 
organs, it is less reliable in detecting 
hollow-organ injury.19-20 Water-soluble 
contrast studies have been used to rule out 
proximal small-bowel injury or disrup­
tion. In patients who sustain vascular 
damage to the mesentery, resulting in 
eventual ischemic necrosis, early radio- 
logic signs may be difficult if not impos­
sible to detect.
Laparoscopy under general or local 
anesthesia has been used in the emergency 
room to replace peritoneal lavage and 
allow complete examination of the 
peritoneal cavity.22 This modality could 
identify patients with potential intestinal 
injuries that might lead to perforation. 
Carefully staged, progressive resumption 
of oral intake should be undertaken with 
this possibility in mind. However, it must 
be remembered that even with laparo­
scopy, serious trauma might be missed. 
Repeat minilaparotomy may be useful in 
this period as Gram’s staining of the 
effluent is more likely to identify a mix­
ture of intestinal organisms.
The pathological findings of the 
resected intestinal segments in one of our 
patients lead us to agree with Bolton and 
colleagues9 that delayed post-traumatic 
perforation of the intestine occurs as a 
result of ischemia either through direct 
trauma to the intestinal wall or indirectly 
by trauma to the mesenteric vessels. 
Robbs and colleagues12 have suggested 
that this process can evolve within 24 to 
48 hours of the initial injury. Presuma­
bly, the most common mechanism of in­
jury to the intestine or adjacent mesen­
tery is due to the lap belt, properly placed 
or otherwise, which compresses these 
structures against the fixed spinal column 
during rapid deceleration of the motor 
vehicle. This would account for the 
associated spinal fractures seen in this ser­
ies as well as others.4’7’11'13 These authors 
subsequently treated another patient who 
suffered localized peritonitis 24 hours 
after blunt abdominal trauma. A segment
of devascularized necrotic jejunum was 
found which undoubtedly would have 
resulted in perforation.
Following blunt abdominal trauma 
caused by the seat-belt in a motor vehi­
cle accident, the persistence of abdomi­
nal pain during the first week should alert 
the attending surgeon that an undiag­
nosed intestinal injury may exist. 
Associated spinal or pelvic fractures 
should heighten the suspicion. The use of 
water-soluble radiologic studies to outline 
the colon or small bowel should be con­
sidered. Repeat minilaparotomy or 
laparoscopy should also be considered if 
the radiologic findings are inconclusive. 
It is obvious that the development of 
peritonitis is an indication for immediate 
laparotomy.
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Preoperative Gelfoam Embolization of 
Supratentorial Meningiomas
Intracranial meningiomas are often highly 
vascular and a successful outcome 
depends upon surgical resection. 
Preoperative embolization of supraten­
torial meningiomas, which have a major 
blood supply from the external carotid 
artery, has been advocated to reduce 
intraoperative bleeding and thus facilitate 
surgical extirpation. The authors carried 
out transfemoral, Gelfoam embolization 
preoperatively in eight patients with 
supratentorial meningiomas. In seven of 
the cases, post-embolization, contrast- 
enhanced, computerized tomography 
was carried out. Areas of low-density 
tumour necrosis were identified in five.
In three of the eight patients, post­
embolization angiography demonstrated 
elimination of the tumour blush and in 
the other five, the blush was reduced in 
intensity. Histologic evidence of tumour 
embolization was identified in each case 
to a varying degree.
Preoperative embolization resulted in 
an identifiable radiologic change in the 
majority of these tumours, but the 
authors could not determine, in this 
small series, whether intraoperative 
bleeding was reduced.
Les meningiomes intracraniens sont sou- 
vent tr&s vascularises et la guerison 
depend souvent de la resection chirurgi- 
cale. Une embolisation preoperatoire des 
meningiomes supratentoriaux qui posse- 
dent une circulation sanguine importante 
provenant de I'artere carotide externe, a 
et6 recommandee pour reduire I'h^morra- 
gie operatoire et, ainsi, faciliter I'extirpa- 
tion chirurgicale. Les auteurs ont 
pratique en preoperatoire une embolisa­
tion transfemorale au Gelfoam chez huit 
patients porteurs de meningiomes supra­
tentoriaux. Apres I'embolisation, on a
From the Department o f  Surgery, Division 
o f Neurosurgery and Department o f  Radio­
logy, Division o f  Neuroradiology, St. 
Michael’s Hospital, and University o f  
Toronto, Toronto, Ont.
Accepted for publication May 21, 1985
Reprint requests to: Dr. P.J. Muller, Head, 
Division o f  Neurosurgery, St. Michael’s 
Hospital Annex, 38 Shuter St., Toronto, 
Ont. M5B 1A6
effectue, dans sept de ces cas, une 
tomographie transverse axiale sur ordina- 
teur avec augmentation du contraste.
Des regions de necrose tumorale a faible 
densite ont ete identifies chez cinq 
patients. Chez trois des huits patients, 
I'angiographie post-embolisation a revele 
('elimination de I'ombre tumorale et dans 
les cinq autres cas I'intensite en etait 
reduite. Des signes histologiques 
d'embolisation tumorale ont ete identifies 
a des degres divers dans tous les cas.
L'embolisation preoperatoire a 
entraine des changements radiologiques 
identifiables pour la majorite des tumeurs 
mais, a cause du petit nombre de sujets 
dans cette etude, il n'a pas ete possible 
pour les auteurs de determiner si elle 
avait reduit les saignements durant 
('intervention chirurgicale.
Meningiomas account for approximately 
14% of all intracranial tumours.1 They 
are usually histologically benign and the 
subsequent outcome depends on the suc­
cess of surgical resection.2 This may be 
compromised by the highly vascular 
nature of many of these tumours. Menin­
giomas arise from arachnoid cap cells, are 
usually attached to dura and often receive 
their main blood supply from the exter­
nal carotid artery. Embolization of the 
vessels supplying the tumour may reduce 
intraoperative bleeding and make total 
surgical resection more likely. The 
preoperative embolization of the external 
carotid feeding vessels was introduced by 
Manelfe and associates in 19733 and has 
been advocated by others.4,5 Both super- 
selective angiography and embolization of 
appropriate external carotid branches4 
and subselective embolization of the ter­
minal external carotid artery proximal to 
the maxillary artery5 have been used.
We report herein the results of preoper­
ative transfemoral embolization in eight 
patients with supratentorial menin­
giomas.
Methods and Findings
Patient Selection
Patients with computerized tomograms
compatible with a supratentorial menin­
gioma were selected for angiographic 
assessment and possible embolization. 
Informed consent was first obtained from 
the patient. Embolization was carried out 
at the time of initial angiography if the 
angiogram confirmed the diagnosis of 
meningioma and demonstrated that the 
external carotid artery formed the main 
blood supply to the tumour. The proce­
dure was carried out under local 
anesthesia.
Patients
The eight patients ranged in age from 
28 to 66 years. There were two men and 
six women. The tumours were located at 
the lateral sphenoid wing in two cases, the 
frontoparietal convexity in five and arose 
from the temporal fossa floor and 
occupied the temporoparietal convexity 
in one case. Maximum tumour diameters, 
as determined from the computerized 
tomograms, ranged from 4.8 to 8.3 cm. 
The ages, sex, clinical presentation, 
tumour location and histologic type are 
summarized in Table I.
Embolization
The transfemoral route was used to 
obtain selective internal and external 
carotid angiograms in each case. Super- 
selective catheterization of feeding vessels 
from the external carotid artery was 
attempted and embolization was carried 
out using Gelfoam powder. Angiography 
was performed immediately after emboli­
zation using the same contrast volume 
and injection sequence as before. No seri­
ous complications occurred; one patient 
had ipsilateral facial pain but it resolved 
spontaneously within 12 hours.
Computerized Tomography
Contrast-enhanced computerized 
tomograms were acquired before emboli­
zation in each case. In seven patients the 
appearance was of a homogeneous, 
hyperdense tumour. In five of seven scans 
obtained after embolization, there were 
areas of low density in the previously 
homogeneously high-density tumours
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(Table II) and they were interpreted as 
areas of ischemic necrosis (Figs. 1 and 2). 
In no case was the contrast enhancement 
totally obliterated.
Angiography
All patients had a demonstrable 
tumour blush on the pre-embolization 
angiogram. Table II summarizes the 
tumour blood supply, the vessels embo- 
lized and the angiographic results of 
embolization. In three patients the 
tumour blush was completely eliminated 
(Figs. 3 and 4). In four it was markedly 
reduced. In one patient the tumour blush, 
although reduced, was still moderately 
intense.
Surgical and Pathological Findings
Total surgical resection of the menin­
giomas was achieved in all cases. All but 
one patient was operated on within 4 days 
of embolization; in that case, surgery was 
delayed 5 months for medical reasons 
unrelated to the tumour or to the emboli­
zation procedure. It is of interest that 
sequential computerized tomograms on 
this patient revealed a reduction in 
tum our size but a return of the 
homogeneous hyperdensity (Figs. 5 and 
6).
Histologic assessment of the surgical 
specimens revealed Gelfoam emboli and 
areas of necrosis in six of the seven 
patients operated on early after emboli­
zation (Table III). The histologic assess­
ment of the patient whose operation was 
delayed revealed blood-vessel hyaliniza- 
tion and ischemic fibrosis within the 
tumour.
Five patients required blood transfu­
sion. An estimate of the intraoperative 
blood loss was made by adding the num­
ber of units of blood transfused and the 
postoperative fall in the hemoglobin level 
(measured in grams per decilitre). A linear 
relation between the estimated blood loss 
and the maximum tumour diameter was 
evident, but in this small series no corre­
lation between blood-loss estimate and 
post-embolization blush could be iden­
tified.
D iscussion
Adegbite and associates2 in their 
review of 114 surgically treated menin­
giomas found that the degree of surgical 
resection was the only important factor 
influencing recurrence. It might be 
assumed that reducing tumour vascular­
ity and thus intraoperative bleeding might 
facilitate the total removal of these 
tumours.
Table I—Patient Data
Case
no.
Age,
V Sex Presentation Tumour location Histologic type
1 36 F Loss of vision, 
headache
Right frontal convexity Transitional
2 66 M Dysphasia,
hemiparesis
Left frontoparietal 
convexity
Transitional
3 27 M Seizure Right lateral sphenoid 
wing
Transitional
4 34 F Headache Right frontoparietal 
convexity
Syncical
5 57 F Dysphasia Left temporal lobe Transitional
6 33 F Seizure, dysphasia Left frontal convexity Transitional
7 77 F Seizure Right frontal convexity Transitional
8 60 F Memory loss Left lateral sphenoid 
wing
Transitional
Table II—Details of Computerized Tomography, Blood Supply to Tumour and Embolization
Patient
no.
Post­
embolization
low-density
changes
Interval from
embolization Tumour blood supply
Vessels
embolized
Post
embolization
tumour
blushh“ MCA OPH MMA STA OCC
1 Yes 12 + -  + + Distal ECA Reduced 50%
2 Yes 12 + + + + - MMA, STA Eliminated
3 Yes 48 -  -  + - INT MAX Eliminated
4 Slight 48 -  -  + - MMA Reduced 50%
5 Mot done — -  -  + -  + INT MAX Reduced 25%
6 Yes 24 -  -  + -  - MMA Eliminated
7 No change 24 -  + + -  - INT MAX Reduced 50%
8 No change 24 -  -  + - MMA Reduced 75%
MCA - middle cerebral artery, OPH -  ophthalmic artery, MMA -  middle meningeal artery,
STA = superficial temporal artery, OCC « occipital artery, ECA -  external carotid artery,
INT MAX -  internal maxillary artery.
Intracranial meningiomas arise from 
arachnoid cap cells and, with few excep­
tions, have a dural attachment. In the 
majority, the main blood supply is from 
the external carotid artery; however, 
branches of the internal carotid are often 
a major source of additional blood sup­
ply. It has been shown that the capsule 
of the tumour tends to have an internal 
carotid supply and the stalk of the tumour 
and much of the interior has an external 
carotid supply.6 The proportion of inter-
FIG. 1—Case 2. Pre-embolization, contrast- 
enhanced, computerized tomogram showing 
large, homogeneously hyperdense meningioma 
located in left frontoparietal convexity.
FIG. 2—Case 2. Post-embolization tomo­
gram shows large areas of low density within 
meningioma.
FIG. 3—Case 3. Pre-embolization angio­
gram showing tumour blush of lateral 
sphenoid-wing meningioma.
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FIG. 4—Case 3. Post-embolization angio­
gram showing obliteration of tumour blush and 
occlusion of distal external carotid branches.
FIG. 5—Case 4. Post-embolization tomo­
gram shows low-density tumour core and mar­
gin of contrast enhancement.
FIG. 6—Case 4. Tomogram obtained 4 
months after embolization showing return of 
homogeneous hyperdensity and 50% reduction 
in tumour size.
nal carotid to external carotid supply is 
quite variable and unpredictable. Even 
when the angiographic assessment fails to 
show an internal carotid blood supply, 
there are often vessels that are too small 
for angiographic detection.4 Further­
more, it has been suggested that after 
external carotid embolization, the inter­
nal carotid supply to the tumour increases 
and may partly negate the effect of 
em bolization.7 Nevertheless, recent 
reports have shown that preoperative 
embolization of meningiomas can result 
in identifiable changes in the tumour.4’5
Richter and Schachenmayer4 described 
four methods by which the effect of 
preoperative embolization might be 
assessed: angiographic demonstration of 
an alteration or elimination of the tumour 
blush; the development of low-density 
areas on post-embolization computerized 
tomograms; the intraoperative assessment 
of vascularity; the histologic identifica­
tion of necrosis, tumour vessel thrombo­
sis and embolism. In their series of 31 
patients with meningiomas who under­
went superselective embolization preoper- 
atively, the external carotid tumour blush 
was eliminated in 24. In 18, histologic evi­
dence of ischemic or hemorrhagic necro­
sis was identified although the areas of 
necrosis were small, ranging from 
microscopic to 5 mm in size. These 
authors concluded that preoperative 
embolization was a useful adjunct to sur­
gical resection of meningiomas, especially 
when the tumour blood supply was 
primarily derived from the external 
carotid artery.
In 23 of 27 patients with intracranial 
meningiomas on whom Teasdale and 
colleagues5 performed subselective exter­
nal carotid  em bolization, p o s t­
embolization angiograms showed elimi­
nation of the external carotid blush. In 
8 of 17 patients who underwent post­
embolization computerized tomography, 
low-density areas were identified. Histo­
logically, 10 of 26 specimens contained 
embolic material and 14 showed evidence 
of necrosis.
Baum and colleagues8 assessed the 
difference in radionuclide scans from two 
patients with meningiomas before and 
after Gelfoam embolization of the exter­
nal carotid feeding vessels; in both cases 
the tumours were no longer visualized in 
the arterial phase but were present in the 
venous phase. Teasdale’s group5 used 
radioisotope imaging to estimate tumour 
blood flow and volume and found no 
correlation between the vascularity 
demonstrated angiographically and the 
assessment of blood flow and volume. In 
patients for whom post-embolization iso­
tope scans were obtained, no gross 
changes were identified overall; in three 
with pure external carotid feeding vessels, 
some reduction in flow was noted; in 
some with both internal and external 
carotid supply, flow and volume 
increased. This observation tends to sub­
stantiate the view of Djindjian and 
Merland7 that internal carotid feeding 
vessels multiply after the obliteration of 
external carotid feeders.
Conclusions
The use of embolization of menin­
giomas preoperatively results in identifi­
able computerized tomographic and 
angiographic changes in the meningioma 
and may reduce intraoperative bleeding 
from external carotid artery feeding ves­
sels; however, the overall reduction in 
vascularity depends on the relative con­
tributions of the internal and external 
feeders. Because of the small numbers, we 
could not speculate as to the efficacy of 
reducing tumour blood loss during 
surgery.
We thank Drs. Wm. Horsey, Wm. Tucker 
and A. Hudson for allowing us to include their 
patients; and Miss Dena Evans for secretarial 
assistance.
Table II I- Details of Tumour Vascularity, Blood Status and Histologic Findings
Tumour
Surgeons' 
description of 
intraoperative 
vascularity
Blood
Patient
no.
diameter
cm
Units
transfused
Hemoglobin 
change, g/dL
Total loss 
units
Histologic
findings
1 5.6 Moderate 6 1.8 7.8 Gelfoam emboli, 
areas of necrosis
2 7.2 High 4 4.8 8.8 Gelfoam emboli
3 4.2 Moderate 4 3.4 7.4 Gelfoam emboli, 
areas of necrosis
4 4.2 Low 0 1.5 1.5 Hyalinization, 
ischemic fibrosis
5 7.0 Moderate 4 4.7 8.7 Gelfoam emboli, 
areas of necrosis
6 4.0 Low 0 2.0 2.0 Gelfoam emboli, 
areas of necrosis
7 4.7 Low 0 2.7 2.7 Single dural 
Gelfoam embolus
8 5.8 Low 2 2.2 4.2 Gelfoam emboli
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B e n ig n  C y s tic  T e ra to m a  o f th e  O vary: a 6 -Y e a r R ev iew
Benign cystic teratom a o f the ovary was 
diagnosed h istologically in 118 patients 
over 6 years at the Sir M ortim er B. 
D avis-Jew ish General Hospital in M on t­
real. The charts w ere reviewed w ith  
respect to  population d is tribu tion, sym p­
tom ato logy, d iagnostic procedures and 
trea tm ent. Of the  118 patients, 8 5 .6%  
were younger than 40 years. Only 3 .4%  
had docum ented recurrence and 6 .8%  
w ere pregnant. Roentgenograms o f the 
pelvis revealed ca lc ifica tion  in 6 4 .1 %  of 
cases. U ltrasonography o f the pelvis 
failed to  make the diagnosis in 19 .4% . 
The m ajority  o f patients had a Pfannen- 
stiel incision (78 .8% ) and underw ent 
oophorectom y (55 .3 % ). In half the 
patients the contralateral ovary was only 
palpated.
En 6 ans, des teratom es kystiques 
benins des ovaires ont ete diagnostiques 
h isto logiquem ent chez 118 patientes. a 
I'H opita l General Ju if Sir M ortim er B. 
Davis de M ontreal. Les dossiers medi- 
caux de ces patientes ont ete etudies 
pour la d istribu tion  de la population, la 
sym ptom atolog ie , les in terventions dia­
gnostiques et le tra item ent. Des 118 
patientes, 8 5 .6%  avaient moins de 40 
ans. Seulement 3 .4 %  on t m ontre des 
preuves de recidive et 6 .8 %  etaient 
enceintes. La roentgenographie du bassin 
a d6m ontr6  la ca lc ification  dans 6 4 .1%  
des cas. L'6chographie ultrasonique du 
bassin n 'a  pas perm is de fa ire  le diagnos­
tic  dans 19 .4%  des cas. La m ajority des 
patientes ont eu une incision de Pfannen- 
stiel (78 .8 % ) et o n t subi une ovariec- 
tom ie  (55 .3% ). Chez la m oiti6  des 
patientes, I'ovaire contra latera l n 'a  6t6 
que palpe.
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Most ovarian teratomas are benign and 
cystic. They are usually of ectodermal ori­
gin and consist of a large compartment, 
containing sebaceous material admixed 
with hair, and a small solid portion 
known as Rokitansky’s protruberance. 
The latter, which is usually located at the 
base of the tumour, may consist of 
mature cartilage, a well-formed calcific 
tooth or ill-defined calcifications.1 Hor­
monally active tissue may be found in 
benign cystic teratomas.2 Ovarian tera­
tomas develop from the products of the 
first meiotic division of a single oocyte 
and are routinely homozygous, contain­
ing a single late replicating X chro­
mosome.2
Patients and Method
Between Jan. 1, 1978 and Dec. 31, 
1983, 118 patients were discharged from
FIG. 1—Distribution of cases of benign 
ovarian cystic teratoma during 6 years of study.
the gynecology service at the Sir Mortimer 
B. Davis-Jewish General Hospital in 
Montreal with a histologic diagnosis of 
benign cystic teratoma of the ovary (Fig. 
1). The medical records of these patients 
were reviewed to determine the popula­
tion distribution, symptomatology and 
the diagnostic procedures, and type of 
treatment used. The series was drawn 
from the pathology department’s com­
puterized list of patients classified as hav­
ing benign cystic teratoma of the ovary, 
within the specified years. The study 
included 123 cysts, since five patients had 
bilateral tumour.
Findings
Population Distribution
Of the 118 patients, 101 (85.6%) were 
younger than 40 years while 12 patients 
(10.2%) were younger than 20 (Fig. 2).
AG E (y ea rs)
FIG. 2—Age distribution.
Table 1—Incidence of Recurrence, Bilaterality and 
Associated Pregnancy
Recurrence/bilaterality/ Patients
pregnancy no./total no. % Reported %2
Recurrence 4/118 3.4
Suspected recurrence 4/118 3.4
Bilateral 5/118 4.2 11.1
Gross 4/5 80.0 82.0
Microscopic 1/5 20.0 18.0
Pregnancy 8/118 6.8
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The age range was from 13 to 66 years. 
The incidences of recurrence, bilaterality 
and a coexisting pregnancy are shown in 
Table I.
Two patients had recurrence in the con­
tralateral ovary and a third patient had 
recurrence twice. This patient underwent 
a right ovarian cystectomy at 18 years of
age, a left ovarian cystectomy at 19 years 
and bilateral ovarian cystectomies at 22 
years. Four other patients (3.4%) had 
undergone ovarian surgery elsewhere 
previously for unknown conditions.
Symptoms
More than half the patients were com­
pletely asymptomatic when the teratoma 
was discovered (Table II). These masses 
were diagnosed on routine pelvic exami­
nation, roentgenography, ultrasonogra­
phy, or incidentally at laparotomy. The 
laparotomies were done for different indi­
cations such as suspected ectopic preg­
nancy, total abdominal hysterectomy and 
cesarean section. Among the sympto­
matic patients, the most common sym­
ptom was abdominal pain (Table III).
Diagnostic Procedures
One third of the patients underwent 
roentgenography and more than half 
ultrasonography (Table IV). Only one 
patient had computerized tomography 
and the tomogram demonstrated the 
lesion. Calcification was apparent on 
64.1% of the roentgenograms. Ultra­
sonography missed 19.4% of the cysts; 
calcification was identified in 13.4%.
Mode o f Treatment
All patients underwent laparotomy, 
usually through a Pfannenstiel incision 
(83.1%). Only 20 patients (16.9%) had a 
midline incision. Right-sided teratomas 
were slightly more common than left 
(Table V). Two thirds of the ovarian ter­
atomas were more than 6 cm in diameter, 
the largest being 18 cm. The smallest cyst 
(1.2 cm in diameter) was discovered as a 
pelvic calcification on the roentgenogram. 
The patients had a variety of procedures 
at laparotomy, ranging from a simple 
ovarian cystectomy to total abdominal 
hysterectomy and bilateral salpingo- 
oophorectomy (Table VI). All patients 
who underwent total hysterectomy were 
more than 37 years of age and had coex­
isting uterine disease. The contralateral 
ovary was simply palpated in half of the 
patients.
Discussion
It is well known that the majority of 
benign cystic teratomas of the ovary occur 
in young women, with a peak incidence 
between 20 and 40 years of age. It is the 
most common ovarian tumour in women 
younger than 20, constituting 38% of 
ovarian neoplasms.3 Benign cystic tera­
tomas are known to recur mainly because 
of incomplete removal of the cyst wall ini­
tially. In our series, 60% had de-novo 
recurrence in the contralateral ovary. 
Benign cystic teratomas usually do not 
interfere with pregnancy and may coex­
ist in the same ovary with a corpus luteum 
cyst. According to the literature,4 benign 
cystic teratomas represent 12.3% to 
44.0% of all tumours complicating preg­
nancy. A bimanual examination in early 
pregnancy should be directed at detect­
ing ovarian masses. Any such mass more
Table II -Diagnostic Test in 64 Asymptomatic Patients
With Benign Ovarian Cystic Teratoma
Test No. %
Routine pelvic examination 46 71.9
Roentgenography 2 3.1
Ultrasonography 1 1.6
Laparotomy 15 23.4
Table Ill-Symptoms in 54 of 118 Patients With 
Benign Ovarian Cystic Teratoma
Symptom No. (symptoms) %
Amenorrhea 3 5.6
Menometrorrhagia 15 27.8
Abdominal pain 49 90.7
Table IV--Diagnostic Procedures: Rate of Use and 
Positive Findings
Procedure
Patients, 
no./total no. %
Roentgenography 39/118 33.1
Calcification seen 25/39 64.1
Computerized tomography 1/118 0.8
Ultrasonography 67/118 56.8
Cyst seen 57/67 80.6
Calcification seen 9/67 13.4
Normal appearance (missed) 13/67 19.4
Table V-Operative Findings
Ovarian cyst No./total no. %
Left ovary 53/118 44.9
Right ovary 60/118 50.8
Bilateral 5/118 4.2
Diameter, cm
< 6 39/123 31.7
> 6 81/123 65.9
Unknown 3/123 2.4
Table VI--Mode of Surgical Treatment in 118 Patients
Procedure No. of patients %
Total abdominal hysterectomy 18 15.3
Cystectomy 54 45.8
Oophorectomy 68 57.6
Other ovary
Palpated 58 49.2
Bisected 13 11.0
Wedge biopsy 21 17.8
Oophorectomy 15 12.7
Unknown 11 9.3
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than 6 cm in diameter or persisting 
beyond the 14th week of gestation should 
be managed surgically. The recommended 
time o f surgery is after the 12th week of 
gestation since the fetal loss secondary to 
the procedure is practically nil.5 The 
most common palpable ovarian mass dur­
ing pregnancy is the corpus luteum cyst, 
followed by the benign cystic teratoma, 
then by cystadenoma.6
The majority o f patients with benign 
cystic teratomas o f the ovary are asymp­
tomatic. The mass is usually discovered 
on routine pelvic examination, or as cal­
cifications seen in the pelvis during proce­
dures done for some other reason. Psam­
moma bodies of the serous cystadenomas 
may show as nonspecific calcifications on 
roentgenograms and should be considered 
in the differential diagnosis. Computer­
ized axial tomography can accurately 
diagnose a teratoma because of the com­
plex appearance of the mass with divid­
ing septae, internal debris, variable 
attenuation and distinct calcification. 
Ultrasonography usually shows highly 
reflective cystic and solid echoes with 
areas o f accoustic shadowing that obscure 
the back wall o f the cyst, suggesting the 
“ tip of the iceberg” sign of a teratoma.2
Bilateral benign cystic teratomas 
represent 11% to 18% of all ovarian
tumours. Most are less than 10 cm in 
diameter. Intraperitoneal rupture 
occurred preoperatively in one patient 
(0.8%) in our series and has been reported 
elsewhere in 1.2% to 1.9% o f cases.7 
The perforation may be acute, resulting 
in signs o f intraperitoneal irritation, or 
may be insidious and fulminant, result­
ing in matted adhesions up to the 
diaphragm mimicking gynecologic malig­
nant disease.
Since most patients are in their 
reproductive years and wish to have chil­
dren, conservative treatment is recom­
mended. Attempts should be made to 
conserve the ovary and to remove the cyst 
wall completely to avoid recurrence. The 
incidence o f torsion o f the pedicle is 
reported to be about 21% and associated 
infarction 10.8%.8 In our series the inci­
dence was 3.2% and 2.4% respectively. 
If the contralateral ovary is normal on 
intraoperative palpation, it is unlikely to 
be diseased and surgical manipulation is 
unnecessary.9
Despite the simplicity o f the operation 
and the benign outcome o f cystic tera­
tomas, the lesion is associated with a wide 
array of bizarre symptoms and findings. 
Benign cystic teratomas may present with 
chronic thyroiditis secondary to thyroid 
antibodies formed against thyroid tissue
in the mass.10 In our series one case of 
struma ovarii occurred in a 51-year-old 
woman who had a palpable thyroid 
gland. Familial occurrence o f benign cys­
tic teratomas of the ovary in a grand­
mother, mother and daughter has been 
reported.3 A case of bilateral benign cys­
tic teratomas in identical twins with 
virilizing effects has also been 
documented.2
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Endometriosis:
an Unusual Cause of Ureteral Obstruction
Endometriosis is a com m on disorder, 
affecting wom en in the child-bearing 
years. While urologic involvement is rare, 
the bladder is more often affected than 
the ureter. The authors describe the case 
of a 30-year-old w om an w ho had uni­
lateral ureteral obstruction secondary to 
an isolated periureteral retroperitoneal 
area of endometriosis. The theories of 
histogenesis are discussed. Current treat­
ment consists of surgery or hormonal 
manipulation or a combination of the 
two.
L 'endometriose est une affection cou- 
rante touchant les fem m es en age de 
concevoir. Bien que les atteintes urologi- 
ques soient rares, la vessie est plus sou- 
vent touchee que les ureteres. Les 
auteurs decrivent le cas d 'une  femme de 
30  ans qui a souffert d 'une  obstruction 
ureterale un ilatera l consecutive a une 
endometriose limitee a la region periure- 
terale retroperitoneale. On commente les 
theories de son histogenese. Le traite- 
ment actuel consiste en une intervention 
chirurgicale, en une manipulation hormo- 
nale ou en une com binaison des deux.
Endometriosis is characterized by the 
presence and proliferation of endometrial 
epithelium and stroma at a site other than 
the uterine cavity. It is said to affect up 
to 20% of women in the child-bearing 
years.1 Clinically important urinary 
involvement is rare, amounting to only 
1 % of cases, but the bladder is more often 
affected than the ureter.2 In the case 
reported here, ureteral obstruction 
occurred as a result of a solitary focus of 
extraperitoneal endometriosis.
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Case Report
A 30-year-old woman (gravida 2 para 2) 
complained of pain in the back, left loin and
■ *»
FIG. 1—Technetium-99m methylene diphosphonate bone scan demonstrates left hydroureteronephrosis. Bones are normal.
left lower quadrant, which was more severe 
during menstruation. Gynecologic examination 
including laparoscopy failed to reveal a cause 
for her symptoms. A bone scan (Fig. 1) showed 
left hydroureteronephrosis. Clinically, she had 
mild flank tenderness, but no pelvic mass or 
fixation. Further radiologic evaluation con­
firmed the left hydroureteronephrosis (Fig. 2) 
and revealed a periureteral mass (Fig. 3) located 
just below the pelvic brim. At laparotomy, a 
localized solitary area of retroperitoneal fibro­
sis, involving the left ureter at the pelvic inlet, 
was found. A frozen-section diagnosis of 
endometriosis was made. The dilated ureter 
was divided as it entered the fibrotic plaque and 
was reimplanted into a Boari-type flap. The 
permanent sections confirmed the diagnosis of 
endometriosis (Figs. 4 and 5).
Discussion
The etiology of endometriosis is 
unknown. Several theories exist, the most 
popular suggesting that viable 
endometrial fragments are regurgitated
FIG. 2—Preoperative intravenous pyelo- gram demonstrates left hydroureteronephro­sis. Obstruction is just below pelvic brim.
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through the Fallopian tubes during men­
struation.3 Other theories to explain the 
histogenesis include that of serosal 
metaplasia, in which embryonic cells of 
Mullerian origin within the peritoneum 
persist and proliferate under ovarian hor­
monal stimulation, and possibly the 
embolization of endometrial tissue along 
lymphatic or vascular channels.4 The 
only proven mechanism for the develop­
ment of endometriosis is direct implan­
tation, when endometrium is implanted 
into surgical incisions during an operation 
in which the uterine cavity is opened.s
The ectopic endometrium undergoes 
the same cyclic change as the uterine 
endometrium. The response to this peri­
odic bleeding is peritoneal irritation, 
proliferation of connective tissue, and 
secondary formation of adhesions of 
varying severity, involving contiguous 
pelvic structures.
While endometriosis has been reported 
to involve all areas of the urinary sys­
tem,610 clinically significant urinary 
involvement is uncommon.” Ureteral 
obstruction is rare, which is surprising 
considering the anatomic relationships 
within the pelvis.12,13 Ureteral involve­
ment can be divided into two groups:14 
extrinsic, where the ureter is caught in a 
fibrotic reaction in the periureteral tissue 
plane, and intrinsic, where the involve­
ment is transmural. The intrinsic type is 
less common, but both types generally 
affect only the pelvic ureter.The current therapeutic approach 
includes surgery or hormonal manipula­
tion, or a combination of the two. Sur­
gery may be conservative, preserving 
reproductive function, or definitive, 
involving not only resection of the 
endometrial deposits but total hysterec­
tomy and bilateral oophorectomy. Occa­
sionally, as in our case, surgery is 
performed to deal with a specific compli­
cation. The surgical approach must be 
tailored to the individual. Certainly when 
there is extensive involvement, a pelvic 
mass or fixation, preoperative assessment 
of the urinary system and preparation of 
the bowel should be considered.
Endocrine therapy evolved from the 
early observation that endometriosis 
undergoes regression during pregnancy 
and the menopause.15 This led to the 
concept that hormonally induced amenor­
rhea might be beneficial. Pseudopreg­
nancy is a state of hyperhormonal 
amenorrhea that is induced by the con­tinuous administration of estrogen- 
progestogen preparations.16 This results 
in decidual transformation, necrosis and 
absorption of the ectopic endometrium.
A more recent approach is the induc­
tion of a state called pseudomeno­
pause.17 Here, complete ovarian suppres­
sion leads to hypoestrogenic amenorrhea. 
This condition is produced by Danazol, 
a synthetic steroid with antigonadotropic
FIG. 3—Transverse sonogram demonstrates 2-cm echo-poor nodule (arrow) in retroperitoneum below pelvic brim.
FIG. 4—Transverse section of ureter demonstrates periureteral fibrosis and endometrial glands (hematoxylin and eosin, original magnification x  25).
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FIG. 5—Higher magnification of endometrial glands and stroma (hematoxylin and eosin, 
original magnification X 65).
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properties. Pseudomenopause appears 
more effective than pseudopregnancy and 
may cure up to 70% of cases, especially 
if the endometriosis is not extensive. Since 
the etiology of endometriosis is enigmatic, 
effective conservative treatment to pre­
vent or permanently cure this condition 
has not been developed.18 At present, 
castrating hysterectomy is the only ther­
apy that offers the possibility of perma­
nent control.19'20
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Empyema: Analysis of Treatment Techniques
Empyema is associated with a high mor­
tality. To study the factors responsible 
for the failure of treatment, the authors 
reviewed 90 cases of nontuberculous 
thoracic empyema seen at the University 
of Western Ontario in London, 
between 1970 and 1980. The most 
common causes of empyema were bron­
chopulmonary infections (6 3 % ), compli­
cations of pulmonary surgery (1 4 % ) and 
secondary infections of hydrothoraces or 
hemothoraces (13% ). In 51 patients 
(57% ) the condition was acquired in 
hospital or was related to previous medi­
cal therapy. Nine cases were recognized 
only at autopsy.
The treatment of empyema was 
assessed in 81 patients, who received 
an average of 2.2 antibiotics during the
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course of treatment. Five patients 
received antibiotics as the only therapy; 
one died. Seventy-two patients were 
treated by surgical drainage; 35 (4 9 % ) 
were cured and 18 (25% ) subsequently 
died. Twelve of 18 decortication proce­
dures were successful including 4 per­
formed as a primary procedure and 8 as 
a secondary procedure. Five of seven 
patients who underwent thoracoplasty 
were cured. The overall mortality in the 
series was 23% .
Prevention and early recognition of 
empyema may reduce the mortality. 
Patients who do not improve promptly 
with surgical drainage may benefit from 
early decortication.
L’empyeme est accompagne d'une forte 
mortalite. Dans le but d'Studier les fac- 
teurs responsables des echecs de traite- 
ment, les auteurs ont etudie 90 cas 
d'empyeme thoracique non tuberculeux 
vus a la University of Western Ontario 
de London, entre 1970 et 1980. Les 
causes les plus frequentes d'empyeme 
ont 6te les infections bronchopulmonai- 
res (63% ), les complications d'interven- 
tions chirurgicales pulmonaires (1 4 % ) et 
les infections secondaires d'hydrothorax 
ou d'hemothorax (1 3 % ). Chez 51 
patients (57% ), il s'agissait d'une infec­
tion d'hopital ou d’une infection reliee a 
un traitement prealable. Neuf cas n'ont 
ete constate qu’& I'autopsie.
Le traitement de I'empyeme a pu etre 
evalue chez 81 patients qui ont repu en 
moyenne 2.2 antibiotiques. Pour cinq 
patients, I'antibiotherapie a constitue 
I'unique traitement; un est mort. 
Soixante-douze patients ont ete traites 
par drainage chirurgical; 35 (4 9 % ) ont 
ete gueris et 18 (2 5 % ) sont morts sub- 
sequemment. Douze interventions de 
decortication sur 18 ont ete couronnees 
de succes, dont 4 interventions primaires 
et 8 secondaires. Cinq des sept patients 
qui ont subi une thoracoplastie ont ete 
gueris. Dans I'ensemble la mortalite a ete 
de 23% .
La prevention et le diagnostic precoce 
de I'empyeme sont susceptibles de 
rgduire la mortalite. Les patients qui ne 
s'ameliorent pas apres un drainage chi­
rurgical peuvent beneficier d'une decorti­
cation immediate.
The current treatment for empyema is 
based on work done by Evarts Graham 
in 1915. He used surgical drainage to treat 
young soldiers with empyema at Camp 
Lee, Virginia, and reported an early mor­
tality of only 4% .' Because of his excel­
lent results, surgical drainage was adopted 
by most surgeons as the standard initial 
therapy for thoracic empyema.
Unfortunately, modern surgeons can­
not match Evarts Graham’s success. 
Recent studies report death rates ranging 
from 15% to 30%, despite the use of
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potent antibiotics and modern surgical 
techniques.2-4 This difference is likely 
due to the changing etiology of empyema. 
Most of Graham’s patients were young 
men with postpneumonic infections. 
Today, the patient with empyema is often 
elderly, debilitated and immunosup- 
pressed. Many have gram-negative, 
anaerobic or mixed infections. For these 
reasons, the treatment of empyema that 
worked so well in 1915 is less effective 
today.
To improve the outcome in this condi­
tion, we may have to modify the tradi­
tional management. We reviewed 90 cases 
of empyema seen at the University of 
Western Ontario between 1970 and 1980 
to determine the results of treatment and 
to identify factors associated with success 
or failure of therapy.
Patients
The charts of all patients with a diag­
nosis of thoracic empyema, seen in the 
three teaching hospitals of the University 
of Western Ontario between 1970 and 
1980, were reviewed. Only those with 
positive cultures of pleural fluid or frank 
pus in the pleural cavity were included.
There were 61 males and 29 females, 
ranging in age from 1 to 91 years (median 
53 years). Nine cases were identified at the 
time of autopsy, and these patients were 
included in the data on etiology and diag­
nosis. The results of treatment are 
reviewed in the remaining 81 patients.
Findings
Etiology
In 39 (43%) of the 90 patients, the 
empyema was acquired in the community; 
in the remaining 51, the condition either 
developed in hospital or resulted from 
previous medical therapy. The common 
causes of empyema included bronchopul­
monary infections (63%), complications 
of pulmonary surgery (14%), secondary 
infections of pleural effusions or 
hem othoraces due to pneumonias 
acquired in hospital or contamination 
from thoracentesis (13%), complications 
of esophageal surgery (4%) and secon­
dary spread of intra-abdominal infections 
(4%). Seven cases occurred after trauma 
from motor vehicle accidents.
Forty-eight patients (53%) had one or 
more risk factors associated with 
decreased host resistance to infection, 
including malnutrition, alcohol abuse, 
malignant disease, diabetes mellitus, 
severe liver or renal disease, or were 
receiving steroids or antineoplastic ther­
apy. Eight patients had respiratory dis­
ease and 24 had cardiovascular disease.
Diagnosis
Patients with empyema presented with 
cough (61 patients, 68%), shortness of 
breath (55 patients, 61%) and fever (54 
patients, 60%). Fatigue, weight loss and 
chest pain were also common complaints. 
The diagnosis was established by 
thoracentesis in 45 patients (50%), 
thoracostomy or thoracotomy in 36 
(40%) and at autopsy in 9 (10%).
The initial culture of the pleural fluid 
was positive in 81 patients (90%). In these 
patients, mixed bacterial infections (30 
patients, 37%) and anaerobic infections 
(26 patients, 32%) were common. The 
most frequent gram-positive aerobes 
included Staphylococcus sp, (3-hemolytic 
streptococci, pneumonococcus and Strep­
tococcus viridans. The most frequent 
gram-negative aerobes included Pseudo­
monas aeruginosa, Escherichia coli and 
Klebsiella pneumoniae. The common 
anaerobes were micrococcal strep­
tococcus, anaerobic streptococcus and 
Bacteroides fragilis.
Treatment
The 81 patients with empyema whose 
treatment was studied received an aver­
age of 2.2 different antibiotics during the 
course of treatment. In eight of the 
patients, the antibiotic therapy was 
suboptimal because of an inadequate 
dose, oral administration or failure to 
cover the bacteria that were cultured. 
Treatment with antibiotics and thora­
centesis resulted in four cures and one 
death — in a patient with alcoholic cir­
rhosis, who was critically ill at the time 
of presentation.
Seventy-two patients had a surgical 
drainage procedure, either a tube 
thoracostomy alone (50), or combined 
with a rib resection (22). When surgical 
drainage was used as the primary treat­
ment, 35 patients (49%) were cured and 
18 (25%) subsequently died. Of the 37 
patients with failed surgical drainage, 5 
were left with persistent chest-tube 
drainage, 14 underwent pulmonary decor­
tication, 4 thoracoplasty and 14 died 
without having another surgical proce­
dure (Fig. 1).
Surgical drainage failed in 61% of 
those with hospital-acquired infections 
(27 patients), in 65% with mixed infec­
tions (18 patients) and in 61% of those 
who were immunocompromised (28 pa­
tients). Of the 45 patients with hospital- 
acquired infections who were treated with 
surgical drainage, 17 (38%) died. Of 11 
patients with secondary infections of 
pleural effusions or hemothoraces due to 
pneumonias acquired in hospital or con­
tamination at the time of thoracentesis, 
8 (73%) died after surgical drainage.
Eighteen patients had decortication, 
which included removal of visceral pleura 
and radical debridement of the abscess 
cavity; 12 of them were cured but the 
procedure failed in 6, including 2 who 
died. Decortication was performed in 14 
patients who already had undergone sur­
gical drainage. In this group, which 
included the two who died, one was left 
with a persistently draining chest tube, 
three failed to improve but later under­
went successful thoracoplasty and the rest 
were cured. The three patients who failed 
to improve with decortication had paren­
chymal lung disease (previous left upper 
lobe resection, large lung abscess in a dis­
eased lobe separate from the empyema 
and restrictive lung disease from an old 
tuberculous infection).
Of the seven patients who underwent 
thoracoplasty, five were cured and there 
were two sudden unexplained deaths.
Overall, of the 81 patients whose treat­
ment for empyema was studied 19 died 
(23%).
Discussion
Surgical drainage was adopted as the 
standard initial therapy for the treatment 
of thoracic empyema on the basis of 
Evarts G raham ’s excellent results 
reported in 1915.1
Recent studies of patients with 
empyema have reported mortality rang­
ing from 25% to 30%.2‘6 The etiology of 
empyema has undergone considerable 
change since Graham’s time, and this may 
explain why his methods are less effective 
today. In the past, most patients with 
empyema were young and the infectious 
agent was usually (J-hemolytic strep­
tococcus or Staphylococcus sp. In con­
trast, over half of our patients were older 
than 40 years, many were immunocom­
promised and gram-negative anaerobic
1. Antibiotics only 5 -• 4 cured (80%)
1 died
2. Surgical drainage 72 -» 35 cured (49%)
failed 37 (51 %)
------------- ►  died 14
► chronic chest tube 5
<-»> cured 8
__ j—► thoracoplasty 3 (cured)
(—►chronic chest tube 1 
'—►died 2
► died 2
3. Decortication 4 -  cured 4 (100%)
FIG. 1—Treatment of thoracic empyema at 
University of Western Ontario, 1970 to 1980.
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infections were common. The overall 
mortality in patients treated for an 
empyema at our institution between 1970 
and 1980 was 23%.
What changes can be made to improve 
these results? Over half of our cases of 
empyema were due to iatrogenic infec­
tions, and these patients accounted for 
over 80% of the deaths in this series. 
These data emphasize the importance of 
standard measures that might prevent 
hospital-acquired empyema, including 
vigorous postoperative physiotherapy to 
reduce the incidence of pulmonary infec­
tion, appropriate antibiotic therapy for 
pneumonias and strict aseptic technique 
when performing diagnostic or therapeu­
tic thoracentesis.
In 10% of our cases, the empyema was 
not diagnosed until autopsy. Thus, acute 
awareness is needed to avoid missing the 
diagnosis and delaying treatment. Any 
patient with a fever and a pleural effu­
sion should be considered to have 
empyema until proven otherwise. 
Although a chest roentgenogram will 
usually localize the empyema, computer­
ized tomography or ultrasonography may 
help in difficult cases.
Adequate drainage of the pleural space 
is still the key element in the treatment of 
empyema; 49% of our patients were suc­
cessfully treated with a drainage proce­
dure alone. Patients who do not improve
quickly with chest-tube drainage may 
benefit from decortication. Recent 
reports have shown that decortication can 
be accomplished with a low morbidity 
and mortality, even in debilitated 
patients.7-9 This allows the surgeon to 
remove all the infected tissue and pus, it 
avoids the debilitating effects of 
prolonged drainage and improves pulmo­
nary function by removing the restrictive 
pulmonary peel.
Our data identified groups of patients 
with empyema who did not have a good 
response to drainage procedures. Patients 
with anaerobic infections, hospital- 
acquired infections, secondary infections 
of the pleural space and those with 
depressed immunity may benefit from 
early decortication.
In our review, 18 patients had a pul­
monary decortication (14 after surgical 
drainage) and this procedure was success­
ful in 12. Patients in whom decortication 
failed included two who died of ongoing 
sepsis, one who had persistent chest-tube 
drainage and three who subsequently 
underwent a thoracoplasty and were 
cured.
Thoracoplasty is an effective treatment 
for empyema in selected patients. Seven 
of our patients had a thoracoplasty: five 
were cured and two died. Three patients 
who failed to improve with decortication 
had parenchymal lung disease which may
have prevented the lung from re-expand- 
ing. These patients were cured with a sub­
sequent thoracoplasty. If patients with 
empyema and parenchymal lung disease 
do not respond to surgical drainage, 
thoracoplasty should be combined with 
decortication as the next procedure.
Thoracic empyema is still common and 
unfortunately often fatal. Prevention, 
early recognition and prompt, effective 
treatment may reduce the morbidity and 
mortality associated with this condition.
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Campylobacter and Endovascular Lesions
Because of the gaps in our knowledge of 
the epidemiology and pathogenesis of 
Campylobacter infections, particularly 
the propensity of Campylobacter fetus
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ssp fetus to infect vascular endothelium, 
the authors describe the case of a 
56-year-old woman with C. fetus ssp 
fetus infection of an aortic aneurysm.
She recovered after a one-stage surgical 
repair and antibiotic therapy with 
erythromycin.
The organism was cultured from sam­
ples of the stool and tissue obtained at 
operation. It was identified from its typi­
cal characteristics: morphology, 
microaerophilic, able to grow at 22°C 
and 37°C but not at 42°C, catalase and 
oxidase positive and resistant to nalidixic 
acid but susceptible to cephalothin.
Considerant les lacunes des connaissan- 
ces actuelles sur I'epidemiologie et la 
pathogen&se des infections a Campylo­
bacter, et particulierement sur I'affinite 
de Campylobacter fetus variete fetus 
pour I'endothelium vasculaire, les auteurs
d^crivent le cas d'une femme de 56 ans 
souffrant d'une infection a C. fetus 
variate fetus colonisant un anevrisme de 
I'aorte. La gugrison a suivi une repara­
tion chirurgicale en une etape accompa- 
gnee d'une antibiotherapie a 
I’erythromycine.
Le microorganisme a pu etre cultive 
des echantillons de selles et des tissus 
preleves a I'operation. II a ete identifie a 
ses caracteristiques typiques: morpholo- 
gie, microaerophile, capable de pousser a 
22°C comme a 37°C mais incapable b 
42°C, catalase et oxydase positif, resis­
tant a I'acide nalidixique mais sensible a 
la cephalothine.
Like Salmonella, Campylobacter fetus  ssp 
fetus has an apparent propensity to infect 
vascular endothelium, although proof 
with the latter is rare. This bacterium has
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been called by various names. According 
to Skerman and associates, 1 the genus 
Campylobacter contains three pathogenic 
species, C. jejuni, C. coli and C. fe tus , 
the last being divided into two subspecies, 
fetus and venerealis. The incidence of 
Campylobacter infection in endovascular 
lesions is unknown and unless appropri­
ate bacteriologic techniques are used, we 
will not be able to diagnose these infec­
tions. We describe such a case to illustrate 
the characteristic findings and appropri­
ate investigations, and to stimulate others 
to seek the diagnosis and thus fill in some 
of the gaps in our knowledge of Cam­
pylobacter syndromes.
Case Report
A 56-year-old woman gave a history of hav­
ing crampy abdominal pain associated with 
nausea and diarrhea without blood or mucus 
for 2 months. She was afebrile, her blood pres­
sure was 140/90 mm Hg and pulse rate 84 
beats/min. An abdominal aortic aneurysm was 
palpable. The hemoglobin value was 136 g/L  
and the leukocyte count was 12.1 x  lO^L 
with 80% neutrophils. Stool sent for culture 
was lost in transit.
She improved with nonspecific therapy. 
Nineteen days after admission she underwent 
elective resection of the aneurysm and tube- 
graft aortic reconstruction. Extensive inflam­
matory tissue was noted in the retroperi- 
toneum, adherent to the aorta. This tissue, and 
stool collected 4 days later, grew C. fetus ssp 
fetus. She received a course of erythromycin 
(500 mg orally four times daily for 7 days). 
Blood cultures drawn while on this therapy 
were sterile. She made a smooth recovery and 
was alive 3 years later, with no evidence of 
recurrence.
The organism was identified on the basis o f  
typical morphology (curved gram-negative 
bacilli) and motility, along with the following 
characteristics o f C. fetus ssp fetus: micro- 
aerophilic, able to grow at 22°C and 37°C but 
not at 42°C, oxidase and catalase positive, 
resistant to nalidixic acid and susceptible to 
cephalothin.
Discussion
Most cases of Campylobacter endovas­
cular infections are incompletely 
documented. In one patient with septice­
mia, endocarditis was proven, but organ­
isms could not be recovered at autopsy. 2 
Six patients had thrombophlebitis and 
Campylobacter septicemia;3'7 in at least 
three of these the isolate was clearly C. 
fe tus  ssp fe tu s .4'5-1 Examination of 
inflamed femoral veins from one patient 
at autopsy failed to reveal organisms. 3
In most reported Campylobacter infec­
tions of aneurysms, the role of the organ­
ism is uncertain. Loeb and associates8 
described a patient with a femoral artery 
aneurysm and Campylobacter septicemia. 
Three patients with C. fetus ssp fetus sep­
ticemia died of ruptured aortic 
aneurysms; 9' 11 cultures from two at 
autopsy were negative, but antibiotics had 
been given.
The present report and one by Marty 
and associates12 describe the only two 
patients with localized endovascular 
infections proven by culture. The other 
patient also had an infected abdominal 
aortic aneurysm; culture of arterial blood 
and aortic wall tissue grew C. fetus  ssp 
fetus. It is interesting that both patients 
were successfully treated with a one-stage 
surgical repair.
Campylobacter fetus  ssp fetus causes 
three distinct syndromes: localized infec­
tion (often accompanied by septicemia), 
cryptogenic septicemia (a benign entity) 
and relapsing septicemia (in immunocom­
promised patients) . 7 The association of 
the organism with vascular endothelial 
lesions is noteworthy.
Awareness of C. fetus  ssp fetus as a 
potential pathogen is essential since it may 
be missed by usual bacteriologic tech­
niques. Little is known about the epidemi­
ology and pathogenesis of this infection. 
Previous reports have used various sys­
tems of nomenclature and often the 
organism was not fully identified. It is 
vital to distinguish C. fetus ssp fetus from 
C. jejuni whenever Campylobacter is cul­
tured from any unusual infection in order 
that we may gain a clearer understand­
ing of the diseases caused by these 
organisms.
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Treatment of the Chronically Infected Median 
Sternotomy Wound With Muscle Flaps
While infection and dehiscence of the 
median sternotomy wound is a serious 
complication, debridement, sternal rewir­
ing and wound irrigation will often result 
in wound healing. However, if these 
measures fail, radical debridement of all 
infected tissue and immediate recon­
struction with muscle flaps is required 
and will give excellent results. The pec- 
toralis major muscle based on the 
thoracoacromial artery is most satisfac­
tory for this reconstruction. The rectus 
abdominis muscle, while also used, is 
not as effective because of variations in 
its proximal blood supply.
The author describes 10 patients with 
chronically infected median sternotomy 
wounds, seen at St. Michael's Hospital 
in Toronto, in whom use of these tech­
niques led to a rapid recovery with few 
complications.
L'infection et le lachage des sutures 
representent de serieuses complications 
de sternotomie mediane. Le debridement, 
la pose de nouvelles broches sternales et 
I'irrigation de la plaie entrainent generale- 
ment la guerison. Lorsque ces mesures 
echouent un debridement radical du tissu 
infecte et une reconstruction immediate 
avec des lambeaux musculaires sont 
requis et donnent d'excellents resultats. 
Le grand pectoral irrigue par I'artere 
acromio-thoracique est juge des plus 
satisfaisants pour cette reconstruction. 
Bien qu'il soit aussi utilise, le grand droit 
de I'abdomen est moins efficace a cause 
des variations de son apport sanguin 
proximal.
L'auteur decrit 10 patients vus au St- 
Michael's Hospital de Toronto alors qu'ils 
etaient porteurs d'infections chroniques
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de plaies de sternotomies medianes, et 
chez qui ces techniques ont entraine une 
guerison rapide avec de rares compli­
cations.
Dehiscence of the median sternotomy 
wound with chronic infection is a serious 
complication. Aggressive early debride­
ment of the wound followed by sternal 
rewiring and continuous wound 
irrigation1 is successful in 90% of early 
cases,2 but if this fails, the morbidity and 
mortality are high.3 Radical debridement 
of the sternum and adjacent cartilage is 
then necessary but results in an extensive 
bone and soft-tissue defect. In the past, 
these wounds were allowed to heal by 
secondary intention or were skin grafted. 
Recent reconstruction of the soft-tissue 
defect with muscle flaps, musculocutane­
ous flaps and omentum4-7 has lowered 
the morbidity and mortality. These flaps 
provide excellent vascularized tissue to fill 
the defect, obliterate dead space and pro­
tect the underlying structures.
Another group of patients who require 
this type of management are those with 
single or multiple sinus tracts. Frequently, 
they have been discharged from hospital 
with a healed sternal wound and initially 
present with evidence of infection several 
months after the operation. The approach 
to treatment in these cases should be 
aggressive because the infection tends to 
recur following surgical treatment.8 Ster­
nal resection followed by reconstruction 
is usually necessary.
We have used pectoralis major and 
rectus abdominis muscle flaps following 
radical debridement of the sternal wound. 
The purpose of this paper is to present the 
experience of our group at St. Michael’s 
Hospital in Toronto with these flaps and 
to describe the technical refinements we 
have made.
Patients
The charts of 10 consecutive patients 
with major sternal infections treated at St. 
Michael’s Hospital between June 1981 
and December 1983 were reviewed. Seven 
represented failure of standard manage­
ment of sternal dehiscence or wound 
infection that consisted of debridement, 
rewiring and wound irrigation . 
Osteomyelitis and mediastinitis developed 
in all patients and eight were critically ill 
as a result. Eight patients were treated 
within 2 months of their cardiac opera­
tions. Two patients had chronic 
osteomyelitis of the sternum; one was 
seen 1 year after and the second 3 years 
after the original procedure. The courses 
of these patients are summarized in Table 
I .
Surgical Techniques
All infected material including skin, 
sternum and costal cartilage is radically 
debrided. Frequently, the entire sternum 
and adjacent cartilage must be removed 
(Figs. 1 and 2), especially when secondary 
rewiring has been performed as in 9 of 
our 10 patients. In chronic osteomyelitis, 
multiple sinus tracts often involve car­
tilage, which must be excised back to the 
costochondral junction. In the vicinity of 
the costal arch care must be taken to 
preserve the internal mammary and 
superior epigastric vessels. The 
manubrium is debrided to healthy appear­
ing bone. Tissue overlying the heart is 
gently removed. Some granulation tissue 
and fibrinous exudate is often left in this 
area. After the wound is irrigated exten­
sively, the defect is closed with muscle 
flaps, using one or both pectoralis major 
muscles and often the rectus abdominis 
muscle.The pectoralis major muscle is dis­
sected as follows. Initially, it is freed from 
the overlying soft tissues. The origin of 
the sternal portion is completely detached 
if this has not already been done during 
the radical debridement. The origin of the 
clavicular head is preserved. The lateral 
border is freed from its soft-tissue attach­
ments. Occasionally, simple muscle 
advancement to the midline will provide 
adequate coverage of the defect as in two 
of our patients. If additional tissue is 
required, the insertion of the sternal head 
into the humerus is divided to mobilize 
the muscle further. A second incision in
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the region of the deltopectoral groove can 
be made but this can also be done through 
the central incision. The muscle is then 
rotated on its thoracoacromial vascular 
pedicle into the defect. Often only one 
muscle needs to be mobilized in this 
fashion but both may be necessary if a 
large defect is present or the muscles are 
small.
In one patient the muscle was not used 
in this fashion but was “ turned over” , 
preserving the internal mammary blood 
supply while dividing the thoracoacromial 
pedicle. We have found it more satisfac­
tory to divide the internal mammary ves­
sels as these may have been damaged dur­
ing the debridement.
Large defects involving the lower one 
third of the sternum may not be ade­
quately covered with the pectoralis major 
muscles alone. This area is very well 
covered by the rectus abdominis muscle 
based on the superior epigastric artery. 
The muscle is dissected by making a 
paramedian incision from the lower end 
of the sternal incision to the level of the 
umbilicus. The anterior sheath is incised. 
The muscle is carefully dissected from the 
sheath, care being taken to preserve the 
superior epigastric vessels. Once adequate 
length has been obtained, the muscle and 
inferior epigastric vessels are transected 
and the proximal vascular pedicle is dis­
sected as necessary to allow the muscle to 
rotate 180°, filling in the lower chest 
defect. The anterior sheath is then closed.
The mobilized pectoralis and rectus 
abdominis muscles are approximated in 
the midline (Figs. 3 and 4), completely 
covering the debrided area and filling in 
the soft-tissue defect. Numerous suction 
drains are inserted to help control fluid 
accumulation and obliterate dead space. 
One is placed beneath the muscle flaps, 
two beneath the skin and two laterally in 
each area of pectoralis detachment. The 
skin is then closed primarily. An elastic 
chest binder is applied over a well-padded 
dressing.
Suction drains are removed 1 week 
after operation. Antibiotics are given
intravenously for 1 week than orally for 
3 weeks, according to culture and sensi­
tivity findings. The patients wear the chest 
binder for 1 month after the operation.
Results
Most patients recovered rapidly and
FIG. 1—Infected sternal wound following 
debridement and wound irrigation.
were discharged from hospital 2 weeks 
after operation. Major complications 
were few. One patient suffered a pulmo­
nary embolism. One died early postoper- 
atively from refractory congestive heart 
failure and renal failure. Sternal infection 
recurred in one patient. This was thought 
to be a failure of reconstruction rather
FIG. 2—Defect following total sternectomy 
and removal of costal cartilage.
IIG. 3 Technique of muscle reconstruction using bilateral pectoralis and rectus abdominis 
muscles.
Table 1-Data on 10 Patients With
atient
no.
<
■
*
£
 
' 
CD
Sex Operation Organism
1 62 M CABG, MV Enterobacter aerogenes
2 66 F CABG Diphtheroids
3 71 M CABG _ _
4 29 M (Trauma) —
5 68 M CABG Enterobacter
6 57 M CABG Klebsiella sp
7 63 M CABG Staphylococcus epidermidis
8 66 M CABG S. epidermidis
9 65 M CABG Staphylococcus aureus
10 71 M CABG Diphtheroids
CABG -  coronary artery bypass grafting, MV -  mitral valve replacement.
Chronic Sternal Infections
Procedure
Bilateral pectoralis, bilateral rectus 
Bilateral pectoralis 
Bilateral pectoralis, right rectus 
Bilateral pectoralis, right rectus 
Bilateral pectoralis, left rectus 
Bilateral pectorallis, left rectus 
Bilateral pectoralis, right rectus 
Bilateral pectoralis, right rectus
Bilateral pectoralis, right rectus 
Bilateral pectoralis, right rectus
_________Outcome
Recurrence of infection 
Healed without complication 
Healed without complication 
Healed without complication 
Hematoma, healed 
Died 2 d postop 
Healed without complication 
Healed without complication, 
pulmonary embolism 
Healed without complication 
Healed without complication
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than inadequate debridement, as at re­
exploration 48 hours after his initial 
reconstructive procedure the rectus mus­
cle and one pectoralis muscle were found 
to be necrotic. The defect had been recon­
structed with the pectoralis turnover mus­
cle flaps, and although the rectus 
abdominis muscle had been used in the 
described fashion, the superior epigastric 
vessels could not be identified. This aspect 
will be discussed further.
Discussion
When debridement, rewiring and 
wound irrigation of the sternum fail to 
heal an infected median sternotomy 
wound or when chronic osteomyelitis has 
developed, complete debridement of all 
infected tissue followed by reconstruction 
is the treatment of choice. New recon­
structive techniques using well- 
vascularized soft tissue in the form of 
muscle have given us the means to carry 
this out. Healthy tissue with a new blood 
supply is brought into the contaminated 
field and this has resulted in decreased 
morbidity and mortality.4 It is important 
that the muscles used for this be reliable. 
Based on our laboratory and clinical 
experience, we have improved the use of 
the muscles normally used for the recon­
struction.
The blood supply to the pectoralis 
major muscle is from the intercostal per­
forators of the internal mammary, the 
lateral pectoral and the thoracoacromial 
vessels. The pectoralis major muscle, 
based on the thoracoacromial vessel, is 
reliable, but the turnover flap of this
FIG. 4—Healed sternal wound 2 weeks after 
reconstruction.
muscle, based on the internal mammary 
vessels, is less so for several reasons. The 
internal mammary vessels may have been 
divided at the previous surgery. If still 
intact, the perforators to the pectoralis 
major muscle have often been interrupted 
during the debridement. These factors 
account for the one treatment failure. 
Unfortunately, in this same patient the 
rectus abdominis muscle also failed 
because of an inadequate blood supply.
The blood supply to the rectus 
abdominis muscle is from the superior 
epigastric vessels (terminal branches of 
the internal mammary), intercostal arter­
ies and the inferior epigastric system. 
Anatomically, the superior epigastric ves­
sels vary as to their size and distri­
bution.9
We have verified this in our anatomi­
cal dissections. In addition, they may also 
be interrupted at the previous surgery. We 
therefore perform selective angiography 
of the internal mammary superior epigas­
tric vessels to verify their patency preoper- 
atively. Complete interruption of the 
internal mammary vessel on one side was 
identified preoperatively in two patients, 
so we used the normal side at surgery. 
Further, based on our clinical findings of 
bleeding at the end of the muscle, the 
supraumbilical portion is in our opinion 
the most reliable, especially when multi­
ple transverse fibrous bands are present 
in the muscle and the longitudinal vessels 
appear attenuated. With these modifica­
tions we have not had any further 
problems related to the rectus abdominis 
muscle flap.
Muscle has been used to cover many 
different contaminated wounds. Uncom­
plicated healing following removal of all 
infected material and primary reconstruc­
tion has become common.10 The benefit 
and reliability of muscle flaps in this sit­
uation has also been demonstrated 
experimentally.11
In most of these patients, the entire 
sternum was infected so that total 
removal was necessary, making sternal 
approximation impossible. Although 
some stabilization of the chest following 
removal of the sternum would be 
expected to be necessary, this has not been 
the case. After a short period of postoper­
ative ventilation, patients had few 
problems with respiratory function. It is 
likely that the soft tissues are fixed to the 
surrounding structures, preventing 
respiratory paradox. The use of foreign 
material or autogenous bone to improve 
chest contour is contraindicated.
Eight of our patients were gravely ill 
at the time of operation and often had 
serious associated diseases, such as 
chronic lung disease, congestive heart 
failure, diabetes mellitus and obesity, 
which increased their difficulties. We 
believed that debridement and reconstruc­
tion in one stage would be the best
approach and this was indeed the case. 
Convalescence was usually rapid. Care­
ful attention to nutritional status led to 
an early discharge.
We concluded that the sternal portion 
of the pectoralis major muscle, based on 
the thoracoacromial vessels, is reliable 
and may suffice for the reconstruction. 
Preservation of the clavicular portion 
retains some pectoralis function if divi­
sion of the insertion is required. The 
supraumbilical portion of the rectus 
abdominis muscle, based on the superior 
epigastric vessels, is useful for lower ster­
nal defects but the viability of its vascu­
lar pedicle must be verified as this can be 
compromised by previous surgery. When 
used in the described fashion, these mus­
cles will provide all the requirements for 
reconstruction, allowing primary repair 
of the chronic sternal wound when 
required and facilitating a rapid convales­
cence.
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Pierre Masson: His Influence on the Teaching 
of Pathology in Canada
Pierre Masson, William Boyd, Louis 
Berger and Lyman Duff: these four men 
were responsible for the development of 
pathology in Canada during the first half 
of this century. Their influence is still 
important and there must be few depart­
ments of pathology in this country that 
do not have one or more pathologists on 
their staff trained by one of these physi­
cians. They are truly the cornerstone of 
pathology in Canada. My paper concerns 
one of these men: Pierre Masson.
Masson was born on Nov. 12, 1880 in 
Dijon, France, in the middle of the rich 
vineyards of Gevrey-Chambertin. His 
family was one of prominent jurists and 
lawyers. After obtaining a licence in 
general chemistry and natural sciences 
from the science faculty of Dijon, Mas­
son moved to Paris and became chief of 
laboratory at Lariboisiere Hospital. In 
1909, he graduated from the Faculty of 
Medicine, University of Paris.
From 1909 to 1919, he worked at the 
Pasteur Institute in Paris in the labora­
tory of Amedee Borrel, a microbiologist. 
In 1911, he became chief of laboratory 
at La Salpetriere, being under the direc­
tion of Pierre Gosset, the chief of surgery. 
Pierre Masson was preparing his unique 
career in the field of pathology. Using his 
knowledge of the chemistry of dyes, he 
developed the personal techniques of 
staining that were to make him world 
renowned. On Aug. 5, 1911, he reported 
his first discovery: by adding saffron to 
hematoxylin and eosin as a third dye in
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the routine colorations, M asson’s 
trichrome stain was born.1
Masson always processed his own 
specimens, cutting and staining, dissect­
ing each cell under the microscope and 
making many new observations. In 1913, 
when he introduced his silver impregna­
tion method for melanin using Fontana’s 
solution, he discovered the argentaffin 
reaction.2 This led to the discovery of 
the argentaffinity of enterochromaffin 
cells: the argentaffin cells. In 1914, he 
described the carcinoid cells of the appen­
dix and the carcinoids. During the same 
year, too early for his era, he noted the 
existence of a diffuse endocrine gland sys­
tem in the intestine. This concept was 
extended to other regions 24 years later 
by the Austrian pathologist Feyrter and 
half a century later, in 1969, by the Brit­
ish histochemist Pearse, when he pro­
claimed the existence of the APUD cell 
system. The original presentation of this 
discovery was given at the Academy of 
Sciences in Paris on Jan. 5, 1914, under 
the title “ The intestinal endocrine gland 
in man” .3
In 1914, the first world war interrupted 
his work. He became an army physician, 
was captured by the enemy and sent to
FIG. 1—Pierre Masson (1880-1959).
Germany as a prisoner of war. After his 
release, he was assigned to the military 
hospital in Dijon and later to a military 
research unit near Reims. There, with 
Rene Leriche, he conducted studies on the 
natural history of scarring of war 
wounds.
Strasbourg Period
With the ending of the war in 1918, the 
provinces of Alsace and Lorraine were 
returned to France. From 1870 to 1918, 
the University of Strasbourg had been led 
by many illustrious German professors 
such as Chiari, Monckeberg, Lobstein 
and von Recklinghausen. The French 
government, when it repossessed the 
university, wanted to continue its excel­
lent academic reputation, albeit with a 
French touch. From all over France, the 
most promising physicians were chosen to 
fill the vacancies left by the departure of 
the Germans.
Masson’s reputation was so great that 
in spite of his lack of a formal academic 
title, he was named chairman of the 
Department of Pathology and chief of the 
Institute of Anatomy and Pathology of 
Strasbourg. He was then only 37 years 
old, by European standards very young 
for such an important post.
From 1919 to 1927, he published 38 
original works mainly on neuromas, car­
cinoids of the appendix, glomus tumours 
and neuronevi. In 1923, he published the 
first edition of his original work: 
“Tumeurs” — diagnostiques histolo- 
giques”.4 Masson’s reputation spread 
and from various parts of the world, 
gifted students came to learn directly 
from the master the basic principles of 
pathology and his personal staining and 
processing techniques. Among those who 
came to work with him were Orban from 
Brussels, Sotero del Rio from Santiago, 
Chile, Prodanoff who later became direc­
tor of the Institute of Pathology of Bul­
garia, Famagalli from Florence, Shtull 
from Prague and Nicaud from Lausanne.
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A few Canadian physicians went there to 
complete their training: Louis-Charles 
Simard who became director of the 
Cancer Institute of Montreal and J. 
Edouard Morin, member of the Royal 
Society of Canada and director of the 
D epartm ent of Pathology at St- 
Sacrement Hospital in Quebec. Masson’s 
reputation was such that Abraham Flex- 
ner from the Rockfeller Foundation 
visited the Institute of Anatomy and 
Pathology of Strasbourg and asked Mas­
son and five of his collaborators to visit 
the United States. France added its own 
recognition of his greatness; in 1923 he 
was created “ Chevalier” of the Legion of 
Honour.
Montreal Period
In 1926, the University of Montreal 
wanted to reorganize the teaching of 
pathology, which until then had been 
unstructured and was generously done by 
volunteer doctors. The chairmanship of 
the department was offered to Pierre 
Masson mainly through the influence of 
several former students, especially Louis- 
Charles Simard. Why did he accept when 
his institute in Strasbourg was doing so 
well? Was it a personal mission or were 
there any political motives? Masson said 
that he received an official mandate from 
the French government for 3 years to 
organize the teaching of pathology at the 
University of Montreal. Thus, at 48 years 
of age he became professor and chairman 
of the Department of Pathology at the 
University of Montreal. He insisted on 
being also consulting pathologist at 
Notre-Dame, Hotel-Dieu and Ste-Justine 
hospitals. Every morning he worked in 
each hospital. All the pathologists, resi­
dents and students were in direct contact 
with him daily. He recruited many faith­
ful collaborators such as Louis-Charles 
Simard, Joseph Luc Riopelle and others.
From 1927 on, Masson published 53 
papers and books. He continued his 
studies from Strasbourg, but also worked 
in new areas: on tumours of peripheral 
nerves, benign mesothelial tumours of 
serosal surfaces, cancers of the genital 
area of women and testicular tumours. 
Finally, he published what was to be his 
masterpiece and certainly his greatest con­
tribution to pathology: “Les tumeurs 
humaines, histologie, diagnostics et tech­
niques”.5 Dr. Sidney Kobernick, a 
graduate of McGill University, translated 
the book with Masson’s permission and 
it was published in English in 1970 by the 
Wayne State University Press.6
The quality of Masson’s work and 
teaching was recognized by many Cana­
dian universities. They awarded him a 
doctorate honoris causa at the University 
of Montreal in 1929, McGill University 
in 1940, Laval University in 1957 and 
the University of Ottawa in 1958.
Although it may be said that he did not 
m aster perfectly the language of 
Shakespeare, he corresponded with 
several leading Canadian and American 
pathologists: William Boyd, Lyman 
Duff, James Ewing, Georges Laidlaw and 
Arthur Purdy Stout. In 1948, he was 
invited by the New York Academy of 
Sciences to speak at a symposium on the 
biology of melanomas.
While Masson was the undisputed 
leader of the French pathologists in Mon­
treal, his influence also extended to the 
anglophone sector. With one of his great 
admirers, F.W. Wiglesworth, professor 
of pathology at McGill University and 
pathologist in chief to the Montreal Chil­
dren’s Hospital, he organized many scien­
tific exchanges with Ste-Justine Hospital. 
Later, one of Masson’s former students, 
Dr. Gilles Tremblay, became professor 
and director of the Department of Pathol­
ogy at the Royal Victoria Hospital.
Masson died on May 11, 1959, but his 
work has been continued by his students, 
all of them being admirers of a great 
pathologist.
His Legacy
Twenty-five years after his death, 
papers and biographies are still being pub­
lished to his memory in French and 
English medical journals as testimony to 
the importance of his work.7-11
To complete this testimony, I will quote 
MacDermot from his history of the first 
100 years of Canadian medicine.12
One of the most distinguished histo- 
pathologists of his time, Professor Masson has 
carried international fame with his work on 
tumours of the nervous system, along with 
many other contributions in pathology; his 
histopathological techniques, particularly his 
trichrome stain, are familiar in all pathologi­
cal laboratories.
I cannot omit that superb statement of 
Sidney Kobernick in his introduction of 
Masson’s traduction: “ Masson’s ap­
proach represents a lost art both in 
technique and observation.”
William Boyd, in 1956, speaking at 
Lyman Duff’s funeral, said: “ Canadians 
do not have the ‘giants’ in medicine.” 13 
Looking back 25 years after the death of 
Pierre Masson and acknowledging his 
enduring influence on pathology, I would 
argue with Boyd’s opinion. I have had the 
privilege to meet and work with Pierre 
Masson who was indeed a giant of 
medicine.
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himself as an administrator, clinician, 
teacher and researcher, Downs has been 
an active member and held offices in 
several medical societies and was a 
founder of the Canadian Society for Vas­
cular Surgery. Known for his expertise in 
vascular research, he also served as exter­
nal referee for the Medical Research 
Council and the Canadian Heart Foun­
dation projects.
In recognition of the contribution of 
Downs to the Department of Surgery, the 
department’s research committee estab­
lished the Allan R. Downs Lecture to be 
delivered annually during the surgical 
research symposium at the University of 
Manitoba.
Trauma in Hawaii in January: 
Surgical Society Beckons
While hundreds of surgeons suffer the 
trauma of another Canadian winter, some 
of their colleagues — members of the
Pan-Pacific Surgical Association — will 
be learning about how to manage the vic­
tims of trauma and, in their spare time, 
will be soaking up the sunshine or sight­
seeing in Hawaii.
The meeting, which is the 18th in a 
series of congresses, will be held Jan. 11 
to 17, 1986. It will feature plenary ses­
sions with trauma experts from the 
United States, Canada, Japan, Australia 
and Korea as well as smaller groups,
Chornell: Join us in Hawaii.
focusing on trauma from the point of 
view of obstetrics and gynecology, general 
surgery, thoracic and cardiovascular sur­
gery, plastic surgery, ophthalmology, 
orthopedic surgery, otolaryngology, urol­
ogy, and neurosurgery as well as 
anesthesiology.
The president of the Canadian chapter 
of the association, J. Gary Chornell, an 
ophthalmologist in Edmonton, is urging 
all Canadian surgeons to join the associ­
ation in time to attend the upcoming con­
gress. The association is committed to 
improving medical and surgical care in the 
Pacific basin countries and, to this pur­
pose, manages an endowment fund that 
is used for temporary placement of cer­
tificated surgeons in countries requesting 
assistance or for continuing education for 
surgeons from isolated developing coun­
tries in the basin. Currently, the associa­
tion numbers about 3000, mostly from 
the United States, and Chornell, who also 
is vice-president for Canada on the execu­
tive of the parent association and, at 42, 
is the youngest to have held the job, is 
hoping that at least 200 Canadians will 
find out what a contradiction in terms 
Hawaii and trauma are.
A my Ch o u in a rd
BOOKS RECEIVED cont’d
Septic Shock. Contemporary Issues in Infec­
tious Diseases. Vol. 4. Edited by Richard 
K. Root and Mele A. Sande. 281 pp. 
Churchill Livingstone, Edinburgh; Aca­
demic Press Canada, Don Mills, 1985. $61. 
ISBN 0-443-08397-5.
Silvergirl’s Surgery. Biliary Tract. Edited by 
James O. Robinson. 233 pp. Illust. Silver- 
girl, Inc., Austin, Tex., 1985. $55.(US) 
(clothbound); $19.(US) (paperbound). 
ISBN 9-941432-14-9.
Surgical Care II. Robert E. Condon and Jer­
ome De Cosse. 431 pp. Illust. Lea & 
Febiger, Philadelphia, 1985. $85.75. ISBN 
0-8121-0931-7.
Surgical Pathology of the Head and Neck (in
two volumes). Edited by Leon Barnes. 1866 
pp. Illust. Marcel Dekker, Inc., New York, 
1955. Price not stated. ISBN 0-8247-7216-4 
(vol. 1); ISBN 0-8247-7269-5 (vol. 2).
Taylor’s Principles and Practice of Medical 
Jurisprudence. 13th ed. Edited by A. Keith 
Mant. 415 pp. Illust. Churchill Livingstone, 
Edinburgh; Academic Press Canada, Don 
Mills, 1984. $85.75. ISBN 0-443-01481-7.
Le traitement de la recto-colite ulcero- 
hemorragique. Rapport presente au 86e 
congres frangais de chirurgie, Paris, 24 au 
27 Septembre 1984. Monographies de t’As- 
sociation frangaise de chirurgie. Ph. Ber- 
ard et R. Parc. 93 pp. Illust. Masson, Paris, 
1984. Prix non mentionne, broche. ISBN 
2-225-80365-X.
Tumors of the Kidney and Urinary Tract.
Color Atlas and Textbook. Steen Olsen. 
291 pp. Illust. Munksgaard International 
Publishers Ltd., Copenhagen, 1984. Price 
not stated. ISBN 87-16-09040-3.
SESAP IV Critique
ITEM 247
The densities and air fluid levels in the pleural space indicate that the patient 
has developed a significant empyema. Inflammatory reaction that has reached 
this stage of organization cannot be resolved by antibiotics alone. Multiple ad­
ditional chest tubes would probably be of little value. Instillation of enzymes 
via the chest tube is ineffective, and may contribute to recurrent or continuing 
air leak. Instillation of antibiotics into the chest tube would be of value only 
in the area served by the tube. If the chest tube is not functioning, antibiotics 
would not be distributed throughout the pleural cavity. This patient has several 
of the indications for operation. These criteria include multiple air fluid levels, 
failure of tube thoracostomy, and a protracted worsening febrile course. The 
patient is an ideal candidate for thoracotomy and evacuation of the preural 
cavity. Although not decortication in the strict sense, this term has often been 
used to describe the procedure. Recovery from the operation is rapid.
0
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